<?xml version="1.0"?>
<rdf:RDF xmlns="https://w3id.org/skgo/pham#"
     xml:base="https://w3id.org/skgo/pham"
     xmlns:dc="http://purl.org/dc/elements/1.1/"
     xmlns:ns="http://www.w3.org/2003/06/sw-vocab-status/ns#"
     xmlns:owl="http://www.w3.org/2002/07/owl#"
     xmlns:phm="https://w3id.org/SKGO/phm##"
     xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#"
     xmlns:wot="http://xmlns.com/wot/0.1/"
     xmlns:xml="http://www.w3.org/XML/1998/namespace"
     xmlns:xsd="http://www.w3.org/2001/XMLSchema#"
     xmlns:bibo="http://purl.org/ontology/bibo/"
     xmlns:foaf="http://xmlns.com/foaf/0.1/"
     xmlns:rdfs="http://www.w3.org/2000/01/rdf-schema#"
     xmlns:skos="http://www.w3.org/2004/02/skos/core#"
     xmlns:vann="http://purl.org/vocab/vann/"
     xmlns:terms="http://purl.org/dc/terms/"
     xmlns:terms1="http://ns.nature.com/terms/">
    <owl:Ontology rdf:about="https://w3id.org/skgo/pham">
        <owl:imports rdf:resource="http://ns.nature.com/terms/"/>
        <owl:imports rdf:resource="http://purl.org/ontology/bibo/"/>
        <owl:imports rdf:resource="http://xmlns.com/foaf/0.1/"/>
        <dc:creator rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Zeynep Say, Aysegul Say, Sahar Vahdati, Said Fathalla</dc:creator>
        <terms:license rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Creative Commons Attribution 3.0 (CC BY 3.0)</terms:license>
        <owl:versionInfo rdf:datatype="http://www.w3.org/2001/XMLSchema#string">2.0</owl:versionInfo>
        <skos:definition rdf:datatype="http://www.w3.org/2001/XMLSchema#string">PharmSci is an Ontology for describing Pharmaceutical Science research.
The aim of building ontology is to help Pharmaceutical Science researchers to find scientific research close to their work or their research topic. Ontology covers the study design for the pharmaceutical science research which is a Clinical Study includes experimental and non-experimental studies.</skos:definition>
    </owl:Ontology>
    


    <!-- 
    ///////////////////////////////////////////////////////////////////////////////////////
    //
    // Annotation properties
    //
    ///////////////////////////////////////////////////////////////////////////////////////
     -->

    


    <!-- http://purl.org/dc/elements/1.1/contributor -->

    <owl:AnnotationProperty rdf:about="http://purl.org/dc/elements/1.1/contributor"/>
    


    <!-- http://purl.org/dc/elements/1.1/coverage -->

    <owl:AnnotationProperty rdf:about="http://purl.org/dc/elements/1.1/coverage"/>
    


    <!-- http://purl.org/dc/elements/1.1/creator -->

    <owl:AnnotationProperty rdf:about="http://purl.org/dc/elements/1.1/creator"/>
    


    <!-- http://purl.org/dc/elements/1.1/format -->

    <owl:AnnotationProperty rdf:about="http://purl.org/dc/elements/1.1/format"/>
    


    <!-- http://purl.org/dc/elements/1.1/identifier -->

    <owl:AnnotationProperty rdf:about="http://purl.org/dc/elements/1.1/identifier"/>
    


    <!-- http://purl.org/dc/elements/1.1/language -->

    <owl:AnnotationProperty rdf:about="http://purl.org/dc/elements/1.1/language"/>
    


    <!-- http://purl.org/dc/elements/1.1/publisher -->

    <owl:AnnotationProperty rdf:about="http://purl.org/dc/elements/1.1/publisher"/>
    


    <!-- http://purl.org/dc/elements/1.1/relation -->

    <owl:AnnotationProperty rdf:about="http://purl.org/dc/elements/1.1/relation"/>
    


    <!-- http://purl.org/dc/elements/1.1/rights -->

    <owl:AnnotationProperty rdf:about="http://purl.org/dc/elements/1.1/rights"/>
    


    <!-- http://purl.org/dc/elements/1.1/source -->

    <owl:AnnotationProperty rdf:about="http://purl.org/dc/elements/1.1/source"/>
    


    <!-- http://purl.org/dc/elements/1.1/subject -->

    <owl:AnnotationProperty rdf:about="http://purl.org/dc/elements/1.1/subject"/>
    


    <!-- http://purl.org/dc/elements/1.1/type -->

    <owl:AnnotationProperty rdf:about="http://purl.org/dc/elements/1.1/type"/>
    


    <!-- http://purl.org/dc/terms/abstract -->

    <owl:AnnotationProperty rdf:about="http://purl.org/dc/terms/abstract">
        <rdfs:subPropertyOf rdf:resource="http://purl.org/dc/elements/1.1/description"/>
    </owl:AnnotationProperty>
    


    <!-- http://purl.org/dc/terms/accessRights -->

    <owl:AnnotationProperty rdf:about="http://purl.org/dc/terms/accessRights">
        <rdfs:subPropertyOf rdf:resource="http://purl.org/dc/elements/1.1/rights"/>
        <rdfs:range rdf:resource="http://purl.org/dc/terms/RightsStatement"/>
    </owl:AnnotationProperty>
    


    <!-- http://purl.org/dc/terms/alternative -->

    <owl:AnnotationProperty rdf:about="http://purl.org/dc/terms/alternative">
        <rdfs:subPropertyOf rdf:resource="http://purl.org/dc/elements/1.1/title"/>
        <rdfs:range rdf:resource="http://www.w3.org/2000/01/rdf-schema#Literal"/>
    </owl:AnnotationProperty>
    


    <!-- http://purl.org/dc/terms/available -->

    <owl:AnnotationProperty rdf:about="http://purl.org/dc/terms/available">
        <rdfs:subPropertyOf rdf:resource="http://purl.org/dc/elements/1.1/date"/>
        <rdfs:range rdf:resource="http://www.w3.org/2000/01/rdf-schema#Literal"/>
    </owl:AnnotationProperty>
    


    <!-- http://purl.org/dc/terms/bibliographicCitation -->

    <owl:AnnotationProperty rdf:about="http://purl.org/dc/terms/bibliographicCitation">
        <rdfs:subPropertyOf rdf:resource="http://purl.org/dc/elements/1.1/identifier"/>
        <rdfs:range rdf:resource="http://www.w3.org/2000/01/rdf-schema#Literal"/>
        <rdfs:domain rdf:resource="http://purl.org/dc/terms/BibliographicResource"/>
    </owl:AnnotationProperty>
    


    <!-- http://purl.org/dc/terms/conformsTo -->

    <owl:AnnotationProperty rdf:about="http://purl.org/dc/terms/conformsTo">
        <rdfs:subPropertyOf rdf:resource="http://purl.org/dc/elements/1.1/relation"/>
        <rdfs:range rdf:resource="http://purl.org/dc/terms/Standard"/>
    </owl:AnnotationProperty>
    


    <!-- http://purl.org/dc/terms/contributor -->

    <owl:AnnotationProperty rdf:about="http://purl.org/dc/terms/contributor">
        <rdfs:subPropertyOf rdf:resource="http://purl.org/dc/elements/1.1/contributor"/>
        <rdfs:range rdf:resource="http://purl.org/dc/terms/Agent"/>
    </owl:AnnotationProperty>
    


    <!-- http://purl.org/dc/terms/coverage -->

    <owl:AnnotationProperty rdf:about="http://purl.org/dc/terms/coverage">
        <rdfs:subPropertyOf rdf:resource="http://purl.org/dc/elements/1.1/coverage"/>
        <rdfs:range rdf:resource="http://purl.org/dc/terms/LocationPeriodOrJurisdiction"/>
    </owl:AnnotationProperty>
    


    <!-- http://purl.org/dc/terms/created -->

    <owl:AnnotationProperty rdf:about="http://purl.org/dc/terms/created">
        <rdfs:subPropertyOf rdf:resource="http://purl.org/dc/elements/1.1/date"/>
        <rdfs:range rdf:resource="http://www.w3.org/2000/01/rdf-schema#Literal"/>
    </owl:AnnotationProperty>
    


    <!-- http://purl.org/dc/terms/creator -->

    <rdf:Description rdf:about="http://purl.org/dc/terms/creator">
        <rdfs:subPropertyOf rdf:resource="http://purl.org/dc/elements/1.1/creator"/>
        <rdfs:range rdf:resource="http://purl.org/dc/terms/Agent"/>
        <rdfs:range rdf:resource="http://www.w3.org/2000/10/swap/pim/contact#Person"/>
    </rdf:Description>
    


    <!-- http://purl.org/dc/terms/date -->

    <owl:AnnotationProperty rdf:about="http://purl.org/dc/terms/date">
        <rdfs:subPropertyOf rdf:resource="http://purl.org/dc/elements/1.1/date"/>
        <rdfs:range rdf:resource="http://www.w3.org/2000/01/rdf-schema#Literal"/>
    </owl:AnnotationProperty>
    


    <!-- http://purl.org/dc/terms/dateAccepted -->

    <owl:AnnotationProperty rdf:about="http://purl.org/dc/terms/dateAccepted">
        <rdfs:subPropertyOf rdf:resource="http://purl.org/dc/elements/1.1/date"/>
        <rdfs:range rdf:resource="http://www.w3.org/2000/01/rdf-schema#Literal"/>
    </owl:AnnotationProperty>
    


    <!-- http://purl.org/dc/terms/dateCopyrighted -->

    <owl:AnnotationProperty rdf:about="http://purl.org/dc/terms/dateCopyrighted">
        <rdfs:subPropertyOf rdf:resource="http://purl.org/dc/elements/1.1/date"/>
        <rdfs:range rdf:resource="http://www.w3.org/2000/01/rdf-schema#Literal"/>
    </owl:AnnotationProperty>
    


    <!-- http://purl.org/dc/terms/dateSubmitted -->

    <owl:AnnotationProperty rdf:about="http://purl.org/dc/terms/dateSubmitted">
        <rdfs:subPropertyOf rdf:resource="http://purl.org/dc/elements/1.1/date"/>
        <rdfs:range rdf:resource="http://www.w3.org/2000/01/rdf-schema#Literal"/>
    </owl:AnnotationProperty>
    


    <!-- http://purl.org/dc/terms/description -->

    <rdf:Description rdf:about="http://purl.org/dc/terms/description">
        <rdfs:subPropertyOf rdf:resource="http://purl.org/dc/elements/1.1/description"/>
        <rdfs:range rdf:resource="http://www.w3.org/2001/XMLSchema#string"/>
        <rdfs:domain rdf:resource="https://w3id.org/ScienceOnto/phm#ResearchStatement"/>
    </rdf:Description>
    


    <!-- http://purl.org/dc/terms/extent -->

    <owl:AnnotationProperty rdf:about="http://purl.org/dc/terms/extent">
        <rdfs:subPropertyOf rdf:resource="http://purl.org/dc/elements/1.1/format"/>
        <rdfs:range rdf:resource="http://purl.org/dc/terms/SizeOrDuration"/>
    </owl:AnnotationProperty>
    


    <!-- http://purl.org/dc/terms/format -->

    <owl:AnnotationProperty rdf:about="http://purl.org/dc/terms/format">
        <rdfs:subPropertyOf rdf:resource="http://purl.org/dc/elements/1.1/format"/>
        <rdfs:range rdf:resource="http://purl.org/dc/terms/MediaTypeOrExtent"/>
    </owl:AnnotationProperty>
    


    <!-- http://purl.org/dc/terms/hasFormat -->

    <owl:AnnotationProperty rdf:about="http://purl.org/dc/terms/hasFormat">
        <rdfs:subPropertyOf rdf:resource="http://purl.org/dc/elements/1.1/relation"/>
    </owl:AnnotationProperty>
    


    <!-- http://purl.org/dc/terms/hasPart -->

    <owl:AnnotationProperty rdf:about="http://purl.org/dc/terms/hasPart">
        <rdfs:subPropertyOf rdf:resource="http://purl.org/dc/elements/1.1/relation"/>
    </owl:AnnotationProperty>
    


    <!-- http://purl.org/dc/terms/hasVersion -->

    <owl:AnnotationProperty rdf:about="http://purl.org/dc/terms/hasVersion">
        <rdfs:subPropertyOf rdf:resource="http://purl.org/dc/elements/1.1/relation"/>
    </owl:AnnotationProperty>
    


    <!-- http://purl.org/dc/terms/identifier -->

    <rdf:Description rdf:about="http://purl.org/dc/terms/identifier">
        <rdfs:subPropertyOf rdf:resource="http://purl.org/dc/elements/1.1/identifier"/>
        <rdfs:range rdf:resource="http://www.w3.org/2000/01/rdf-schema#Literal"/>
    </rdf:Description>
    


    <!-- http://purl.org/dc/terms/isFormatOf -->

    <owl:AnnotationProperty rdf:about="http://purl.org/dc/terms/isFormatOf">
        <rdfs:subPropertyOf rdf:resource="http://purl.org/dc/elements/1.1/relation"/>
    </owl:AnnotationProperty>
    


    <!-- http://purl.org/dc/terms/isPartOf -->

    <owl:AnnotationProperty rdf:about="http://purl.org/dc/terms/isPartOf">
        <rdfs:subPropertyOf rdf:resource="http://purl.org/dc/elements/1.1/relation"/>
    </owl:AnnotationProperty>
    


    <!-- http://purl.org/dc/terms/isReferencedBy -->

    <owl:AnnotationProperty rdf:about="http://purl.org/dc/terms/isReferencedBy">
        <rdfs:subPropertyOf rdf:resource="http://purl.org/dc/elements/1.1/relation"/>
    </owl:AnnotationProperty>
    


    <!-- http://purl.org/dc/terms/isReplacedBy -->

    <owl:AnnotationProperty rdf:about="http://purl.org/dc/terms/isReplacedBy">
        <rdfs:subPropertyOf rdf:resource="http://purl.org/dc/elements/1.1/relation"/>
    </owl:AnnotationProperty>
    


    <!-- http://purl.org/dc/terms/isRequiredBy -->

    <owl:AnnotationProperty rdf:about="http://purl.org/dc/terms/isRequiredBy">
        <rdfs:subPropertyOf rdf:resource="http://purl.org/dc/elements/1.1/relation"/>
    </owl:AnnotationProperty>
    


    <!-- http://purl.org/dc/terms/isVersionOf -->

    <owl:AnnotationProperty rdf:about="http://purl.org/dc/terms/isVersionOf">
        <rdfs:subPropertyOf rdf:resource="http://purl.org/dc/elements/1.1/relation"/>
    </owl:AnnotationProperty>
    


    <!-- http://purl.org/dc/terms/issued -->

    <owl:AnnotationProperty rdf:about="http://purl.org/dc/terms/issued">
        <rdfs:subPropertyOf rdf:resource="http://purl.org/dc/elements/1.1/date"/>
        <rdfs:range rdf:resource="http://www.w3.org/2000/01/rdf-schema#Literal"/>
    </owl:AnnotationProperty>
    


    <!-- http://purl.org/dc/terms/language -->

    <owl:AnnotationProperty rdf:about="http://purl.org/dc/terms/language">
        <rdfs:subPropertyOf rdf:resource="http://purl.org/dc/elements/1.1/language"/>
        <rdfs:range rdf:resource="http://purl.org/dc/terms/LinguisticSystem"/>
    </owl:AnnotationProperty>
    


    <!-- http://purl.org/dc/terms/license -->

    <owl:AnnotationProperty rdf:about="http://purl.org/dc/terms/license">
        <rdfs:subPropertyOf rdf:resource="http://purl.org/dc/elements/1.1/rights"/>
        <rdfs:range rdf:resource="http://purl.org/dc/terms/LicenseDocument"/>
    </owl:AnnotationProperty>
    


    <!-- http://purl.org/dc/terms/medium -->

    <owl:AnnotationProperty rdf:about="http://purl.org/dc/terms/medium">
        <rdfs:subPropertyOf rdf:resource="http://purl.org/dc/elements/1.1/format"/>
        <rdfs:range rdf:resource="http://purl.org/dc/terms/PhysicalMedium"/>
    </owl:AnnotationProperty>
    


    <!-- http://purl.org/dc/terms/modified -->

    <owl:AnnotationProperty rdf:about="http://purl.org/dc/terms/modified">
        <rdfs:subPropertyOf rdf:resource="http://purl.org/dc/elements/1.1/date"/>
        <rdfs:range rdf:resource="http://www.w3.org/2000/01/rdf-schema#Literal"/>
    </owl:AnnotationProperty>
    


    <!-- http://purl.org/dc/terms/publisher -->

    <owl:AnnotationProperty rdf:about="http://purl.org/dc/terms/publisher">
        <rdfs:subPropertyOf rdf:resource="http://purl.org/dc/elements/1.1/publisher"/>
        <rdfs:range rdf:resource="http://purl.org/dc/terms/Agent"/>
    </owl:AnnotationProperty>
    


    <!-- http://purl.org/dc/terms/references -->

    <owl:AnnotationProperty rdf:about="http://purl.org/dc/terms/references">
        <rdfs:subPropertyOf rdf:resource="http://purl.org/dc/elements/1.1/relation"/>
    </owl:AnnotationProperty>
    


    <!-- http://purl.org/dc/terms/relation -->

    <owl:AnnotationProperty rdf:about="http://purl.org/dc/terms/relation">
        <rdfs:subPropertyOf rdf:resource="http://purl.org/dc/elements/1.1/relation"/>
    </owl:AnnotationProperty>
    


    <!-- http://purl.org/dc/terms/replaces -->

    <owl:AnnotationProperty rdf:about="http://purl.org/dc/terms/replaces">
        <rdfs:subPropertyOf rdf:resource="http://purl.org/dc/elements/1.1/relation"/>
    </owl:AnnotationProperty>
    


    <!-- http://purl.org/dc/terms/requires -->

    <owl:AnnotationProperty rdf:about="http://purl.org/dc/terms/requires">
        <rdfs:subPropertyOf rdf:resource="http://purl.org/dc/elements/1.1/relation"/>
    </owl:AnnotationProperty>
    


    <!-- http://purl.org/dc/terms/rights -->

    <owl:AnnotationProperty rdf:about="http://purl.org/dc/terms/rights">
        <rdfs:subPropertyOf rdf:resource="http://purl.org/dc/elements/1.1/rights"/>
        <rdfs:range rdf:resource="http://purl.org/dc/terms/RightsStatement"/>
    </owl:AnnotationProperty>
    


    <!-- http://purl.org/dc/terms/source -->

    <owl:AnnotationProperty rdf:about="http://purl.org/dc/terms/source">
        <rdfs:subPropertyOf rdf:resource="http://purl.org/dc/elements/1.1/source"/>
    </owl:AnnotationProperty>
    


    <!-- http://purl.org/dc/terms/spatial -->

    <owl:AnnotationProperty rdf:about="http://purl.org/dc/terms/spatial">
        <rdfs:subPropertyOf rdf:resource="http://purl.org/dc/elements/1.1/coverage"/>
        <rdfs:range rdf:resource="http://purl.org/dc/terms/Location"/>
    </owl:AnnotationProperty>
    


    <!-- http://purl.org/dc/terms/subject -->

    <owl:AnnotationProperty rdf:about="http://purl.org/dc/terms/subject">
        <rdfs:subPropertyOf rdf:resource="http://purl.org/dc/elements/1.1/subject"/>
    </owl:AnnotationProperty>
    


    <!-- http://purl.org/dc/terms/tableOfContents -->

    <owl:AnnotationProperty rdf:about="http://purl.org/dc/terms/tableOfContents">
        <rdfs:subPropertyOf rdf:resource="http://purl.org/dc/elements/1.1/description"/>
    </owl:AnnotationProperty>
    


    <!-- http://purl.org/dc/terms/temporal -->

    <owl:AnnotationProperty rdf:about="http://purl.org/dc/terms/temporal">
        <rdfs:subPropertyOf rdf:resource="http://purl.org/dc/elements/1.1/coverage"/>
        <rdfs:range rdf:resource="http://purl.org/dc/terms/PeriodOfTime"/>
    </owl:AnnotationProperty>
    


    <!-- http://purl.org/dc/terms/title -->

    <rdf:Description rdf:about="http://purl.org/dc/terms/title">
        <rdfs:subPropertyOf rdf:resource="http://purl.org/dc/elements/1.1/title"/>
        <rdfs:range rdf:resource="http://www.w3.org/2000/01/rdf-schema#Literal"/>
    </rdf:Description>
    


    <!-- http://purl.org/dc/terms/type -->

    <owl:AnnotationProperty rdf:about="http://purl.org/dc/terms/type">
        <rdfs:subPropertyOf rdf:resource="http://purl.org/dc/elements/1.1/type"/>
        <rdfs:range rdf:resource="http://www.w3.org/2000/01/rdf-schema#Class"/>
    </owl:AnnotationProperty>
    


    <!-- http://purl.org/dc/terms/valid -->

    <owl:AnnotationProperty rdf:about="http://purl.org/dc/terms/valid">
        <rdfs:subPropertyOf rdf:resource="http://purl.org/dc/elements/1.1/date"/>
        <rdfs:range rdf:resource="http://www.w3.org/2000/01/rdf-schema#Literal"/>
    </owl:AnnotationProperty>
    


    <!-- 
    ///////////////////////////////////////////////////////////////////////////////////////
    //
    // Datatypes
    //
    ///////////////////////////////////////////////////////////////////////////////////////
     -->

    


    <!-- http://purl.org/dc/terms/Box -->

    <rdfs:Datatype rdf:about="http://purl.org/dc/terms/Box"/>
    


    <!-- http://purl.org/dc/terms/ISO3166 -->

    <rdfs:Datatype rdf:about="http://purl.org/dc/terms/ISO3166"/>
    


    <!-- http://purl.org/dc/terms/ISO639-2 -->

    <rdfs:Datatype rdf:about="http://purl.org/dc/terms/ISO639-2"/>
    


    <!-- http://purl.org/dc/terms/ISO639-3 -->

    <rdfs:Datatype rdf:about="http://purl.org/dc/terms/ISO639-3"/>
    


    <!-- http://purl.org/dc/terms/Period -->

    <rdfs:Datatype rdf:about="http://purl.org/dc/terms/Period"/>
    


    <!-- http://purl.org/dc/terms/Point -->

    <rdfs:Datatype rdf:about="http://purl.org/dc/terms/Point"/>
    


    <!-- http://purl.org/dc/terms/RFC1766 -->

    <rdfs:Datatype rdf:about="http://purl.org/dc/terms/RFC1766"/>
    


    <!-- http://purl.org/dc/terms/RFC3066 -->

    <rdfs:Datatype rdf:about="http://purl.org/dc/terms/RFC3066"/>
    


    <!-- http://purl.org/dc/terms/RFC4646 -->

    <rdfs:Datatype rdf:about="http://purl.org/dc/terms/RFC4646"/>
    


    <!-- http://purl.org/dc/terms/RFC5646 -->

    <rdfs:Datatype rdf:about="http://purl.org/dc/terms/RFC5646"/>
    


    <!-- http://purl.org/dc/terms/URI -->

    <rdfs:Datatype rdf:about="http://purl.org/dc/terms/URI"/>
    


    <!-- http://purl.org/dc/terms/W3CDTF -->

    <rdfs:Datatype rdf:about="http://purl.org/dc/terms/W3CDTF"/>
    


    <!-- http://www.w3.org/2001/XMLSchema#date -->

    <rdfs:Datatype rdf:about="http://www.w3.org/2001/XMLSchema#date"/>
    


    <!-- http://www.w3.org/2001/XMLSchema#gYear -->

    <rdfs:Datatype rdf:about="http://www.w3.org/2001/XMLSchema#gYear"/>
    


    <!-- 
    ///////////////////////////////////////////////////////////////////////////////////////
    //
    // Object Properties
    //
    ///////////////////////////////////////////////////////////////////////////////////////
     -->

    


    <!-- http://ns.nature.com/terms/relation -->

    <rdf:Description rdf:about="http://ns.nature.com/terms/relation">
        <rdfs:subPropertyOf rdf:resource="http://www.w3.org/2002/07/owl#topObjectProperty"/>
    </rdf:Description>
    


    <!-- http://purl.org/dc/terms/alternative -->

    <owl:ObjectProperty rdf:about="http://purl.org/dc/terms/alternative">
        <rdfs:subPropertyOf rdf:resource="http://purl.org/dc/terms/title"/>
    </owl:ObjectProperty>
    


    <!-- http://purl.org/dc/terms/coverage -->

    <owl:ObjectProperty rdf:about="http://purl.org/dc/terms/coverage"/>
    


    <!-- http://purl.org/dc/terms/creator -->

    <owl:ObjectProperty rdf:about="http://purl.org/dc/terms/creator">
        <rdfs:subPropertyOf rdf:resource="http://purl.org/dc/terms/contributor"/>
        <rdfs:domain rdf:resource="http://purl.org/ontology/bibo/Article"/>
    </owl:ObjectProperty>
    


    <!-- http://purl.org/dc/terms/hasPart -->

    <rdf:Description rdf:about="http://purl.org/dc/terms/hasPart">
        <rdfs:subPropertyOf rdf:resource="http://purl.org/dc/terms/relation"/>
    </rdf:Description>
    


    <!-- http://purl.org/dc/terms/isPartOf -->

    <rdf:Description rdf:about="http://purl.org/dc/terms/isPartOf">
        <rdfs:subPropertyOf rdf:resource="http://purl.org/dc/terms/relation"/>
    </rdf:Description>
    


    <!-- http://purl.org/dc/terms/isReferencedBy -->

    <rdf:Description rdf:about="http://purl.org/dc/terms/isReferencedBy">
        <rdfs:subPropertyOf rdf:resource="http://purl.org/dc/terms/relation"/>
    </rdf:Description>
    


    <!-- http://purl.org/dc/terms/isVersionOf -->

    <rdf:Description rdf:about="http://purl.org/dc/terms/isVersionOf">
        <rdfs:subPropertyOf rdf:resource="http://purl.org/dc/terms/relation"/>
    </rdf:Description>
    


    <!-- http://purl.org/dc/terms/publisher -->

    <rdf:Description rdf:about="http://purl.org/dc/terms/publisher">
        <rdfs:domain rdf:resource="http://ns.nature.com/terms/Publication"/>
    </rdf:Description>
    


    <!-- http://purl.org/dc/terms/references -->

    <rdf:Description rdf:about="http://purl.org/dc/terms/references">
        <rdfs:subPropertyOf rdf:resource="http://purl.org/dc/terms/relation"/>
    </rdf:Description>
    


    <!-- http://purl.org/dc/terms/title -->

    <rdf:Description rdf:about="http://purl.org/dc/terms/title">
        <rdfs:domain>
            <owl:Class>
                <owl:unionOf rdf:parseType="Collection">
                    <rdf:Description rdf:about="http://ns.nature.com/terms/Publication"/>
                    <rdf:Description rdf:about="http://purl.org/ontology/bibo/Article"/>
                </owl:unionOf>
            </owl:Class>
        </rdfs:domain>
    </rdf:Description>
    


    <!-- http://purl.org/dc/terms/type -->

    <owl:ObjectProperty rdf:about="http://purl.org/dc/terms/type"/>
    


    <!-- https://w3id.org/skgo/pham#addressesStudy -->

    <owl:ObjectProperty rdf:about="https://w3id.org/skgo/pham#addressesStudy">
        <rdfs:subPropertyOf rdf:resource="http://www.w3.org/2002/07/owl#topObjectProperty"/>
        <rdf:type rdf:resource="http://www.w3.org/2002/07/owl#AsymmetricProperty"/>
        <rdf:type rdf:resource="http://www.w3.org/2002/07/owl#IrreflexiveProperty"/>
        <rdfs:domain rdf:resource="http://ns.nature.com/terms/Publication"/>
        <rdfs:range rdf:resource="https://w3id.org/skgo/pham#ClinicalStudy"/>
        <dc:description xml:lang="en">To give attention to or deal with a research or study.</dc:description>
        <rdfs:label xml:lang="en">addressesStudy</rdfs:label>
    </owl:ObjectProperty>
    


    <!-- https://w3id.org/skgo/pham#examinedBy -->

    <owl:ObjectProperty rdf:about="https://w3id.org/skgo/pham#examinedBy">
        <rdfs:subPropertyOf rdf:resource="http://www.w3.org/2002/07/owl#topObjectProperty"/>
        <rdf:type rdf:resource="http://www.w3.org/2002/07/owl#AsymmetricProperty"/>
        <rdf:type rdf:resource="http://www.w3.org/2002/07/owl#ReflexiveProperty"/>
        <rdfs:domain>
            <owl:Class>
                <owl:unionOf rdf:parseType="Collection">
                    <rdf:Description rdf:about="https://w3id.org/skgo/pham#Hypothesis"/>
                    <rdf:Description rdf:about="https://w3id.org/skgo/pham#levels_of_mdr1_mRNA"/>
                </owl:unionOf>
            </owl:Class>
        </rdfs:domain>
        <rdfs:range rdf:resource="https://w3id.org/skgo/pham#Multidrug_resistance_to_cancer_cells"/>
        <dc:description xml:lang="en">To look at or consider a statement carefully and in detail in order to explore and discover.</dc:description>
        <rdfs:label xml:lang="en">examinedBy</rdfs:label>
    </owl:ObjectProperty>
    


    <!-- https://w3id.org/skgo/pham#hasBlotAnalysis -->

    <owl:ObjectProperty rdf:about="https://w3id.org/skgo/pham#hasBlotAnalysis">
        <rdfs:subPropertyOf rdf:resource="http://www.w3.org/2002/07/owl#topObjectProperty"/>
        <rdf:type rdf:resource="http://www.w3.org/2002/07/owl#AsymmetricProperty"/>
        <rdf:type rdf:resource="http://www.w3.org/2002/07/owl#IrreflexiveProperty"/>
        <rdfs:domain rdf:resource="https://w3id.org/skgo/pham#Multidrug_resistance_to_cancer_cells"/>
        <rdfs:range rdf:resource="https://w3id.org/skgo/pham#BlotAnalysis"/>
        <dc:description xml:lang="en">Experiment uses as a method for the transfer of protein, RNA or DNA molecules.</dc:description>
        <rdfs:label xml:lang="en">useBlotAnalysis</rdfs:label>
    </owl:ObjectProperty>
    


    <!-- https://w3id.org/skgo/pham#hasClinicalProblem -->

    <owl:ObjectProperty rdf:about="https://w3id.org/skgo/pham#hasClinicalProblem">
        <rdfs:subPropertyOf rdf:resource="http://www.w3.org/2002/07/owl#topObjectProperty"/>
        <rdf:type rdf:resource="http://www.w3.org/2002/07/owl#AsymmetricProperty"/>
        <rdf:type rdf:resource="http://www.w3.org/2002/07/owl#IrreflexiveProperty"/>
        <rdfs:domain rdf:resource="https://w3id.org/skgo/pham#Treatment"/>
        <rdfs:range rdf:resource="https://w3id.org/skgo/pham#ClinicalProblem"/>
        <dc:description xml:lang="en">Problem or a difficulty, disorder, condition occurs in Clinical Study.</dc:description>
        <rdfs:label xml:lang="en">hasClinicalProblem</rdfs:label>
    </owl:ObjectProperty>
    


    <!-- https://w3id.org/skgo/pham#hasDisease -->

    <owl:ObjectProperty rdf:about="https://w3id.org/skgo/pham#hasDisease">
        <rdfs:subPropertyOf rdf:resource="http://www.w3.org/2002/07/owl#topObjectProperty"/>
        <rdf:type rdf:resource="http://www.w3.org/2002/07/owl#AsymmetricProperty"/>
        <rdf:type rdf:resource="http://www.w3.org/2002/07/owl#IrreflexiveProperty"/>
        <rdfs:domain rdf:resource="https://w3id.org/skgo/pham#Patient"/>
        <rdfs:range rdf:resource="https://w3id.org/skgo/pham#Disease"/>
        <dc:description xml:lang="en">Person who shows a definite pathological process having a characteristic set of signs and symptoms.</dc:description>
        <rdfs:label xml:lang="en">hasDisease</rdfs:label>
    </owl:ObjectProperty>
    


    <!-- https://w3id.org/skgo/pham#hasExperiment -->

    <owl:ObjectProperty rdf:about="https://w3id.org/skgo/pham#hasExperiment">
        <rdfs:subPropertyOf rdf:resource="http://www.w3.org/2002/07/owl#topObjectProperty"/>
        <rdf:type rdf:resource="http://www.w3.org/2002/07/owl#AsymmetricProperty"/>
        <rdf:type rdf:resource="http://www.w3.org/2002/07/owl#IrreflexiveProperty"/>
        <rdfs:domain rdf:resource="https://w3id.org/skgo/pham#ClinicalStudy"/>
        <rdfs:range rdf:resource="https://w3id.org/skgo/pham#Multidrug_resistance_to_cancer_cells"/>
        <dc:description xml:lang="en">Study has a procedure done in order to discover or demonstrate some fact or general truth</dc:description>
        <rdfs:label xml:lang="en">hasExperiment</rdfs:label>
    </owl:ObjectProperty>
    


    <!-- https://w3id.org/skgo/pham#hasExperimentKit -->

    <owl:ObjectProperty rdf:about="https://w3id.org/skgo/pham#hasExperimentKit">
        <rdfs:subPropertyOf rdf:resource="http://www.w3.org/2002/07/owl#topObjectProperty"/>
        <rdf:type rdf:resource="http://www.w3.org/2002/07/owl#AsymmetricProperty"/>
        <rdf:type rdf:resource="http://www.w3.org/2002/07/owl#IrreflexiveProperty"/>
        <rdfs:domain rdf:resource="https://w3id.org/skgo/pham#Multidrug_resistance_to_cancer_cells"/>
        <rdfs:range rdf:resource="https://w3id.org/skgo/pham#ExperimentKit"/>
        <dc:description xml:lang="en">Identification of the kit/biologicals used in the experiment.</dc:description>
        <rdfs:label xml:lang="en">hasExperimentKit</rdfs:label>
    </owl:ObjectProperty>
    


    <!-- https://w3id.org/skgo/pham#hasExperimentMaterial -->

    <owl:ObjectProperty rdf:about="https://w3id.org/skgo/pham#hasExperimentMaterial">
        <rdfs:subPropertyOf rdf:resource="http://www.w3.org/2002/07/owl#topObjectProperty"/>
        <rdf:type rdf:resource="http://www.w3.org/2002/07/owl#AsymmetricProperty"/>
        <rdf:type rdf:resource="http://www.w3.org/2002/07/owl#IrreflexiveProperty"/>
        <rdfs:domain rdf:resource="https://w3id.org/skgo/pham#Multidrug_resistance_to_cancer_cells"/>
        <rdfs:range rdf:resource="https://w3id.org/skgo/pham#ExperimentMaterial"/>
        <dc:description xml:lang="en">Experiment has materials are culture collections and chemicals used for executing of an experiment.</dc:description>
        <rdfs:label xml:lang="en">hasExperimentMaterial</rdfs:label>
    </owl:ObjectProperty>
    


    <!-- https://w3id.org/skgo/pham#hasExperimentMethod -->

    <owl:ObjectProperty rdf:about="https://w3id.org/skgo/pham#hasExperimentMethod">
        <rdfs:subPropertyOf rdf:resource="http://www.w3.org/2002/07/owl#topObjectProperty"/>
        <rdf:type rdf:resource="http://www.w3.org/2002/07/owl#AsymmetricProperty"/>
        <rdf:type rdf:resource="http://www.w3.org/2002/07/owl#IrreflexiveProperty"/>
        <rdfs:domain rdf:resource="https://w3id.org/skgo/pham#Multidrug_resistance_to_cancer_cells"/>
        <rdfs:range rdf:resource="https://w3id.org/skgo/pham#Antibody-mediated_cytolysis_experiment"/>
        <dc:description xml:lang="en">An experiment has method is a way to solve a scientific task by executing a scientific experiment.</dc:description>
        <rdfs:label xml:lang="en">hasExperimentMethod</rdfs:label>
    </owl:ObjectProperty>
    


    <!-- https://w3id.org/skgo/pham#hasExperimentalSetting -->

    <owl:ObjectProperty rdf:about="https://w3id.org/skgo/pham#hasExperimentalSetting">
        <rdfs:subPropertyOf rdf:resource="http://www.w3.org/2002/07/owl#topObjectProperty"/>
        <rdf:type rdf:resource="http://www.w3.org/2002/07/owl#AsymmetricProperty"/>
        <rdf:type rdf:resource="http://www.w3.org/2002/07/owl#IrreflexiveProperty"/>
        <rdfs:domain rdf:resource="https://w3id.org/skgo/pham#Multidrug_resistance_to_cancer_cells"/>
        <rdfs:range rdf:resource="https://w3id.org/skgo/pham#ExperimentSetting"/>
        <dc:description xml:lang="en">Experiment identifies the designed experiment involves the investigator assigning some or all conditions to subjects.</dc:description>
        <rdfs:label xml:lang="en">hasExperimentSetting</rdfs:label>
    </owl:ObjectProperty>
    


    <!-- https://w3id.org/skgo/pham#hasHypothesis -->

    <owl:ObjectProperty rdf:about="https://w3id.org/skgo/pham#hasHypothesis">
        <rdfs:subPropertyOf rdf:resource="http://www.w3.org/2002/07/owl#topObjectProperty"/>
        <rdf:type rdf:resource="http://www.w3.org/2002/07/owl#AsymmetricProperty"/>
        <rdf:type rdf:resource="http://www.w3.org/2002/07/owl#IrreflexiveProperty"/>
        <rdfs:domain rdf:resource="https://w3id.org/skgo/pham#ClinicalStudy"/>
        <rdfs:range rdf:resource="https://w3id.org/skgo/pham#levels_of_mdr1_mRNA"/>
        <dc:description xml:lang="en">Referencing a claim, focus, goal or hypothes is supported by the study findings and examined by the study experiment.</dc:description>
        <rdfs:label xml:lang="en">hasResearchStatement</rdfs:label>
    </owl:ObjectProperty>
    


    <!-- https://w3id.org/skgo/pham#hasInvestigation -->

    <owl:ObjectProperty rdf:about="https://w3id.org/skgo/pham#hasInvestigation">
        <rdfs:subPropertyOf rdf:resource="http://www.w3.org/2002/07/owl#topObjectProperty"/>
        <rdf:type rdf:resource="http://www.w3.org/2002/07/owl#AsymmetricProperty"/>
        <rdf:type rdf:resource="http://www.w3.org/2002/07/owl#IrreflexiveProperty"/>
        <rdfs:domain rdf:resource="https://w3id.org/skgo/pham#ClinicalStudy"/>
        <rdfs:range rdf:resource="https://w3id.org/skgo/pham#Investigation"/>
        <dc:description xml:lang="en">Study which acts or processes of examining.</dc:description>
        <rdfs:label xml:lang="en">hasInvestigation</rdfs:label>
    </owl:ObjectProperty>
    


    <!-- https://w3id.org/skgo/pham#hasProtein -->

    <owl:ObjectProperty rdf:about="https://w3id.org/skgo/pham#hasProtein">
        <rdfs:subPropertyOf rdf:resource="http://www.w3.org/2002/07/owl#topObjectProperty"/>
        <rdf:type rdf:resource="http://www.w3.org/2002/07/owl#AsymmetricProperty"/>
        <rdf:type rdf:resource="http://www.w3.org/2002/07/owl#IrreflexiveProperty"/>
        <rdfs:domain rdf:resource="https://w3id.org/skgo/pham#Cell"/>
        <rdfs:range rdf:resource="https://w3id.org/skgo/pham#Gene"/>
        <dc:description xml:lang="en">Referencing any of a group of complex organic macromolecules .</dc:description>
        <rdfs:label xml:lang="en">hasProtein</rdfs:label>
    </owl:ObjectProperty>
    


    <!-- https://w3id.org/skgo/pham#hasStudyDesign -->

    <owl:ObjectProperty rdf:about="https://w3id.org/skgo/pham#hasStudyDesign">
        <rdfs:subPropertyOf rdf:resource="http://www.w3.org/2002/07/owl#topObjectProperty"/>
        <rdf:type rdf:resource="http://www.w3.org/2002/07/owl#AsymmetricProperty"/>
        <rdf:type rdf:resource="http://www.w3.org/2002/07/owl#IrreflexiveProperty"/>
        <rdfs:domain rdf:resource="https://w3id.org/skgo/pham#ClinicalStudy"/>
        <rdfs:range rdf:resource="https://w3id.org/skgo/pham#StudyDesign"/>
        <dc:description xml:lang="en">Clinical Study defines the study design for the trials and experiments, as well as observational studies in medical, clinical and other types of research involving human beings.</dc:description>
        <rdfs:label xml:lang="en">hasStudyDesign</rdfs:label>
    </owl:ObjectProperty>
    


    <!-- https://w3id.org/skgo/pham#hasTreatment -->

    <owl:ObjectProperty rdf:about="https://w3id.org/skgo/pham#hasTreatment">
        <rdfs:subPropertyOf rdf:resource="http://www.w3.org/2002/07/owl#topObjectProperty"/>
        <rdf:type rdf:resource="http://www.w3.org/2002/07/owl#AsymmetricProperty"/>
        <rdf:type rdf:resource="http://www.w3.org/2002/07/owl#IrreflexiveProperty"/>
        <rdfs:domain>
            <owl:Class>
                <owl:unionOf rdf:parseType="Collection">
                    <rdf:Description rdf:about="https://w3id.org/skgo/pham#Antibody-mediated_cytolysis_experiment"/>
                    <rdf:Description rdf:about="https://w3id.org/skgo/pham#Multidrug_resistance_to_cancer_cells"/>
                </owl:unionOf>
            </owl:Class>
        </rdfs:domain>
        <rdfs:range rdf:resource="https://w3id.org/skgo/pham#Treatment"/>
        <dc:description xml:lang="en">Defining a period in a clinical study during which subjects receive therapeutic treatment.</dc:description>
        <rdfs:label xml:lang="en">useTreatment</rdfs:label>
    </owl:ObjectProperty>
    


    <!-- https://w3id.org/skgo/pham#has_Treatment -->

    <owl:ObjectProperty rdf:about="https://w3id.org/skgo/pham#has_Treatment">
        <rdfs:subPropertyOf rdf:resource="http://www.w3.org/2002/07/owl#topObjectProperty"/>
        <rdf:type rdf:resource="http://www.w3.org/2002/07/owl#AsymmetricProperty"/>
        <rdf:type rdf:resource="http://www.w3.org/2002/07/owl#IrreflexiveProperty"/>
        <rdfs:domain rdf:resource="https://w3id.org/skgo/pham#Disease"/>
        <rdfs:range rdf:resource="https://w3id.org/skgo/pham#Treatment"/>
        <dc:description xml:lang="en">Disease that has a therapeutic treatment.</dc:description>
        <rdfs:label xml:lang="en">hasTreatment</rdfs:label>
    </owl:ObjectProperty>
    


    <!-- https://w3id.org/skgo/pham#investigate -->

    <owl:ObjectProperty rdf:about="https://w3id.org/skgo/pham#investigate">
        <rdfs:subPropertyOf rdf:resource="http://www.w3.org/2002/07/owl#topObjectProperty"/>
        <rdf:type rdf:resource="http://www.w3.org/2002/07/owl#AsymmetricProperty"/>
        <rdf:type rdf:resource="http://www.w3.org/2002/07/owl#ReflexiveProperty"/>
        <rdfs:domain rdf:resource="https://w3id.org/skgo/pham#ClinicalStudy"/>
        <rdfs:range rdf:resource="https://w3id.org/skgo/pham#Disease"/>
        <dc:description xml:lang="en">To observe or inquire into in detail; examine systematically.</dc:description>
        <rdfs:label xml:lang="en">investigate</rdfs:label>
    </owl:ObjectProperty>
    


    <!-- https://w3id.org/skgo/pham#investigatesProblem -->

    <owl:ObjectProperty rdf:about="https://w3id.org/skgo/pham#investigatesProblem">
        <rdfs:subPropertyOf rdf:resource="http://www.w3.org/2002/07/owl#topObjectProperty"/>
        <rdf:type rdf:resource="http://www.w3.org/2002/07/owl#AsymmetricProperty"/>
        <rdf:type rdf:resource="http://www.w3.org/2002/07/owl#IrreflexiveProperty"/>
        <rdfs:domain rdf:resource="https://w3id.org/skgo/pham#ClinicalStudy"/>
        <rdfs:range rdf:resource="https://w3id.org/skgo/pham#ClinicalProblem"/>
        <dc:description xml:lang="en">To examine an issue, problem, statement of research or study.</dc:description>
        <rdfs:label xml:lang="en">investigatesProblem</rdfs:label>
    </owl:ObjectProperty>
    


    <!-- https://w3id.org/skgo/pham#isClinicalTrial -->

    <owl:ObjectProperty rdf:about="https://w3id.org/skgo/pham#isClinicalTrial">
        <rdfs:subPropertyOf rdf:resource="http://www.w3.org/2002/07/owl#topObjectProperty"/>
        <rdf:type rdf:resource="http://www.w3.org/2002/07/owl#SymmetricProperty"/>
        <rdf:type rdf:resource="http://www.w3.org/2002/07/owl#ReflexiveProperty"/>
        <rdfs:domain rdf:resource="https://w3id.org/skgo/pham#Patient"/>
        <rdfs:range rdf:resource="https://w3id.org/skgo/pham#ClinicalTrial"/>
        <dc:description xml:lang="en">Patients are chosen as Clinical Trial for Clinical Study.</dc:description>
        <rdfs:label xml:lang="en">isClinicalTrial</rdfs:label>
        <skos:definition xml:lang="en">Patients are chosen as Clinical Trial for Clinical Study.</skos:definition>
    </owl:ObjectProperty>
    


    <!-- https://w3id.org/skgo/pham#obtainedfrom -->

    <owl:ObjectProperty rdf:about="https://w3id.org/skgo/pham#obtainedfrom">
        <rdf:type rdf:resource="http://www.w3.org/2002/07/owl#AsymmetricProperty"/>
        <rdf:type rdf:resource="http://www.w3.org/2002/07/owl#IrreflexiveProperty"/>
        <rdfs:domain>
            <owl:Class>
                <owl:unionOf rdf:parseType="Collection">
                    <rdf:Description rdf:about="https://w3id.org/skgo/pham#ExperimentKit"/>
                    <rdf:Description rdf:about="https://w3id.org/skgo/pham#ExperimentMaterial"/>
                </owl:unionOf>
            </owl:Class>
        </rdfs:domain>
        <rdfs:range rdf:resource="http://xmlns.com/foaf/0.1/Organization"/>
        <dc:description xml:lang="en">Get, acquire, or secure something.</dc:description>
        <rdfs:label xml:lang="en">obtainedfrom</rdfs:label>
    </owl:ObjectProperty>
    


    <!-- https://w3id.org/skgo/pham#obtainedfromPatient -->

    <owl:ObjectProperty rdf:about="https://w3id.org/skgo/pham#obtainedfromPatient">
        <rdfs:subPropertyOf rdf:resource="http://www.w3.org/2002/07/owl#topObjectProperty"/>
        <rdf:type rdf:resource="http://www.w3.org/2002/07/owl#AsymmetricProperty"/>
        <rdf:type rdf:resource="http://www.w3.org/2002/07/owl#IrreflexiveProperty"/>
        <rdfs:domain rdf:resource="https://w3id.org/skgo/pham#Specimen"/>
        <rdfs:range rdf:resource="https://w3id.org/skgo/pham#Patient"/>
        <dc:description xml:lang="en">Get, acquire, or secure specimen from patient.</dc:description>
        <rdfs:label xml:lang="en">obtainedfromPatient</rdfs:label>
    </owl:ObjectProperty>
    


    <!-- https://w3id.org/skgo/pham#performsExperiment -->

    <owl:ObjectProperty rdf:about="https://w3id.org/skgo/pham#performsExperiment">
        <rdfs:subPropertyOf rdf:resource="http://www.w3.org/2002/07/owl#topObjectProperty"/>
        <rdf:type rdf:resource="http://www.w3.org/2002/07/owl#AsymmetricProperty"/>
        <rdf:type rdf:resource="http://www.w3.org/2002/07/owl#IrreflexiveProperty"/>
        <rdfs:domain rdf:resource="https://w3id.org/skgo/pham#ClinicalStudy"/>
        <rdfs:range rdf:resource="https://w3id.org/skgo/pham#Multidrug_resistance_to_cancer_cells"/>
        <dc:description xml:lang="en">Clinical Study performs particular Experiment.</dc:description>
        <rdfs:label xml:lang="en">performsExperiment</rdfs:label>
    </owl:ObjectProperty>
    


    <!-- https://w3id.org/skgo/pham#refersExperiment -->

    <owl:ObjectProperty rdf:about="https://w3id.org/skgo/pham#refersExperiment">
        <rdfs:subPropertyOf rdf:resource="http://www.w3.org/2002/07/owl#topObjectProperty"/>
        <rdf:type rdf:resource="http://www.w3.org/2002/07/owl#AsymmetricProperty"/>
        <rdf:type rdf:resource="http://www.w3.org/2002/07/owl#IrreflexiveProperty"/>
        <rdfs:domain rdf:resource="https://w3id.org/skgo/pham#Investigation"/>
        <rdfs:range rdf:resource="https://w3id.org/skgo/pham#Multidrug_resistance_to_cancer_cells"/>
        <dc:description xml:lang="en">To relate investigation to a particular Experiment.</dc:description>
        <rdfs:label xml:lang="en">refersExperiment</rdfs:label>
    </owl:ObjectProperty>
    


    <!-- https://w3id.org/skgo/pham#resistantTo -->

    <owl:ObjectProperty rdf:about="https://w3id.org/skgo/pham#resistantTo">
        <rdfs:subPropertyOf rdf:resource="http://www.w3.org/2002/07/owl#topObjectProperty"/>
        <rdf:type rdf:resource="http://www.w3.org/2002/07/owl#AsymmetricProperty"/>
        <rdf:type rdf:resource="http://www.w3.org/2002/07/owl#IrreflexiveProperty"/>
        <rdfs:domain rdf:resource="https://w3id.org/skgo/pham#Cell"/>
        <rdfs:range rdf:resource="https://w3id.org/skgo/pham#Drug"/>
        <dc:description xml:lang="en">Cell definitions resistant to drugs.</dc:description>
        <rdfs:label xml:lang="en">resistantTo</rdfs:label>
    </owl:ObjectProperty>
    


    <!-- https://w3id.org/skgo/pham#testOn -->

    <owl:ObjectProperty rdf:about="https://w3id.org/skgo/pham#testOn">
        <rdfs:subPropertyOf rdf:resource="http://www.w3.org/2002/07/owl#topObjectProperty"/>
        <rdf:type rdf:resource="http://www.w3.org/2002/07/owl#AsymmetricProperty"/>
        <rdf:type rdf:resource="http://www.w3.org/2002/07/owl#IrreflexiveProperty"/>
        <rdfs:domain rdf:resource="https://w3id.org/skgo/pham#Drug"/>
        <rdfs:range rdf:resource="https://w3id.org/skgo/pham#ClinicalTrial"/>
        <dc:description xml:lang="en">To prove; to try a substance; to determine the chemical nature of a substance on Patient.</dc:description>
        <rdfs:label xml:lang="en">testOn</rdfs:label>
    </owl:ObjectProperty>
    


    <!-- https://w3id.org/skgo/pham#useAssay -->

    <owl:ObjectProperty rdf:about="https://w3id.org/skgo/pham#useAssay">
        <rdfs:subPropertyOf rdf:resource="http://www.w3.org/2002/07/owl#topObjectProperty"/>
        <rdf:type rdf:resource="http://www.w3.org/2002/07/owl#AsymmetricProperty"/>
        <rdf:type rdf:resource="http://www.w3.org/2002/07/owl#IrreflexiveProperty"/>
        <rdfs:domain rdf:resource="https://w3id.org/skgo/pham#Multidrug_resistance_to_cancer_cells"/>
        <rdfs:range rdf:resource="https://w3id.org/skgo/pham#Assay"/>
        <dc:description xml:lang="en">Method referencing a assay to carry out experiments for the purpose of testing the effect of a perturbing agent in a biological model system.</dc:description>
        <rdfs:label xml:lang="en">useAssay</rdfs:label>
    </owl:ObjectProperty>
    


    <!-- https://w3id.org/skgo/pham#useCellLine -->

    <owl:ObjectProperty rdf:about="https://w3id.org/skgo/pham#useCellLine">
        <rdfs:subPropertyOf rdf:resource="http://www.w3.org/2002/07/owl#topObjectProperty"/>
        <rdf:type rdf:resource="http://www.w3.org/2002/07/owl#AsymmetricProperty"/>
        <rdf:type rdf:resource="http://www.w3.org/2002/07/owl#IrreflexiveProperty"/>
        <rdfs:domain>
            <owl:Class>
                <owl:unionOf rdf:parseType="Collection">
                    <rdf:Description rdf:about="https://w3id.org/skgo/pham#ExperimentMaterial"/>
                    <rdf:Description rdf:about="https://w3id.org/skgo/pham#Multidrug_resistance_to_cancer_cells"/>
                </owl:unionOf>
            </owl:Class>
        </rdfs:domain>
        <rdfs:range rdf:resource="https://w3id.org/skgo/pham#CellLine"/>
    </owl:ObjectProperty>
    


    <!-- https://w3id.org/skgo/pham#useDrug -->

    <owl:ObjectProperty rdf:about="https://w3id.org/skgo/pham#useDrug">
        <rdfs:subPropertyOf rdf:resource="http://www.w3.org/2002/07/owl#topObjectProperty"/>
        <rdf:type rdf:resource="http://www.w3.org/2002/07/owl#AsymmetricProperty"/>
        <rdf:type rdf:resource="http://www.w3.org/2002/07/owl#IrreflexiveProperty"/>
        <rdfs:domain>
            <owl:Class>
                <owl:unionOf rdf:parseType="Collection">
                    <rdf:Description rdf:about="https://w3id.org/skgo/pham#ExperimentMaterial"/>
                    <rdf:Description rdf:about="https://w3id.org/skgo/pham#Multidrug_resistance_to_cancer_cells"/>
                    <rdf:Description rdf:about="https://w3id.org/skgo/pham#Treatment"/>
                </owl:unionOf>
            </owl:Class>
        </rdfs:domain>
        <rdfs:range rdf:resource="https://w3id.org/skgo/pham#Drug"/>
    </owl:ObjectProperty>
    


    <!-- https://w3id.org/skgo/pham#useGene -->

    <owl:ObjectProperty rdf:about="https://w3id.org/skgo/pham#useGene">
        <rdfs:subPropertyOf rdf:resource="http://www.w3.org/2002/07/owl#topObjectProperty"/>
        <rdf:type rdf:resource="http://www.w3.org/2002/07/owl#AsymmetricProperty"/>
        <rdf:type rdf:resource="http://www.w3.org/2002/07/owl#IrreflexiveProperty"/>
        <rdfs:domain>
            <owl:Class>
                <owl:unionOf rdf:parseType="Collection">
                    <rdf:Description rdf:about="https://w3id.org/skgo/pham#ExperimentMaterial"/>
                    <rdf:Description rdf:about="https://w3id.org/skgo/pham#Multidrug_resistance_to_cancer_cells"/>
                </owl:unionOf>
            </owl:Class>
        </rdfs:domain>
        <rdfs:range rdf:resource="https://w3id.org/skgo/pham#Gene"/>
    </owl:ObjectProperty>
    


    <!-- https://w3id.org/skgo/pham#useProbe -->

    <owl:ObjectProperty rdf:about="https://w3id.org/skgo/pham#useProbe">
        <rdfs:subPropertyOf rdf:resource="http://www.w3.org/2002/07/owl#topObjectProperty"/>
        <rdf:type rdf:resource="http://www.w3.org/2002/07/owl#AsymmetricProperty"/>
        <rdf:type rdf:resource="http://www.w3.org/2002/07/owl#IrreflexiveProperty"/>
        <rdfs:domain>
            <owl:Class>
                <owl:unionOf rdf:parseType="Collection">
                    <rdf:Description rdf:about="https://w3id.org/skgo/pham#ExperimentMaterial"/>
                    <rdf:Description rdf:about="https://w3id.org/skgo/pham#Multidrug_resistance_to_cancer_cells"/>
                </owl:unionOf>
            </owl:Class>
        </rdfs:domain>
        <rdfs:range rdf:resource="https://w3id.org/skgo/pham#Probe"/>
    </owl:ObjectProperty>
    


    <!-- https://w3id.org/skgo/pham#useReagent -->

    <owl:ObjectProperty rdf:about="https://w3id.org/skgo/pham#useReagent">
        <rdfs:subPropertyOf rdf:resource="http://www.w3.org/2002/07/owl#topObjectProperty"/>
        <rdf:type rdf:resource="http://www.w3.org/2002/07/owl#AsymmetricProperty"/>
        <rdf:type rdf:resource="http://www.w3.org/2002/07/owl#IrreflexiveProperty"/>
        <rdfs:domain rdf:resource="https://w3id.org/skgo/pham#Multidrug_resistance_to_cancer_cells"/>
        <rdfs:range rdf:resource="https://w3id.org/skgo/pham#Reagent"/>
    </owl:ObjectProperty>
    


    <!-- https://w3id.org/skgo/pham#useSpecimen -->

    <owl:ObjectProperty rdf:about="https://w3id.org/skgo/pham#useSpecimen">
        <rdfs:subPropertyOf rdf:resource="http://www.w3.org/2002/07/owl#topObjectProperty"/>
        <rdf:type rdf:resource="http://www.w3.org/2002/07/owl#AsymmetricProperty"/>
        <rdf:type rdf:resource="http://www.w3.org/2002/07/owl#IrreflexiveProperty"/>
        <rdfs:domain>
            <owl:Class>
                <owl:unionOf rdf:parseType="Collection">
                    <rdf:Description rdf:about="https://w3id.org/skgo/pham#ExperimentMaterial"/>
                    <rdf:Description rdf:about="https://w3id.org/skgo/pham#Treatment"/>
                </owl:unionOf>
            </owl:Class>
        </rdfs:domain>
        <rdfs:range rdf:resource="https://w3id.org/skgo/pham#Specimen"/>
    </owl:ObjectProperty>
    


    <!-- https://w3id.org/skgo/pham#useStatisticalAnalysis -->

    <owl:ObjectProperty rdf:about="https://w3id.org/skgo/pham#useStatisticalAnalysis">
        <rdfs:subPropertyOf rdf:resource="http://www.w3.org/2002/07/owl#topObjectProperty"/>
        <rdf:type rdf:resource="http://www.w3.org/2002/07/owl#AsymmetricProperty"/>
        <rdf:type rdf:resource="http://www.w3.org/2002/07/owl#IrreflexiveProperty"/>
        <rdfs:domain rdf:resource="https://w3id.org/skgo/pham#ClinicalStudy"/>
        <rdfs:range rdf:resource="https://w3id.org/skgo/pham#StatisticalAnalysis"/>
    </owl:ObjectProperty>
    


    <!-- 
    ///////////////////////////////////////////////////////////////////////////////////////
    //
    // Data properties
    //
    ///////////////////////////////////////////////////////////////////////////////////////
     -->

    


    <!-- http://ns.nature.com/terms/name -->

    <rdf:Description rdf:about="http://ns.nature.com/terms/name">
        <rdfs:domain>
            <owl:Class>
                <owl:unionOf rdf:parseType="Collection">
                    <rdf:Description rdf:about="http://ns.nature.com/terms/Contributor"/>
                    <rdf:Description rdf:about="http://ns.nature.com/terms/Publisher"/>
                    <rdf:Description rdf:about="https://w3id.org/skgo/pham#ClinicalStudy"/>
                    <rdf:Description rdf:about="https://w3id.org/skgo/pham#Multidrug_resistance_to_cancer_cells"/>
                </owl:unionOf>
            </owl:Class>
        </rdfs:domain>
    </rdf:Description>
    


    <!-- http://purl.org/dc/terms/abstract -->

    <owl:DatatypeProperty rdf:about="http://purl.org/dc/terms/abstract">
        <rdfs:subPropertyOf rdf:resource="http://purl.org/dc/terms/description"/>
    </owl:DatatypeProperty>
    


    <!-- http://purl.org/dc/terms/alternative -->

    <owl:DatatypeProperty rdf:about="http://purl.org/dc/terms/alternative"/>
    


    <!-- http://purl.org/dc/terms/bibliographicCitation -->

    <owl:DatatypeProperty rdf:about="http://purl.org/dc/terms/bibliographicCitation">
        <rdfs:subPropertyOf rdf:resource="http://purl.org/dc/terms/identifier"/>
    </owl:DatatypeProperty>
    


    <!-- http://purl.org/dc/terms/identifier -->

    <owl:DatatypeProperty rdf:about="http://purl.org/dc/terms/identifier"/>
    


    <!-- http://purl.org/dc/terms/title -->

    <owl:DatatypeProperty rdf:about="http://purl.org/dc/terms/title"/>
    


    <!-- http://purl.org/ontology/bibo/abstract -->

    <rdf:Description rdf:about="http://purl.org/ontology/bibo/abstract">
        <rdfs:domain>
            <owl:Class>
                <owl:unionOf rdf:parseType="Collection">
                    <rdf:Description rdf:about="http://purl.org/ontology/bibo/Article"/>
                    <rdf:Description rdf:about="http://www.w3.org/2000/01/rdf-schema#Resource"/>
                </owl:unionOf>
            </owl:Class>
        </rdfs:domain>
        <dc:description xml:lang="en">A summary of the resource.</dc:description>
    </rdf:Description>
    


    <!-- https://w3id.org/skgo/pham#assayTitle -->

    <owl:DatatypeProperty rdf:about="https://w3id.org/skgo/pham#assayTitle">
        <rdfs:subPropertyOf rdf:resource="http://www.w3.org/2002/07/owl#topDataProperty"/>
        <rdfs:domain rdf:resource="https://w3id.org/skgo/pham#Assay"/>
        <rdfs:range rdf:resource="http://www.w3.org/2000/01/rdf-schema#Literal"/>
        <dc:description xml:lang="en">Title of the assay.</dc:description>
        <rdfs:label xml:lang="en">assayTitle</rdfs:label>
    </owl:DatatypeProperty>
    


    <!-- https://w3id.org/skgo/pham#failureReason -->

    <owl:DatatypeProperty rdf:about="https://w3id.org/skgo/pham#failureReason">
        <rdfs:subPropertyOf rdf:resource="http://www.w3.org/2002/07/owl#topDataProperty"/>
        <rdfs:domain rdf:resource="https://w3id.org/skgo/pham#Treatment"/>
        <rdfs:range rdf:resource="http://www.w3.org/2001/XMLSchema#string"/>
        <dc:description xml:lang="en">The reasons or causes of a condition or  a fact of not achieving the desired end or ends.</dc:description>
        <rdfs:label xml:lang="en">failureReason</rdfs:label>
    </owl:DatatypeProperty>
    


    <!-- https://w3id.org/skgo/pham#hasAssayMethod -->

    <owl:DatatypeProperty rdf:about="https://w3id.org/skgo/pham#hasAssayMethod">
        <rdfs:subPropertyOf rdf:resource="http://www.w3.org/2002/07/owl#topDataProperty"/>
        <rdfs:domain rdf:resource="https://w3id.org/skgo/pham#Assay"/>
        <rdfs:range rdf:resource="http://www.w3.org/2000/01/rdf-schema#Literal"/>
    </owl:DatatypeProperty>
    


    <!-- https://w3id.org/skgo/pham#hasDrugEffects -->

    <owl:DatatypeProperty rdf:about="https://w3id.org/skgo/pham#hasDrugEffects">
        <rdfs:subPropertyOf rdf:resource="http://www.w3.org/2002/07/owl#topDataProperty"/>
        <rdfs:domain rdf:resource="https://w3id.org/skgo/pham#Drug"/>
        <rdfs:range rdf:resource="http://www.w3.org/2000/01/rdf-schema#Literal"/>
    </owl:DatatypeProperty>
    


    <!-- https://w3id.org/skgo/pham#hasEligibilityCriteria -->

    <owl:DatatypeProperty rdf:about="https://w3id.org/skgo/pham#hasEligibilityCriteria">
        <rdfs:subPropertyOf rdf:resource="http://www.w3.org/2002/07/owl#topDataProperty"/>
        <rdfs:domain>
            <owl:Class>
                <owl:unionOf rdf:parseType="Collection">
                    <rdf:Description rdf:about="https://w3id.org/skgo/pham#ClinicalTrial"/>
                    <rdf:Description rdf:about="https://w3id.org/skgo/pham#Patient"/>
                </owl:unionOf>
            </owl:Class>
        </rdfs:domain>
        <rdfs:range rdf:resource="http://www.w3.org/2000/01/rdf-schema#Literal"/>
    </owl:DatatypeProperty>
    


    <!-- https://w3id.org/skgo/pham#hasEvidence -->

    <owl:DatatypeProperty rdf:about="https://w3id.org/skgo/pham#hasEvidence">
        <rdfs:subPropertyOf rdf:resource="http://www.w3.org/2002/07/owl#topDataProperty"/>
        <rdfs:domain rdf:resource="https://w3id.org/skgo/pham#ClinicalStudy"/>
        <rdfs:range rdf:resource="http://www.w3.org/2000/01/rdf-schema#Literal"/>
        <dc:description xml:lang="en">Information, including verifiable facts and data that support a practice or belief.</dc:description>
        <rdfs:label xml:lang="en">hasEvidence</rdfs:label>
    </owl:DatatypeProperty>
    


    <!-- https://w3id.org/skgo/pham#hasExperimentalResult -->

    <owl:DatatypeProperty rdf:about="https://w3id.org/skgo/pham#hasExperimentalResult">
        <rdfs:subPropertyOf rdf:resource="http://www.w3.org/2002/07/owl#topDataProperty"/>
        <rdfs:domain rdf:resource="https://w3id.org/skgo/pham#Multidrug_resistance_to_cancer_cells"/>
        <rdfs:range rdf:resource="http://www.w3.org/2000/01/rdf-schema#Literal"/>
    </owl:DatatypeProperty>
    


    <!-- https://w3id.org/skgo/pham#hasFindings -->

    <owl:DatatypeProperty rdf:about="https://w3id.org/skgo/pham#hasFindings">
        <rdfs:subPropertyOf rdf:resource="http://www.w3.org/2002/07/owl#topDataProperty"/>
        <rdfs:domain rdf:resource="https://w3id.org/skgo/pham#ClinicalStudy"/>
        <rdfs:range rdf:resource="http://www.w3.org/2000/01/rdf-schema#Literal"/>
    </owl:DatatypeProperty>
    


    <!-- https://w3id.org/skgo/pham#hasLimitations -->

    <owl:DatatypeProperty rdf:about="https://w3id.org/skgo/pham#hasLimitations">
        <rdfs:subPropertyOf rdf:resource="http://www.w3.org/2002/07/owl#topDataProperty"/>
        <rdfs:domain rdf:resource="https://w3id.org/skgo/pham#ClinicalStudy"/>
        <rdfs:range rdf:resource="http://www.w3.org/2000/01/rdf-schema#Literal"/>
        <dc:description xml:lang="en">Conditions or restrictions of research study.</dc:description>
        <rdfs:label xml:lang="en">hasLimitations</rdfs:label>
    </owl:DatatypeProperty>
    


    <!-- https://w3id.org/skgo/pham#hasMutationResult -->

    <owl:DatatypeProperty rdf:about="https://w3id.org/skgo/pham#hasMutationResult">
        <rdfs:subPropertyOf rdf:resource="http://www.w3.org/2002/07/owl#topDataProperty"/>
        <rdfs:domain rdf:resource="https://w3id.org/skgo/pham#ClinicalProblem"/>
        <rdfs:range rdf:resource="http://www.w3.org/2000/01/rdf-schema#Literal"/>
    </owl:DatatypeProperty>
    


    <!-- https://w3id.org/skgo/pham#hasOverexpressionGene -->

    <owl:DatatypeProperty rdf:about="https://w3id.org/skgo/pham#hasOverexpressionGene">
        <rdfs:subPropertyOf rdf:resource="http://www.w3.org/2002/07/owl#topDataProperty"/>
        <rdfs:domain rdf:resource="https://w3id.org/skgo/pham#ClinicalProblem"/>
        <rdfs:range rdf:resource="http://www.w3.org/2000/01/rdf-schema#Literal"/>
        <dc:description xml:lang="en">The Gene that has overexpression which leads to the abundant target protein expression subsequently.</dc:description>
        <rdfs:label xml:lang="en">hasOverexpressionGene</rdfs:label>
    </owl:DatatypeProperty>
    


    <!-- https://w3id.org/skgo/pham#hasProblemSolution -->

    <owl:DatatypeProperty rdf:about="https://w3id.org/skgo/pham#hasProblemSolution">
        <rdfs:subPropertyOf rdf:resource="http://www.w3.org/2002/07/owl#topDataProperty"/>
        <rdfs:domain rdf:resource="https://w3id.org/skgo/pham#ClinicalProblem"/>
        <rdfs:range rdf:resource="http://www.w3.org/2000/01/rdf-schema#Literal"/>
        <dc:description xml:lang="en">Problem has the answer  or the explanation for something.</dc:description>
        <rdfs:label xml:lang="en">hasProblemSolution</rdfs:label>
    </owl:DatatypeProperty>
    


    <!-- https://w3id.org/skgo/pham#hasSuggestion -->

    <owl:DatatypeProperty rdf:about="https://w3id.org/skgo/pham#hasSuggestion">
        <rdfs:subPropertyOf rdf:resource="http://www.w3.org/2002/07/owl#topDataProperty"/>
        <rdfs:domain rdf:resource="https://w3id.org/skgo/pham#ClinicalStudy"/>
        <rdfs:range rdf:resource="http://www.w3.org/2000/01/rdf-schema#Literal"/>
    </owl:DatatypeProperty>
    


    <!-- https://w3id.org/skgo/pham#hasTargetingMethod -->

    <owl:DatatypeProperty rdf:about="https://w3id.org/skgo/pham#hasTargetingMethod">
        <rdfs:subPropertyOf rdf:resource="http://www.w3.org/2002/07/owl#topDataProperty"/>
        <rdfs:domain rdf:resource="https://w3id.org/skgo/pham#ClinicalProblem"/>
        <rdfs:range rdf:resource="http://www.w3.org/2000/01/rdf-schema#Literal"/>
        <dc:description xml:lang="en">The process of having proteins contain certain signals such that the proteins are directed specifically towards certain cellular locations</dc:description>
        <rdfs:label xml:lang="en">hasTargetingMethod</rdfs:label>
    </owl:DatatypeProperty>
    


    <!-- https://w3id.org/skgo/pham#hasTissueLocalization -->

    <owl:DatatypeProperty rdf:about="https://w3id.org/skgo/pham#hasTissueLocalization">
        <rdfs:subPropertyOf rdf:resource="http://www.w3.org/2002/07/owl#topDataProperty"/>
        <rdfs:domain rdf:resource="https://w3id.org/skgo/pham#ClinicalProblem"/>
        <rdfs:range rdf:resource="http://www.w3.org/2001/XMLSchema#string"/>
    </owl:DatatypeProperty>
    


    <!-- https://w3id.org/skgo/pham#hasTitle -->

    <owl:DatatypeProperty rdf:about="https://w3id.org/skgo/pham#hasTitle">
        <rdfs:subPropertyOf rdf:resource="http://www.w3.org/2002/07/owl#topDataProperty"/>
        <rdfs:domain>
            <owl:Class>
                <owl:unionOf rdf:parseType="Collection">
                    <rdf:Description rdf:about="https://w3id.org/skgo/pham#ClinicalStudy"/>
                    <rdf:Description rdf:about="https://w3id.org/skgo/pham#Multidrug_resistance_to_cancer_cells"/>
                </owl:unionOf>
            </owl:Class>
        </rdfs:domain>
        <rdfs:range rdf:resource="http://www.w3.org/2000/01/rdf-schema#Literal"/>
        <dc:description xml:lang="en">A name that describes something.</dc:description>
        <rdfs:label xml:lang="en">hasTitle</rdfs:label>
    </owl:DatatypeProperty>
    


    <!-- https://w3id.org/skgo/pham#name -->

    <owl:DatatypeProperty rdf:about="https://w3id.org/skgo/pham#name">
        <rdfs:subPropertyOf rdf:resource="http://www.w3.org/2002/07/owl#topDataProperty"/>
        <rdfs:domain>
            <owl:Class>
                <owl:unionOf rdf:parseType="Collection">
                    <rdf:Description rdf:about="https://w3id.org/skgo/pham#Disease"/>
                    <rdf:Description rdf:about="https://w3id.org/skgo/pham#Drug"/>
                    <rdf:Description rdf:about="https://w3id.org/skgo/pham#Multidrug_resistance_to_cancer_cells"/>
                </owl:unionOf>
            </owl:Class>
        </rdfs:domain>
        <rdfs:range rdf:resource="http://www.w3.org/2001/XMLSchema#string"/>
        <dc:description xml:lang="en">A word or words by which an entity is designated and distinguished from others.</dc:description>
    </owl:DatatypeProperty>
    


    <!-- https://w3id.org/skgo/pham#treatmentOutcome -->

    <owl:DatatypeProperty rdf:about="https://w3id.org/skgo/pham#treatmentOutcome">
        <rdfs:subPropertyOf rdf:resource="http://www.w3.org/2002/07/owl#topDataProperty"/>
        <rdfs:domain rdf:resource="https://w3id.org/skgo/pham#Treatment"/>
        <rdfs:range rdf:resource="http://www.w3.org/2000/01/rdf-schema#Literal"/>
        <dc:description xml:lang="en">A final product or end result of treatment.</dc:description>
        <rdfs:label xml:lang="en">treatmentOutcome</rdfs:label>
    </owl:DatatypeProperty>
    


    <!-- 
    ///////////////////////////////////////////////////////////////////////////////////////
    //
    // Classes
    //
    ///////////////////////////////////////////////////////////////////////////////////////
     -->

    


    <!-- http://ns.nature.com/terms/Publication -->

    <rdf:Description rdf:about="http://ns.nature.com/terms/Publication">
        <dc:description xml:lang="en">The :Publication class groups together all individuals (or part of) created as the result of the publishing process. Note that we are not referring here to the physical artefacts, but just their abstract counterparts.</dc:description>
    </rdf:Description>
    


    <!-- http://ns.nature.com/terms/Publisher -->

    <rdf:Description rdf:about="http://ns.nature.com/terms/Publisher">
        <dc:description xml:lang="en">The :Publisher class represents organizations involved in the publishing business.</dc:description>
    </rdf:Description>
    


    <!-- http://purl.org/dc/dcam/VocabularyEncodingScheme -->

    <owl:Class rdf:about="http://purl.org/dc/dcam/VocabularyEncodingScheme"/>
    


    <!-- http://purl.org/dc/dcmitype/Collection -->

    <owl:Class rdf:about="http://purl.org/dc/dcmitype/Collection"/>
    


    <!-- http://purl.org/dc/terms/AgentClass -->

    <owl:Class rdf:about="http://purl.org/dc/terms/AgentClass">
        <rdfs:subClassOf rdf:resource="http://www.w3.org/2000/01/rdf-schema#Class"/>
    </owl:Class>
    


    <!-- http://purl.org/dc/terms/BibliographicResource -->

    <owl:Class rdf:about="http://purl.org/dc/terms/BibliographicResource"/>
    


    <!-- http://purl.org/dc/terms/Frequency -->

    <owl:Class rdf:about="http://purl.org/dc/terms/Frequency"/>
    


    <!-- http://purl.org/dc/terms/LicenseDocument -->

    <owl:Class rdf:about="http://purl.org/dc/terms/LicenseDocument">
        <rdfs:subClassOf rdf:resource="http://purl.org/dc/terms/RightsStatement"/>
    </owl:Class>
    


    <!-- http://purl.org/dc/terms/LinguisticSystem -->

    <owl:Class rdf:about="http://purl.org/dc/terms/LinguisticSystem"/>
    


    <!-- http://purl.org/dc/terms/MethodOfAccrual -->

    <owl:Class rdf:about="http://purl.org/dc/terms/MethodOfAccrual"/>
    


    <!-- http://purl.org/dc/terms/MethodOfInstruction -->

    <owl:Class rdf:about="http://purl.org/dc/terms/MethodOfInstruction"/>
    


    <!-- http://purl.org/dc/terms/PhysicalResource -->

    <owl:Class rdf:about="http://purl.org/dc/terms/PhysicalResource"/>
    


    <!-- http://purl.org/dc/terms/Policy -->

    <owl:Class rdf:about="http://purl.org/dc/terms/Policy"/>
    


    <!-- http://purl.org/dc/terms/ProvenanceStatement -->

    <owl:Class rdf:about="http://purl.org/dc/terms/ProvenanceStatement"/>
    


    <!-- http://purl.org/dc/terms/RightsStatement -->

    <owl:Class rdf:about="http://purl.org/dc/terms/RightsStatement"/>
    


    <!-- http://purl.org/dc/terms/Standard -->

    <owl:Class rdf:about="http://purl.org/dc/terms/Standard"/>
    


    <!-- http://www.w3.org/2000/10/swap/pim/contact#Person -->

    <owl:Class rdf:about="http://www.w3.org/2000/10/swap/pim/contact#Person"/>
    


    <!-- https://w3id.org/skgo/pham#Antibody-mediated_cytolysis_experiment -->

    <owl:Class rdf:about="https://w3id.org/skgo/pham#Antibody-mediated_cytolysis_experiment">
        <rdfs:subClassOf rdf:resource="https://w3id.org/skgo/pham#Study"/>
        <dc:description xml:lang="en">An experimental method is a way to solve a scientific task by executing a scientific experiment.</dc:description>
        <rdfs:label xml:lang="en">ExperimentMethod</rdfs:label>
    </owl:Class>
    


    <!-- https://w3id.org/skgo/pham#Assay -->

    <owl:Class rdf:about="https://w3id.org/skgo/pham#Assay">
        <rdfs:subClassOf rdf:resource="https://w3id.org/skgo/pham#Study"/>
        <dc:description xml:lang="en">A set of instructions, methodology, operations, required reagents, instruments to carry out experiments for the purpose of testing the effect of a perturbing agent in a biological model system.</dc:description>
        <rdfs:label xml:lang="en">Assay</rdfs:label>
    </owl:Class>
    


    <!-- https://w3id.org/skgo/pham#AssayKit -->

    <owl:Class rdf:about="https://w3id.org/skgo/pham#AssayKit">
        <rdfs:subClassOf rdf:resource="https://w3id.org/skgo/pham#Assay"/>
    </owl:Class>
    


    <!-- https://w3id.org/skgo/pham#AssayMethod -->

    <owl:Class rdf:about="https://w3id.org/skgo/pham#AssayMethod">
        <rdfs:subClassOf rdf:resource="https://w3id.org/skgo/pham#Assay"/>
    </owl:Class>
    


    <!-- https://w3id.org/skgo/pham#BlotAnalysis -->

    <owl:Class rdf:about="https://w3id.org/skgo/pham#BlotAnalysis">
        <rdfs:subClassOf rdf:resource="https://w3id.org/skgo/pham#Study"/>
        <dc:description xml:lang="en">The transfer of protein, RNA or DNA molecules from a thick acrylamide or agarose gel to a paper like membrane by capilliarity or an electric field, preserving the spatial arrangement.</dc:description>
        <rdfs:label xml:lang="en">BlotAnalysis</rdfs:label>
    </owl:Class>
    


    <!-- https://w3id.org/skgo/pham#Calculations -->

    <owl:Class rdf:about="https://w3id.org/skgo/pham#Calculations"/>
    


    <!-- https://w3id.org/skgo/pham#Cell -->

    <owl:Class rdf:about="https://w3id.org/skgo/pham#Cell">
        <rdfs:subClassOf rdf:resource="https://w3id.org/skgo/pham#Study"/>
        <dc:description xml:lang="en">A material entity of anatomical origin (part of or deriving from an organism) that has as its parts a maximally connected cell compartment surrounded by a plasma membrane.</dc:description>
        <rdfs:label xml:lang="en">Cell</rdfs:label>
    </owl:Class>
    


    <!-- https://w3id.org/skgo/pham#CellLine -->

    <owl:Class rdf:about="https://w3id.org/skgo/pham#CellLine">
        <rdfs:subClassOf rdf:resource="https://w3id.org/skgo/pham#ExperimentMaterial"/>
        <rdfs:label xml:lang="en">CellLine</rdfs:label>
        <skos:definition xml:lang="en">The term &apos;line&apos; is used when a culture has undergone an intentional experimental process to establish a more uniform and stable population of cells.</skos:definition>
    </owl:Class>
    


    <!-- https://w3id.org/skgo/pham#Chemical -->

    <owl:Class rdf:about="https://w3id.org/skgo/pham#Chemical">
        <rdfs:subClassOf rdf:resource="https://w3id.org/skgo/pham#ExperimentMaterial"/>
        <rdfs:label xml:lang="en">Chemical</rdfs:label>
        <skos:definition xml:lang="en">A substance composed of chemical elements.</skos:definition>
    </owl:Class>
    


    <!-- https://w3id.org/skgo/pham#ClinicalProblem -->

    <owl:Class rdf:about="https://w3id.org/skgo/pham#ClinicalProblem">
        <rdfs:subClassOf rdf:resource="https://w3id.org/skgo/pham#Study"/>
        <dc:description xml:lang="en">A difficulty, disorder, or condition needing resolution.</dc:description>
        <rdfs:label xml:lang="en">ClinicalProblem</rdfs:label>
    </owl:Class>
    


    <!-- https://w3id.org/skgo/pham#ClinicalStudy -->

    <owl:Class rdf:about="https://w3id.org/skgo/pham#ClinicalStudy">
        <rdfs:subClassOf rdf:resource="https://w3id.org/skgo/pham#Study"/>
        <dc:description xml:lang="en">A research study involving human subjects designed to answer specific questions about the safety and efficacy of a biomedical intervention (drug, treatment, device), or new ways of using a known drug, treatment or device.</dc:description>
        <rdfs:label xml:lang="en">ClinicalStudy</rdfs:label>
    </owl:Class>
    


    <!-- https://w3id.org/skgo/pham#ClinicalTrial -->

    <owl:Class rdf:about="https://w3id.org/skgo/pham#ClinicalTrial">
        <rdfs:subClassOf rdf:resource="https://w3id.org/skgo/pham#Study"/>
        <dc:description xml:lang="en">Clinical trial an experiment performed on human beings in order to evaluate the comparative efficacy of two or more therapies.</dc:description>
        <rdfs:label xml:lang="en">ClinicalTrial</rdfs:label>
    </owl:Class>
    


    <!-- https://w3id.org/skgo/pham#Disease -->

    <owl:Class rdf:about="https://w3id.org/skgo/pham#Disease">
        <rdfs:subClassOf rdf:resource="https://w3id.org/skgo/pham#Study"/>
        <dc:description xml:lang="en">A definite pathological process having a characteristic set of signs and symptoms. It may affect the whole body or any of its parts, and its etiology, pathology, and prognosis may be known or unknown.</dc:description>
        <rdfs:label xml:lang="en">Disease</rdfs:label>
    </owl:Class>
    


    <!-- https://w3id.org/skgo/pham#Drug -->

    <owl:Class rdf:about="https://w3id.org/skgo/pham#Drug">
        <rdfs:subClassOf rdf:resource="https://w3id.org/skgo/pham#ExperimentMaterial"/>
        <rdfs:label xml:lang="en">Drug</rdfs:label>
        <skos:definition xml:lang="en">Therapeutic agent; any substance, other than food, used in the prevention, diagnosis, alleviation, treatment, or cure of disease. For types or classifications of drugs, see the specific name.</skos:definition>
    </owl:Class>
    


    <!-- https://w3id.org/skgo/pham#EasternBlotting -->

    <owl:Class rdf:about="https://w3id.org/skgo/pham#EasternBlotting">
        <rdfs:subClassOf rdf:resource="https://w3id.org/skgo/pham#BlotAnalysis"/>
    </owl:Class>
    


    <!-- https://w3id.org/skgo/pham#ExperimentKit -->

    <owl:Class rdf:about="https://w3id.org/skgo/pham#ExperimentKit">
        <rdfs:subClassOf rdf:resource="https://w3id.org/skgo/pham#Study"/>
        <dc:description xml:lang="en">The title of the kit/biologicals used in the experiment.</dc:description>
        <rdfs:label xml:lang="en">ExperimentKit</rdfs:label>
    </owl:Class>
    


    <!-- https://w3id.org/skgo/pham#ExperimentMaterial -->

    <owl:Class rdf:about="https://w3id.org/skgo/pham#ExperimentMaterial">
        <rdfs:subClassOf rdf:resource="https://w3id.org/skgo/pham#Study"/>
        <dc:description xml:lang="en">Materials are culture collections and chemicals used for executing of an experiment.</dc:description>
        <rdfs:label xml:lang="en">ExperimentMaterial</rdfs:label>
    </owl:Class>
    


    <!-- https://w3id.org/skgo/pham#ExperimentSetting -->

    <owl:Class rdf:about="https://w3id.org/skgo/pham#ExperimentSetting">
        <rdfs:subClassOf rdf:resource="https://w3id.org/skgo/pham#Study"/>
        <dc:description xml:lang="en">A designed experiment involves the investigator assigning (preferably randomly) some or all conditions to subjects.</dc:description>
        <rdfs:label xml:lang="en">ExperimentSetting</rdfs:label>
    </owl:Class>
    


    <!-- https://w3id.org/skgo/pham#ExperimentalStudy -->

    <owl:Class rdf:about="https://w3id.org/skgo/pham#ExperimentalStudy">
        <rdfs:subClassOf rdf:resource="https://w3id.org/skgo/pham#StudyDesign"/>
    </owl:Class>
    


    <!-- https://w3id.org/skgo/pham#Gene -->

    <owl:Class rdf:about="https://w3id.org/skgo/pham#Gene">
        <rdfs:subClassOf rdf:resource="https://w3id.org/skgo/pham#ExperimentMaterial"/>
        <rdfs:label xml:lang="en">Gene</rdfs:label>
        <skos:definition xml:lang="en">One of the biologic units of heredity, self-reproducing, and located at a definite position (locus) on a particular chromosome.</skos:definition>
    </owl:Class>
    


    <!-- https://w3id.org/skgo/pham#Hypothesis -->

    <owl:Class rdf:about="https://w3id.org/skgo/pham#Hypothesis">
        <rdfs:subClassOf rdf:resource="https://w3id.org/skgo/pham#Study"/>
        <dc:description xml:lang="en">A supposition that appears to explain a group of phenomena and is advanced as a bases for further investigation.</dc:description>
        <rdfs:label xml:lang="en">Hypothesis</rdfs:label>
    </owl:Class>
    


    <!-- https://w3id.org/skgo/pham#Investigation -->

    <owl:Class rdf:about="https://w3id.org/skgo/pham#Investigation">
        <rdfs:subClassOf rdf:resource="https://w3id.org/skgo/pham#Study"/>
        <dc:description xml:lang="en">Investigation is the process of carrying out a plan or procedure so as to discover facts or information about the object of study.</dc:description>
        <rdfs:label xml:lang="en">Investigation</rdfs:label>
    </owl:Class>
    


    <!-- https://w3id.org/skgo/pham#Multidrug_resistance_to_cancer_cells -->

    <owl:Class rdf:about="https://w3id.org/skgo/pham#Multidrug_resistance_to_cancer_cells">
        <rdfs:subClassOf rdf:resource="https://w3id.org/skgo/pham#Study"/>
        <dc:description xml:lang="en">A procedure done in order to discover or demonstrate some fact or general truth.</dc:description>
        <rdfs:label xml:lang="en">Experiment</rdfs:label>
    </owl:Class>
    


    <!-- https://w3id.org/skgo/pham#NorthernBlotting -->

    <owl:Class rdf:about="https://w3id.org/skgo/pham#NorthernBlotting">
        <rdfs:subClassOf rdf:resource="https://w3id.org/skgo/pham#BlotAnalysis"/>
        <dc:description xml:lang="en">A technique used to detect a specific mRNA sequence, which consists of electrophoresing RNA fragments, transferring those fragments to a membrane, then adding a labelled nucleic acid probe to the milieu.</dc:description>
        <rdfs:label xml:lang="en">NorthernBlotting</rdfs:label>
    </owl:Class>
    


    <!-- https://w3id.org/skgo/pham#ObservationalStudy -->

    <owl:Class rdf:about="https://w3id.org/skgo/pham#ObservationalStudy">
        <rdfs:subClassOf rdf:resource="https://w3id.org/skgo/pham#StudyDesign"/>
    </owl:Class>
    


    <!-- https://w3id.org/skgo/pham#Patient -->

    <owl:Class rdf:about="https://w3id.org/skgo/pham#Patient">
        <rdfs:subClassOf rdf:resource="https://w3id.org/skgo/pham#Study"/>
        <dc:description xml:lang="en">A person who is under medical care or treatment.</dc:description>
        <rdfs:label xml:lang="en">Patient</rdfs:label>
    </owl:Class>
    


    <!-- https://w3id.org/skgo/pham#Probe -->

    <owl:Class rdf:about="https://w3id.org/skgo/pham#Probe">
        <rdfs:subClassOf rdf:resource="https://w3id.org/skgo/pham#ExperimentMaterial"/>
        <rdfs:label xml:lang="en">Probe</rdfs:label>
        <skos:definition xml:lang="en">A radioactive or chemiluminescent DNA or RNA fragment used to detect the presence of a complementary fragment.</skos:definition>
    </owl:Class>
    


    <!-- https://w3id.org/skgo/pham#Reagent -->

    <owl:Class rdf:about="https://w3id.org/skgo/pham#Reagent">
        <rdfs:subClassOf rdf:resource="https://w3id.org/skgo/pham#ExperimentMaterial"/>
        <rdfs:label xml:lang="en">Reagent</rdfs:label>
        <skos:definition xml:lang="en">A substance used to produce a chemical reaction so as to detect, measure, or produce other substances.</skos:definition>
    </owl:Class>
    


    <!-- https://w3id.org/skgo/pham#ReviewStudy -->

    <owl:Class rdf:about="https://w3id.org/skgo/pham#ReviewStudy">
        <rdfs:subClassOf rdf:resource="https://w3id.org/skgo/pham#StudyDesign"/>
        <dc:description xml:lang="en">Reviews are a type of literature review that uses systematic methods to collect secondary data, critically appraise research studies, and synthesize findings qualitatively or quantitatively.</dc:description>
        <rdfs:label xml:lang="en">ReviewStudy</rdfs:label>
    </owl:Class>
    


    <!-- https://w3id.org/skgo/pham#SouthernBlotting -->

    <owl:Class rdf:about="https://w3id.org/skgo/pham#SouthernBlotting">
        <rdfs:subClassOf rdf:resource="https://w3id.org/skgo/pham#BlotAnalysis"/>
        <dc:description xml:lang="en">A technique for the detection of specific DNA fragments that have been separated by polyacrylamide-gel electrophoresis, transferred to a nitrocellulose or other type of paper or nylon membrane, and detected by hybridization and visualization with a labeled probe.</dc:description>
        <rdfs:label xml:lang="en">SouthernBlotting</rdfs:label>
    </owl:Class>
    


    <!-- https://w3id.org/skgo/pham#Specimen -->

    <owl:Class rdf:about="https://w3id.org/skgo/pham#Specimen">
        <rdfs:subClassOf rdf:resource="https://w3id.org/skgo/pham#ExperimentMaterial"/>
        <rdfs:label xml:lang="en">Specimen</rdfs:label>
        <skos:definition xml:lang="en">A small sample or part taken to show the nature of the whole, such as a small quantity of urine for urinalysis or a small fragment of tissue for microscopic study.</skos:definition>
    </owl:Class>
    


    <!-- https://w3id.org/skgo/pham#StatisticalAnalysis -->

    <owl:Class rdf:about="https://w3id.org/skgo/pham#StatisticalAnalysis">
        <rdfs:subClassOf rdf:resource="https://w3id.org/skgo/pham#Study"/>
    </owl:Class>
    


    <!-- https://w3id.org/skgo/pham#Study -->

    <owl:Class rdf:about="https://w3id.org/skgo/pham#Study"/>
    


    <!-- https://w3id.org/skgo/pham#StudyDesign -->

    <owl:Class rdf:about="https://w3id.org/skgo/pham#StudyDesign">
        <rdfs:subClassOf rdf:resource="https://w3id.org/skgo/pham#Study"/>
        <dc:description xml:lang="en">Study design is the formulation of trials and experiments, as well as observational studies in medical, clinical and other types of research involving human beings.</dc:description>
        <rdfs:label xml:lang="en">StudyDesign</rdfs:label>
    </owl:Class>
    


    <!-- https://w3id.org/skgo/pham#Treatment -->

    <owl:Class rdf:about="https://w3id.org/skgo/pham#Treatment">
        <rdfs:subClassOf rdf:resource="https://w3id.org/skgo/pham#Study"/>
        <dc:description xml:lang="en">A period in a clinical study during which subjects receive therapeutic treatment or an action or administration of therapeutic agents to produce an effect that is intended to alter or stop a pathologic process.</dc:description>
        <rdfs:label xml:lang="en">Treatment</rdfs:label>
    </owl:Class>
    


    <!-- https://w3id.org/skgo/pham#WesternBlotting -->

    <owl:Class rdf:about="https://w3id.org/skgo/pham#WesternBlotting">
        <rdfs:subClassOf rdf:resource="https://w3id.org/skgo/pham#BlotAnalysis"/>
        <dc:description xml:lang="en">A laboratory procedure for the detection or identification of proteins or peptides that have been separated by gel electrophoresis and transferred onto nitrocellulose or other type of paper or nylon membrane.</dc:description>
        <rdfs:label xml:lang="en">WesternBlotting</rdfs:label>
    </owl:Class>
    


    <!-- https://w3id.org/skgo/pham#ex_vivo -->

    <owl:Class rdf:about="https://w3id.org/skgo/pham#ex_vivo">
        <rdfs:subClassOf rdf:resource="https://w3id.org/skgo/pham#ExperimentSetting"/>
    </owl:Class>
    


    <!-- https://w3id.org/skgo/pham#in_silico -->

    <owl:Class rdf:about="https://w3id.org/skgo/pham#in_silico">
        <rdfs:subClassOf rdf:resource="https://w3id.org/skgo/pham#ExperimentSetting"/>
    </owl:Class>
    


    <!-- https://w3id.org/skgo/pham#in_vitro -->

    <owl:Class rdf:about="https://w3id.org/skgo/pham#in_vitro">
        <rdfs:subClassOf rdf:resource="https://w3id.org/skgo/pham#ExperimentSetting"/>
    </owl:Class>
    


    <!-- https://w3id.org/skgo/pham#in_vivo -->

    <owl:Class rdf:about="https://w3id.org/skgo/pham#in_vivo">
        <rdfs:subClassOf rdf:resource="https://w3id.org/skgo/pham#ExperimentSetting"/>
    </owl:Class>
    


    <!-- https://w3id.org/skgo/pham#levels_of_mdr1_mRNA -->

    <owl:Class rdf:about="https://w3id.org/skgo/pham#levels_of_mdr1_mRNA">
        <rdfs:subClassOf rdf:resource="https://w3id.org/skgo/pham#Study"/>
        <dc:description xml:lang="en">It is a claim, focus, goal or hypothes is supported by the study findings and examined by the study experiment.</dc:description>
        <rdfs:label xml:lang="en">ResearchStatement</rdfs:label>
    </owl:Class>
    


    <!-- 
    ///////////////////////////////////////////////////////////////////////////////////////
    //
    // Individuals
    //
    ///////////////////////////////////////////////////////////////////////////////////////
     -->

    


    <!-- http://purl.org/dc/aboutdcmi#DCMI -->

    <owl:NamedIndividual rdf:about="http://purl.org/dc/aboutdcmi#DCMI"/>
    


    <!-- http://purl.org/dc/terms/ -->

    <owl:NamedIndividual rdf:about="http://purl.org/dc/terms/">
        <terms:modified rdf:datatype="http://www.w3.org/2001/XMLSchema#date">2012-06-14</terms:modified>
        <terms:publisher rdf:resource="http://purl.org/dc/aboutdcmi#DCMI"/>
        <terms:title xml:lang="en">DCMI Metadata Terms - other</terms:title>
    </owl:NamedIndividual>
    


    <!-- http://purl.org/dc/terms/Agent -->

    <owl:NamedIndividual rdf:about="http://purl.org/dc/terms/Agent">
        <rdf:type rdf:resource="http://purl.org/dc/terms/AgentClass"/>
    </owl:NamedIndividual>
    


    <!-- http://purl.org/dc/terms/AgentClass -->

    <owl:NamedIndividual rdf:about="http://purl.org/dc/terms/AgentClass"/>
    


    <!-- http://purl.org/dc/terms/BibliographicResource -->

    <owl:NamedIndividual rdf:about="http://purl.org/dc/terms/BibliographicResource"/>
    


    <!-- http://purl.org/dc/terms/Box -->

    <owl:NamedIndividual rdf:about="http://purl.org/dc/terms/Box"/>
    


    <!-- http://purl.org/dc/terms/DCMIType -->

    <owl:NamedIndividual rdf:about="http://purl.org/dc/terms/DCMIType">
        <rdf:type rdf:resource="http://purl.org/dc/dcam/VocabularyEncodingScheme"/>
        <terms:hasVersion rdf:resource="http://dublincore.org/usage/terms/history/#DCMIType-005"/>
        <terms:issued rdf:datatype="http://www.w3.org/2001/XMLSchema#date">2000-07-11</terms:issued>
        <terms:modified rdf:datatype="http://www.w3.org/2001/XMLSchema#date">2012-06-14</terms:modified>
        <rdfs:comment xml:lang="en">The set of classes specified by the DCMI Type Vocabulary, used to categorize the nature or genre of the resource.</rdfs:comment>
        <rdfs:isDefinedBy rdf:resource="http://purl.org/dc/terms/"/>
        <rdfs:label xml:lang="en">DCMI Type Vocabulary</rdfs:label>
        <rdfs:seeAlso rdf:resource="http://purl.org/dc/dcmitype/"/>
    </owl:NamedIndividual>
    


    <!-- http://purl.org/dc/terms/DDC -->

    <owl:NamedIndividual rdf:about="http://purl.org/dc/terms/DDC">
        <rdf:type rdf:resource="http://purl.org/dc/dcam/VocabularyEncodingScheme"/>
        <terms:hasVersion rdf:resource="http://dublincore.org/usage/terms/history/#DDC-003"/>
        <terms:issued rdf:datatype="http://www.w3.org/2001/XMLSchema#date">2000-07-11</terms:issued>
        <terms:modified rdf:datatype="http://www.w3.org/2001/XMLSchema#date">2008-01-14</terms:modified>
        <rdfs:comment xml:lang="en">The set of conceptual resources specified by the Dewey Decimal Classification.</rdfs:comment>
        <rdfs:isDefinedBy rdf:resource="http://purl.org/dc/terms/"/>
        <rdfs:label xml:lang="en">DDC</rdfs:label>
        <rdfs:seeAlso rdf:resource="http://www.oclc.org/dewey/"/>
    </owl:NamedIndividual>
    


    <!-- http://purl.org/dc/terms/FileFormat -->

    <owl:NamedIndividual rdf:about="http://purl.org/dc/terms/FileFormat"/>
    


    <!-- http://purl.org/dc/terms/Frequency -->

    <owl:NamedIndividual rdf:about="http://purl.org/dc/terms/Frequency"/>
    


    <!-- http://purl.org/dc/terms/IMT -->

    <owl:NamedIndividual rdf:about="http://purl.org/dc/terms/IMT">
        <rdf:type rdf:resource="http://purl.org/dc/dcam/VocabularyEncodingScheme"/>
        <terms:hasVersion rdf:resource="http://dublincore.org/usage/terms/history/#IMT-004"/>
        <terms:issued rdf:datatype="http://www.w3.org/2001/XMLSchema#date">2000-07-11</terms:issued>
        <terms:modified rdf:datatype="http://www.w3.org/2001/XMLSchema#date">2008-01-14</terms:modified>
        <rdfs:comment xml:lang="en">The set of media types specified by the Internet Assigned Numbers Authority.</rdfs:comment>
        <rdfs:isDefinedBy rdf:resource="http://purl.org/dc/terms/"/>
        <rdfs:label xml:lang="en">IMT</rdfs:label>
        <rdfs:seeAlso rdf:resource="http://www.iana.org/assignments/media-types/"/>
    </owl:NamedIndividual>
    


    <!-- http://purl.org/dc/terms/ISO3166 -->

    <owl:NamedIndividual rdf:about="http://purl.org/dc/terms/ISO3166"/>
    


    <!-- http://purl.org/dc/terms/ISO639-2 -->

    <owl:NamedIndividual rdf:about="http://purl.org/dc/terms/ISO639-2"/>
    


    <!-- http://purl.org/dc/terms/ISO639-3 -->

    <owl:NamedIndividual rdf:about="http://purl.org/dc/terms/ISO639-3"/>
    


    <!-- http://purl.org/dc/terms/Jurisdiction -->

    <owl:NamedIndividual rdf:about="http://purl.org/dc/terms/Jurisdiction"/>
    


    <!-- http://purl.org/dc/terms/LCC -->

    <owl:NamedIndividual rdf:about="http://purl.org/dc/terms/LCC">
        <rdf:type rdf:resource="http://purl.org/dc/dcam/VocabularyEncodingScheme"/>
        <terms:hasVersion rdf:resource="http://dublincore.org/usage/terms/history/#LCC-003"/>
        <terms:issued rdf:datatype="http://www.w3.org/2001/XMLSchema#date">2000-07-11</terms:issued>
        <terms:modified rdf:datatype="http://www.w3.org/2001/XMLSchema#date">2008-01-14</terms:modified>
        <rdfs:comment xml:lang="en">The set of conceptual resources specified by the Library of Congress Classification.</rdfs:comment>
        <rdfs:isDefinedBy rdf:resource="http://purl.org/dc/terms/"/>
        <rdfs:label xml:lang="en">LCC</rdfs:label>
        <rdfs:seeAlso rdf:resource="http://lcweb.loc.gov/catdir/cpso/lcco/lcco.html"/>
    </owl:NamedIndividual>
    


    <!-- http://purl.org/dc/terms/LCSH -->

    <owl:NamedIndividual rdf:about="http://purl.org/dc/terms/LCSH">
        <rdf:type rdf:resource="http://purl.org/dc/dcam/VocabularyEncodingScheme"/>
        <terms:hasVersion rdf:resource="http://dublincore.org/usage/terms/history/#LCSH-003"/>
        <terms:issued rdf:datatype="http://www.w3.org/2001/XMLSchema#date">2000-07-11</terms:issued>
        <terms:modified rdf:datatype="http://www.w3.org/2001/XMLSchema#date">2008-01-14</terms:modified>
        <rdfs:comment xml:lang="en">The set of labeled concepts specified by the Library of Congress Subject Headings.</rdfs:comment>
        <rdfs:isDefinedBy rdf:resource="http://purl.org/dc/terms/"/>
        <rdfs:label xml:lang="en">LCSH</rdfs:label>
    </owl:NamedIndividual>
    


    <!-- http://purl.org/dc/terms/LicenseDocument -->

    <owl:NamedIndividual rdf:about="http://purl.org/dc/terms/LicenseDocument"/>
    


    <!-- http://purl.org/dc/terms/LinguisticSystem -->

    <owl:NamedIndividual rdf:about="http://purl.org/dc/terms/LinguisticSystem"/>
    


    <!-- http://purl.org/dc/terms/Location -->

    <owl:NamedIndividual rdf:about="http://purl.org/dc/terms/Location"/>
    


    <!-- http://purl.org/dc/terms/LocationPeriodOrJurisdiction -->

    <owl:NamedIndividual rdf:about="http://purl.org/dc/terms/LocationPeriodOrJurisdiction"/>
    


    <!-- http://purl.org/dc/terms/MESH -->

    <owl:NamedIndividual rdf:about="http://purl.org/dc/terms/MESH">
        <rdf:type rdf:resource="http://purl.org/dc/dcam/VocabularyEncodingScheme"/>
        <terms:hasVersion rdf:resource="http://dublincore.org/usage/terms/history/#MESH-003"/>
        <terms:issued rdf:datatype="http://www.w3.org/2001/XMLSchema#date">2000-07-11</terms:issued>
        <terms:modified rdf:datatype="http://www.w3.org/2001/XMLSchema#date">2008-01-14</terms:modified>
        <rdfs:comment xml:lang="en">The set of labeled concepts specified by the Medical Subject Headings.</rdfs:comment>
        <rdfs:isDefinedBy rdf:resource="http://purl.org/dc/terms/"/>
        <rdfs:label xml:lang="en">MeSH</rdfs:label>
        <rdfs:seeAlso rdf:resource="http://www.nlm.nih.gov/mesh/meshhome.html"/>
    </owl:NamedIndividual>
    


    <!-- http://purl.org/dc/terms/MediaType -->

    <owl:NamedIndividual rdf:about="http://purl.org/dc/terms/MediaType"/>
    


    <!-- http://purl.org/dc/terms/MediaTypeOrExtent -->

    <owl:NamedIndividual rdf:about="http://purl.org/dc/terms/MediaTypeOrExtent"/>
    


    <!-- http://purl.org/dc/terms/MethodOfAccrual -->

    <owl:NamedIndividual rdf:about="http://purl.org/dc/terms/MethodOfAccrual"/>
    


    <!-- http://purl.org/dc/terms/MethodOfInstruction -->

    <owl:NamedIndividual rdf:about="http://purl.org/dc/terms/MethodOfInstruction"/>
    


    <!-- http://purl.org/dc/terms/NLM -->

    <owl:NamedIndividual rdf:about="http://purl.org/dc/terms/NLM">
        <rdf:type rdf:resource="http://purl.org/dc/dcam/VocabularyEncodingScheme"/>
        <terms:hasVersion rdf:resource="http://dublincore.org/usage/terms/history/#NLM-002"/>
        <terms:issued rdf:datatype="http://www.w3.org/2001/XMLSchema#date">2005-06-13</terms:issued>
        <terms:modified rdf:datatype="http://www.w3.org/2001/XMLSchema#date">2008-01-14</terms:modified>
        <rdfs:comment xml:lang="en">The set of conceptual resources specified by the National Library of Medicine Classification.</rdfs:comment>
        <rdfs:isDefinedBy rdf:resource="http://purl.org/dc/terms/"/>
        <rdfs:label xml:lang="en">NLM</rdfs:label>
        <rdfs:seeAlso rdf:resource="http://wwwcf.nlm.nih.gov/class/"/>
    </owl:NamedIndividual>
    


    <!-- http://purl.org/dc/terms/Period -->

    <owl:NamedIndividual rdf:about="http://purl.org/dc/terms/Period"/>
    


    <!-- http://purl.org/dc/terms/PeriodOfTime -->

    <owl:NamedIndividual rdf:about="http://purl.org/dc/terms/PeriodOfTime"/>
    


    <!-- http://purl.org/dc/terms/PhysicalMedium -->

    <owl:NamedIndividual rdf:about="http://purl.org/dc/terms/PhysicalMedium"/>
    


    <!-- http://purl.org/dc/terms/PhysicalResource -->

    <owl:NamedIndividual rdf:about="http://purl.org/dc/terms/PhysicalResource"/>
    


    <!-- http://purl.org/dc/terms/Point -->

    <owl:NamedIndividual rdf:about="http://purl.org/dc/terms/Point"/>
    


    <!-- http://purl.org/dc/terms/Policy -->

    <owl:NamedIndividual rdf:about="http://purl.org/dc/terms/Policy"/>
    


    <!-- http://purl.org/dc/terms/ProvenanceStatement -->

    <owl:NamedIndividual rdf:about="http://purl.org/dc/terms/ProvenanceStatement"/>
    


    <!-- http://purl.org/dc/terms/RFC1766 -->

    <owl:NamedIndividual rdf:about="http://purl.org/dc/terms/RFC1766"/>
    


    <!-- http://purl.org/dc/terms/RFC3066 -->

    <owl:NamedIndividual rdf:about="http://purl.org/dc/terms/RFC3066"/>
    


    <!-- http://purl.org/dc/terms/RFC4646 -->

    <owl:NamedIndividual rdf:about="http://purl.org/dc/terms/RFC4646"/>
    


    <!-- http://purl.org/dc/terms/RFC5646 -->

    <owl:NamedIndividual rdf:about="http://purl.org/dc/terms/RFC5646"/>
    


    <!-- http://purl.org/dc/terms/RightsStatement -->

    <owl:NamedIndividual rdf:about="http://purl.org/dc/terms/RightsStatement"/>
    


    <!-- http://purl.org/dc/terms/SizeOrDuration -->

    <owl:NamedIndividual rdf:about="http://purl.org/dc/terms/SizeOrDuration"/>
    


    <!-- http://purl.org/dc/terms/Standard -->

    <owl:NamedIndividual rdf:about="http://purl.org/dc/terms/Standard"/>
    


    <!-- http://purl.org/dc/terms/TGN -->

    <owl:NamedIndividual rdf:about="http://purl.org/dc/terms/TGN">
        <rdf:type rdf:resource="http://purl.org/dc/dcam/VocabularyEncodingScheme"/>
        <terms:hasVersion rdf:resource="http://dublincore.org/usage/terms/history/#TGN-003"/>
        <terms:issued rdf:datatype="http://www.w3.org/2001/XMLSchema#date">2000-07-11</terms:issued>
        <terms:modified rdf:datatype="http://www.w3.org/2001/XMLSchema#date">2008-01-14</terms:modified>
        <rdfs:comment xml:lang="en">The set of places specified by the Getty Thesaurus of Geographic Names.</rdfs:comment>
        <rdfs:isDefinedBy rdf:resource="http://purl.org/dc/terms/"/>
        <rdfs:label xml:lang="en">TGN</rdfs:label>
        <rdfs:seeAlso rdf:resource="http://www.getty.edu/research/tools/vocabulary/tgn/index.html"/>
    </owl:NamedIndividual>
    


    <!-- http://purl.org/dc/terms/UDC -->

    <owl:NamedIndividual rdf:about="http://purl.org/dc/terms/UDC">
        <rdf:type rdf:resource="http://purl.org/dc/dcam/VocabularyEncodingScheme"/>
        <terms:hasVersion rdf:resource="http://dublincore.org/usage/terms/history/#UDC-003"/>
        <terms:issued rdf:datatype="http://www.w3.org/2001/XMLSchema#date">2000-07-11</terms:issued>
        <terms:modified rdf:datatype="http://www.w3.org/2001/XMLSchema#date">2008-01-14</terms:modified>
        <rdfs:comment xml:lang="en">The set of conceptual resources specified by the Universal Decimal Classification.</rdfs:comment>
        <rdfs:isDefinedBy rdf:resource="http://purl.org/dc/terms/"/>
        <rdfs:label xml:lang="en">UDC</rdfs:label>
        <rdfs:seeAlso rdf:resource="http://www.udcc.org/"/>
    </owl:NamedIndividual>
    


    <!-- http://purl.org/dc/terms/URI -->

    <owl:NamedIndividual rdf:about="http://purl.org/dc/terms/URI"/>
    


    <!-- http://purl.org/dc/terms/W3CDTF -->

    <owl:NamedIndividual rdf:about="http://purl.org/dc/terms/W3CDTF"/>
    


    <!-- http://purl.org/dc/terms/abstract -->

    <owl:NamedIndividual rdf:about="http://purl.org/dc/terms/abstract"/>
    


    <!-- http://purl.org/dc/terms/accessRights -->

    <owl:NamedIndividual rdf:about="http://purl.org/dc/terms/accessRights"/>
    


    <!-- http://purl.org/dc/terms/accrualMethod -->

    <owl:NamedIndividual rdf:about="http://purl.org/dc/terms/accrualMethod"/>
    


    <!-- http://purl.org/dc/terms/accrualPeriodicity -->

    <owl:NamedIndividual rdf:about="http://purl.org/dc/terms/accrualPeriodicity"/>
    


    <!-- http://purl.org/dc/terms/accrualPolicy -->

    <owl:NamedIndividual rdf:about="http://purl.org/dc/terms/accrualPolicy"/>
    


    <!-- http://purl.org/dc/terms/alternative -->

    <owl:NamedIndividual rdf:about="http://purl.org/dc/terms/alternative"/>
    


    <!-- http://purl.org/dc/terms/audience -->

    <owl:NamedIndividual rdf:about="http://purl.org/dc/terms/audience"/>
    


    <!-- http://purl.org/dc/terms/available -->

    <owl:NamedIndividual rdf:about="http://purl.org/dc/terms/available"/>
    


    <!-- http://purl.org/dc/terms/bibliographicCitation -->

    <owl:NamedIndividual rdf:about="http://purl.org/dc/terms/bibliographicCitation"/>
    


    <!-- http://purl.org/dc/terms/conformsTo -->

    <owl:NamedIndividual rdf:about="http://purl.org/dc/terms/conformsTo"/>
    


    <!-- http://purl.org/dc/terms/contributor -->

    <owl:NamedIndividual rdf:about="http://purl.org/dc/terms/contributor"/>
    


    <!-- http://purl.org/dc/terms/coverage -->

    <owl:NamedIndividual rdf:about="http://purl.org/dc/terms/coverage"/>
    


    <!-- http://purl.org/dc/terms/created -->

    <owl:NamedIndividual rdf:about="http://purl.org/dc/terms/created"/>
    


    <!-- http://purl.org/dc/terms/creator -->

    <owl:NamedIndividual rdf:about="http://purl.org/dc/terms/creator"/>
    


    <!-- http://purl.org/dc/terms/date -->

    <owl:NamedIndividual rdf:about="http://purl.org/dc/terms/date"/>
    


    <!-- http://purl.org/dc/terms/dateAccepted -->

    <owl:NamedIndividual rdf:about="http://purl.org/dc/terms/dateAccepted"/>
    


    <!-- http://purl.org/dc/terms/dateCopyrighted -->

    <owl:NamedIndividual rdf:about="http://purl.org/dc/terms/dateCopyrighted"/>
    


    <!-- http://purl.org/dc/terms/dateSubmitted -->

    <owl:NamedIndividual rdf:about="http://purl.org/dc/terms/dateSubmitted"/>
    


    <!-- http://purl.org/dc/terms/description -->

    <owl:NamedIndividual rdf:about="http://purl.org/dc/terms/description"/>
    


    <!-- http://purl.org/dc/terms/educationLevel -->

    <owl:NamedIndividual rdf:about="http://purl.org/dc/terms/educationLevel"/>
    


    <!-- http://purl.org/dc/terms/extent -->

    <owl:NamedIndividual rdf:about="http://purl.org/dc/terms/extent"/>
    


    <!-- http://purl.org/dc/terms/format -->

    <owl:NamedIndividual rdf:about="http://purl.org/dc/terms/format"/>
    


    <!-- http://purl.org/dc/terms/hasFormat -->

    <owl:NamedIndividual rdf:about="http://purl.org/dc/terms/hasFormat"/>
    


    <!-- http://purl.org/dc/terms/hasPart -->

    <owl:NamedIndividual rdf:about="http://purl.org/dc/terms/hasPart"/>
    


    <!-- http://purl.org/dc/terms/hasVersion -->

    <owl:NamedIndividual rdf:about="http://purl.org/dc/terms/hasVersion"/>
    


    <!-- http://purl.org/dc/terms/identifier -->

    <owl:NamedIndividual rdf:about="http://purl.org/dc/terms/identifier"/>
    


    <!-- http://purl.org/dc/terms/instructionalMethod -->

    <owl:NamedIndividual rdf:about="http://purl.org/dc/terms/instructionalMethod"/>
    


    <!-- http://purl.org/dc/terms/isFormatOf -->

    <owl:NamedIndividual rdf:about="http://purl.org/dc/terms/isFormatOf"/>
    


    <!-- http://purl.org/dc/terms/isPartOf -->

    <owl:NamedIndividual rdf:about="http://purl.org/dc/terms/isPartOf"/>
    


    <!-- http://purl.org/dc/terms/isReferencedBy -->

    <owl:NamedIndividual rdf:about="http://purl.org/dc/terms/isReferencedBy"/>
    


    <!-- http://purl.org/dc/terms/isReplacedBy -->

    <owl:NamedIndividual rdf:about="http://purl.org/dc/terms/isReplacedBy"/>
    


    <!-- http://purl.org/dc/terms/isRequiredBy -->

    <owl:NamedIndividual rdf:about="http://purl.org/dc/terms/isRequiredBy"/>
    


    <!-- http://purl.org/dc/terms/isVersionOf -->

    <owl:NamedIndividual rdf:about="http://purl.org/dc/terms/isVersionOf"/>
    


    <!-- http://purl.org/dc/terms/issued -->

    <owl:NamedIndividual rdf:about="http://purl.org/dc/terms/issued"/>
    


    <!-- http://purl.org/dc/terms/language -->

    <owl:NamedIndividual rdf:about="http://purl.org/dc/terms/language"/>
    


    <!-- http://purl.org/dc/terms/license -->

    <owl:NamedIndividual rdf:about="http://purl.org/dc/terms/license"/>
    


    <!-- http://purl.org/dc/terms/mediator -->

    <owl:NamedIndividual rdf:about="http://purl.org/dc/terms/mediator"/>
    


    <!-- http://purl.org/dc/terms/medium -->

    <owl:NamedIndividual rdf:about="http://purl.org/dc/terms/medium"/>
    


    <!-- http://purl.org/dc/terms/modified -->

    <owl:NamedIndividual rdf:about="http://purl.org/dc/terms/modified"/>
    


    <!-- http://purl.org/dc/terms/provenance -->

    <owl:NamedIndividual rdf:about="http://purl.org/dc/terms/provenance"/>
    


    <!-- http://purl.org/dc/terms/publisher -->

    <owl:NamedIndividual rdf:about="http://purl.org/dc/terms/publisher"/>
    


    <!-- http://purl.org/dc/terms/references -->

    <owl:NamedIndividual rdf:about="http://purl.org/dc/terms/references"/>
    


    <!-- http://purl.org/dc/terms/relation -->

    <owl:NamedIndividual rdf:about="http://purl.org/dc/terms/relation"/>
    


    <!-- http://purl.org/dc/terms/replaces -->

    <owl:NamedIndividual rdf:about="http://purl.org/dc/terms/replaces"/>
    


    <!-- http://purl.org/dc/terms/requires -->

    <owl:NamedIndividual rdf:about="http://purl.org/dc/terms/requires"/>
    


    <!-- http://purl.org/dc/terms/rights -->

    <owl:NamedIndividual rdf:about="http://purl.org/dc/terms/rights"/>
    


    <!-- http://purl.org/dc/terms/rightsHolder -->

    <owl:NamedIndividual rdf:about="http://purl.org/dc/terms/rightsHolder"/>
    


    <!-- http://purl.org/dc/terms/source -->

    <owl:NamedIndividual rdf:about="http://purl.org/dc/terms/source"/>
    


    <!-- http://purl.org/dc/terms/spatial -->

    <owl:NamedIndividual rdf:about="http://purl.org/dc/terms/spatial"/>
    


    <!-- http://purl.org/dc/terms/subject -->

    <owl:NamedIndividual rdf:about="http://purl.org/dc/terms/subject"/>
    


    <!-- http://purl.org/dc/terms/tableOfContents -->

    <owl:NamedIndividual rdf:about="http://purl.org/dc/terms/tableOfContents"/>
    


    <!-- http://purl.org/dc/terms/temporal -->

    <owl:NamedIndividual rdf:about="http://purl.org/dc/terms/temporal"/>
    


    <!-- http://purl.org/dc/terms/title -->

    <owl:NamedIndividual rdf:about="http://purl.org/dc/terms/title"/>
    


    <!-- http://purl.org/dc/terms/type -->

    <owl:NamedIndividual rdf:about="http://purl.org/dc/terms/type"/>
    


    <!-- http://purl.org/dc/terms/valid -->

    <owl:NamedIndividual rdf:about="http://purl.org/dc/terms/valid"/>
    


    <!-- https://w3id.org/skgo/pham#A._T._FoJo -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#A._T._FoJo">
        <rdf:type rdf:resource="http://xmlns.com/foaf/0.1/Person"/>
        <rdfs:label>A. T. Fojo</rdfs:label>
    </owl:NamedIndividual>
    


    <!-- https://w3id.org/skgo/pham#ABCA2 -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#ABCA2">
        <rdf:type rdf:resource="https://w3id.org/skgo/pham#Gene"/>
        <rdfs:label xml:lang="en">ABCA2</rdfs:label>
    </owl:NamedIndividual>
    


    <!-- https://w3id.org/skgo/pham#ABC_genes -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#ABC_genes">
        <rdf:type rdf:resource="https://w3id.org/skgo/pham#Gene"/>
        <rdfs:label xml:lang="en">ABC_genes</rdfs:label>
    </owl:NamedIndividual>
    


    <!-- https://w3id.org/skgo/pham#ABC_transporters_and_in_vitro_MDR -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#ABC_transporters_and_in_vitro_MDR">
        <rdf:type rdf:resource="https://w3id.org/skgo/pham#Multidrug_resistance_to_cancer_cells"/>
        <hasExperimentMethod rdf:resource="https://w3id.org/skgo/pham#antibody-mediated_cytolysis_experiment"/>
        <useDrug rdf:resource="https://w3id.org/skgo/pham#CAVE"/>
        <useDrug rdf:resource="https://w3id.org/skgo/pham#Cyclosporine"/>
        <useDrug rdf:resource="https://w3id.org/skgo/pham#Cytarabine"/>
        <useDrug rdf:resource="https://w3id.org/skgo/pham#Daunorubicin"/>
        <useDrug rdf:resource="https://w3id.org/skgo/pham#Epirubicin"/>
        <useDrug rdf:resource="https://w3id.org/skgo/pham#Etoposide"/>
        <useDrug rdf:resource="https://w3id.org/skgo/pham#IL-2"/>
        <useDrug rdf:resource="https://w3id.org/skgo/pham#Mitoxantrone"/>
        <useDrug rdf:resource="https://w3id.org/skgo/pham#Paclitaxel"/>
        <useDrug rdf:resource="https://w3id.org/skgo/pham#VAD"/>
        <useDrug rdf:resource="https://w3id.org/skgo/pham#Vindesine"/>
        <useDrug rdf:resource="https://w3id.org/skgo/pham#CAV/EP"/>
        <rdfs:label xml:lang="en">ABC_transporters_and_in_vitro_MDR</rdfs:label>
    </owl:NamedIndividual>
    


    <!-- https://w3id.org/skgo/pham#ABC_transporters_as_multidrug_resistance_mechanisms_and_the_development_of_chemosensitizers_for_their_reversal -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#ABC_transporters_as_multidrug_resistance_mechanisms_and_the_development_of_chemosensitizers_for_their_reversal">
        <rdf:type rdf:resource="http://ns.nature.com/terms/Publication"/>
        <rdf:type rdf:resource="http://purl.org/ontology/bibo/Article"/>
        <addressesStudy rdf:resource="https://w3id.org/skgo/pham#The_physiological_functions_and_structures_of_ABC_transporters"/>
        <terms1:publicationYear rdf:datatype="http://www.w3.org/2001/XMLSchema#gYear">2005</terms1:publicationYear>
        <bibo:abstract rdf:datatype="http://www.w3.org/2000/01/rdf-schema#Literal">One of the major problems related with anticancer chemotherapy is resistance against anticancer drugs. The ATP-binding cassette (ABC) transporters are a family of transporter proteins that are responsible for drug resistance and a low bioavailability of drugs by pumping a variety of drugs out cells at the expense of ATP hydrolysis. One strategy for reversal of the resistance of tumor cells
expressing ABC transporters is combined use of anticancer drugs with chemosensitizers. In this review, the physiological functions and structures of ABC transporters, and the development of chemosensitizers are described focusing on well-known proteins including P-glycoprotein, multidrug resistance associated protein, and breast cancer resistance protein.</bibo:abstract>
        <terms:creator rdf:resource="https://w3id.org/skgo/pham#Cheol-Hee_Choi"/>
        <terms:publisher rdf:resource="https://w3id.org/skgo/pham#Cancer_Cell_International"/>
        <terms:title rdf:datatype="http://www.w3.org/2000/01/rdf-schema#Literal">ABC transporters as multidrug resistance mechanisms and the
development of chemosensitizers for their reversal</terms:title>
    </owl:NamedIndividual>
    


    <!-- https://w3id.org/skgo/pham#ABC_transporters_in_human_cancers -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#ABC_transporters_in_human_cancers">
        <rdf:type rdf:resource="https://w3id.org/skgo/pham#ClinicalStudy"/>
        <investigate rdf:resource="https://w3id.org/skgo/pham#Breast_Cancer"/>
        <investigate rdf:resource="https://w3id.org/skgo/pham#Leukaemia"/>
        <investigate rdf:resource="https://w3id.org/skgo/pham#Lung_cancer"/>
        <investigate rdf:resource="https://w3id.org/skgo/pham#Non_Smallcell_Lung_Cancer"/>
        <investigate rdf:resource="https://w3id.org/skgo/pham#Small_Cell_Lung_Cancer"/>
        <investigatesProblem rdf:resource="https://w3id.org/skgo/pham#Drug_Resistance"/>
        <performsExperiment rdf:resource="https://w3id.org/skgo/pham#multidrug_resistance_to_cancer_cells"/>
        <terms1:name>MULTIDRUG RESISTANCE IN CANCER</terms1:name>
        <rdfs:label xml:lang="en">ABC transporters in human cancers</rdfs:label>
    </owl:NamedIndividual>
    


    <!-- https://w3id.org/skgo/pham#ADE -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#ADE">
        <rdf:type rdf:resource="https://w3id.org/skgo/pham#Drug"/>
        <rdfs:label xml:lang="en">ADE</rdfs:label>
    </owl:NamedIndividual>
    


    <!-- https://w3id.org/skgo/pham#ALL -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#ALL">
        <rdf:type rdf:resource="https://w3id.org/skgo/pham#Disease"/>
        <rdfs:label xml:lang="en">ALL</rdfs:label>
    </owl:NamedIndividual>
    


    <!-- https://w3id.org/skgo/pham#AML -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#AML">
        <rdf:type rdf:resource="https://w3id.org/skgo/pham#Disease"/>
        <rdfs:label xml:lang="en">AML</rdfs:label>
    </owl:NamedIndividual>
    


    <!-- https://w3id.org/skgo/pham#AML_sample -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#AML_sample">
        <rdf:type rdf:resource="https://w3id.org/skgo/pham#Specimen"/>
        <obtainedfromPatient rdf:resource="https://w3id.org/skgo/pham#Phase_III_clinical_trials_with_ABC_transporter_inhibitors"/>
        <rdfs:label xml:lang="en">AML_sample</rdfs:label>
    </owl:NamedIndividual>
    


    <!-- https://w3id.org/skgo/pham#ARUN_K._RISHI -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#ARUN_K._RISHI">
        <rdf:type rdf:resource="http://xmlns.com/foaf/0.1/Person"/>
        <rdfs:label>Arun k. Rishi</rdfs:label>
    </owl:NamedIndividual>
    


    <!-- https://w3id.org/skgo/pham#A_multidrug_resistance_transporter_from_human_MCF-7_breast_cancer_cells -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#A_multidrug_resistance_transporter_from_human_MCF-7_breast_cancer_cells">
        <rdf:type rdf:resource="http://ns.nature.com/terms/Publication"/>
        <rdf:type rdf:resource="http://purl.org/ontology/bibo/Article"/>
        <addressesStudy rdf:resource="https://w3id.org/skgo/pham#Differentially_overexpressed_in_MCF-7/AdrVp_cells_compared_with_MCF-7_cells"/>
        <terms1:publicationYear rdf:datatype="http://www.w3.org/2001/XMLSchema#gYear">1998</terms1:publicationYear>
        <bibo:abstract xml:lang="en">MCF-7yAdrVp is a multidrug-resistant human breast cancer subline that displays an ATP-dependent reduction in the intracellular accumulation of anthracycline anticancer drugs in the absence of overexpression of known multidrug resistance transporters such as P glycoprotein or the multidrug resistance protein. RNA fingerprinting led to the identification of a 2.4-kb mRNA that is overexpressed in
MCF-7yAdrVp cells relative to parental MCF-7 cells. The mRNA encodes a 663-aa member of the ATP-binding cassette superfamily of transporters that we term breast cancer resistance protein (BCRP). Enforced expression of the full-length
BCRP cDNA in MCF-7 breast cancer cells confers resistance to mitoxantrone, doxorubicin, and daunorubicin, reduces daunorubicin accumulation and retention, and causes an ATP-dependent enhancement of the efflux of rhodamine 123
in the cloned transfected cells. BCRP is a xenobiotic transporter that appears to play a major role in the multidrug resistance phenotype of MCF-7yAdrVp human breast cancer cells.</bibo:abstract>
        <terms:creator rdf:resource="https://w3id.org/skgo/pham#ARUN_K._RISHI"/>
        <terms:creator rdf:resource="https://w3id.org/skgo/pham#DOUGLAS_D._ROSS"/>
        <terms:creator rdf:resource="https://w3id.org/skgo/pham#L._AUSTIN_DOYLE"/>
        <terms:creator rdf:resource="https://w3id.org/skgo/pham#LYNNE_V._ABRUZZO"/>
        <terms:creator rdf:resource="https://w3id.org/skgo/pham#TAMMY_KROGMANN"/>
        <terms:creator rdf:resource="https://w3id.org/skgo/pham#WEIDONG_YANG"/>
        <terms:creator rdf:resource="https://w3id.org/skgo/pham#YONGMING_GAO"/>
        <terms:publisher rdf:resource="https://w3id.org/skgo/pham#Proc._Nati._Acad._Sci._USA"/>
        <terms:title rdf:datatype="http://www.w3.org/2000/01/rdf-schema#Literal">A multidrug resistance transporter from human MCF-7 breast cancer cells</terms:title>
    </owl:NamedIndividual>
    


    <!-- https://w3id.org/skgo/pham#Accumulation_Bioassay -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#Accumulation_Bioassay">
        <rdf:type rdf:resource="https://w3id.org/skgo/pham#Assay"/>
        <rdfs:label xml:lang="en">Accumulation_Bioassay</rdfs:label>
    </owl:NamedIndividual>
    


    <!-- https://w3id.org/skgo/pham#Actinomycin_D -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#Actinomycin_D">
        <rdf:type rdf:resource="https://w3id.org/skgo/pham#Drug"/>
        <rdfs:label xml:lang="en">Actinomycin_D</rdfs:label>
    </owl:NamedIndividual>
    


    <!-- https://w3id.org/skgo/pham#Acute_lymphoblastic_leukemia -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#Acute_lymphoblastic_leukemia">
        <rdf:type rdf:resource="https://w3id.org/skgo/pham#Disease"/>
        <rdfs:label xml:lang="en">Acute_lymphoblastic_leukemia</rdfs:label>
    </owl:NamedIndividual>
    


    <!-- https://w3id.org/skgo/pham#Adrenocortical_Cancer -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#Adrenocortical_Cancer">
        <rdf:type rdf:resource="https://w3id.org/skgo/pham#Disease"/>
        <rdfs:label xml:lang="en">Adrenocortical_Cancer</rdfs:label>
    </owl:NamedIndividual>
    


    <!-- https://w3id.org/skgo/pham#Advanced_and_recurrent_breast_cancer_sample -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#Advanced_and_recurrent_breast_cancer_sample">
        <rdf:type rdf:resource="https://w3id.org/skgo/pham#Specimen"/>
        <obtainedfromPatient rdf:resource="https://w3id.org/skgo/pham#Phase_III_clinical_trials_with_ABC_transporter_inhibitors"/>
        <rdfs:label xml:lang="en">Advanced_and_recurrent_breast_cancer_sample</rdfs:label>
    </owl:NamedIndividual>
    


    <!-- https://w3id.org/skgo/pham#American_Type_Culture_Collection -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#American_Type_Culture_Collection">
        <rdf:type rdf:resource="http://xmlns.com/foaf/0.1/Organization"/>
    </owl:NamedIndividual>
    


    <!-- https://w3id.org/skgo/pham#Analysis_of_leukemic_blast_MDR_function -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#Analysis_of_leukemic_blast_MDR_function">
        <rdf:type rdf:resource="https://w3id.org/skgo/pham#ClinicalStudy"/>
        <investigate rdf:resource="https://w3id.org/skgo/pham#AML"/>
        <investigate rdf:resource="https://w3id.org/skgo/pham#Leukaemia"/>
        <investigatesProblem rdf:resource="https://w3id.org/skgo/pham#Multidrug_resistance_MDR_efflux_pumps_capable_of_eliminating_chemotherapeutic_drugs_from_tumor_cells"/>
        <performsExperiment rdf:resource="https://w3id.org/skgo/pham#Zosuquidar_AML_experiments"/>
        <rdfs:label xml:lang="en">Analysis_of_leukemic_blast_MDR_function</rdfs:label>
    </owl:NamedIndividual>
    


    <!-- https://w3id.org/skgo/pham#Anthracyclines-doxorubucin_daunorubicin_epirubicin -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#Anthracyclines-doxorubucin_daunorubicin_epirubicin">
        <rdf:type rdf:resource="https://w3id.org/skgo/pham#Drug"/>
        <rdfs:label xml:lang="en">Anthracyclines-doxorubucin_daunorubicin_epirubicin</rdfs:label>
    </owl:NamedIndividual>
    


    <!-- https://w3id.org/skgo/pham#Anthranilic-acid-based_drug -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#Anthranilic-acid-based_drug">
        <rdf:type rdf:resource="https://w3id.org/skgo/pham#Drug"/>
        <rdfs:label xml:lang="en">Anthranilic-acid-based_drug</rdfs:label>
    </owl:NamedIndividual>
    


    <!-- https://w3id.org/skgo/pham#AssayKit -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#AssayKit">
        <foaf:name xml:lang="en">AssayKit</foaf:name>
    </owl:NamedIndividual>
    


    <!-- https://w3id.org/skgo/pham#AssayKit15 -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#AssayKit15"/>
    


    <!-- https://w3id.org/skgo/pham#AssayKit16 -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#AssayKit16"/>
    


    <!-- https://w3id.org/skgo/pham#AssayKit17 -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#AssayKit17"/>
    


    <!-- https://w3id.org/skgo/pham#AssayKit18 -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#AssayKit18"/>
    


    <!-- https://w3id.org/skgo/pham#AssayKit19 -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#AssayKit19"/>
    


    <!-- https://w3id.org/skgo/pham#AssayKit2 -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#AssayKit2"/>
    


    <!-- https://w3id.org/skgo/pham#AssayKit20 -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#AssayKit20"/>
    


    <!-- https://w3id.org/skgo/pham#AssayKit3 -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#AssayKit3"/>
    


    <!-- https://w3id.org/skgo/pham#AssayKit4 -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#AssayKit4"/>
    


    <!-- https://w3id.org/skgo/pham#AssayKit5 -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#AssayKit5"/>
    


    <!-- https://w3id.org/skgo/pham#AssayKit6 -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#AssayKit6"/>
    


    <!-- https://w3id.org/skgo/pham#AssayKit7 -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#AssayKit7"/>
    


    <!-- https://w3id.org/skgo/pham#AssayKit8 -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#AssayKit8"/>
    


    <!-- https://w3id.org/skgo/pham#AssayKit9 -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#AssayKit9"/>
    


    <!-- https://w3id.org/skgo/pham#AssayMethod -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#AssayMethod">
        <foaf:name xml:lang="en">AssayMethod</foaf:name>
    </owl:NamedIndividual>
    


    <!-- https://w3id.org/skgo/pham#Asuka_Mizutani -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#Asuka_Mizutani">
        <rdf:type rdf:resource="http://xmlns.com/foaf/0.1/Person"/>
        <rdfs:label>Asuka Mizutani</rdfs:label>
    </owl:NamedIndividual>
    


    <!-- https://w3id.org/skgo/pham#BBR3390 -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#BBR3390">
        <rdf:type rdf:resource="https://w3id.org/skgo/pham#Drug"/>
        <rdfs:label xml:lang="en">BBR3390</rdfs:label>
    </owl:NamedIndividual>
    


    <!-- https://w3id.org/skgo/pham#BCRP -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#BCRP">
        <rdf:type rdf:resource="https://w3id.org/skgo/pham#Gene"/>
        <rdfs:label xml:lang="en">BCRP</rdfs:label>
    </owl:NamedIndividual>
    


    <!-- https://w3id.org/skgo/pham#BD_Biosciences_La_Jolla_CA -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#BD_Biosciences_La_Jolla_CA">
        <rdf:type rdf:resource="http://xmlns.com/foaf/0.1/Organization"/>
    </owl:NamedIndividual>
    


    <!-- https://w3id.org/skgo/pham#BH3_profiling -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#BH3_profiling">
        <rdf:type rdf:resource="https://w3id.org/skgo/pham#Multidrug_resistance_to_cancer_cells"/>
        <hasExperimentMethod rdf:resource="https://w3id.org/skgo/pham#BH3_profiling_method"/>
        <useCellLine rdf:resource="https://w3id.org/skgo/pham#Gastrointestinal_stromal_tumour_GIST_cell_lines"/>
        <useCellLine rdf:resource="https://w3id.org/skgo/pham#Melanoma"/>
        <useCellLine rdf:resource="https://w3id.org/skgo/pham#Pancreatic_cancer_cell_lines"/>
        <useCellLine rdf:resource="https://w3id.org/skgo/pham#ERBB2‑amplified_breast_cancer_cell_lines"/>
        <useDrug rdf:resource="https://w3id.org/skgo/pham#Bevacizumab"/>
        <useDrug rdf:resource="https://w3id.org/skgo/pham#Bortezomib"/>
        <useDrug rdf:resource="https://w3id.org/skgo/pham#Cetuximab"/>
        <useDrug rdf:resource="https://w3id.org/skgo/pham#Crizotinib"/>
        <useDrug rdf:resource="https://w3id.org/skgo/pham#Dasatinib"/>
        <useDrug rdf:resource="https://w3id.org/skgo/pham#Gefitinib"/>
        <useDrug rdf:resource="https://w3id.org/skgo/pham#Nilotinib"/>
        <useDrug rdf:resource="https://w3id.org/skgo/pham#Trastuzumab"/>
        <useDrug rdf:resource="https://w3id.org/skgo/pham#Vemurafenib"/>
        <rdfs:label xml:lang="en">BH3_profiling</rdfs:label>
    </owl:NamedIndividual>
    


    <!-- https://w3id.org/skgo/pham#BH3_profiling_method -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#BH3_profiling_method">
        <rdf:type rdf:resource="https://w3id.org/skgo/pham#Antibody-mediated_cytolysis_experiment"/>
        <useAssay rdf:resource="https://w3id.org/skgo/pham#Functional_Assay"/>
        <rdfs:label xml:lang="en">BH3_profiling_method</rdfs:label>
    </owl:NamedIndividual>
    


    <!-- https://w3id.org/skgo/pham#Bevacizumab -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#Bevacizumab">
        <rdf:type rdf:resource="https://w3id.org/skgo/pham#Drug"/>
        <rdfs:label xml:lang="en">Bevacizumab</rdfs:label>
    </owl:NamedIndividual>
    


    <!-- https://w3id.org/skgo/pham#Blast_populations_in_the_two_bioassays -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#Blast_populations_in_the_two_bioassays">
        <rdf:type rdf:resource="https://w3id.org/skgo/pham#StatisticalAnalysis"/>
        <rdfs:label xml:lang="en">Blast populations in the two bioassays</rdfs:label>
        <skos:definition xml:lang="en">P-gp accumulation ratio, P-gp efflux ratio, percent unimpeded efflux for total MDR activity, percent efflux in the presence of zosuquidar, and percent inhibition of efflux by zosuquidar</skos:definition>
    </owl:NamedIndividual>
    


    <!-- https://w3id.org/skgo/pham#Bone_marrow_aspirates -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#Bone_marrow_aspirates">
        <rdf:type rdf:resource="https://w3id.org/skgo/pham#Specimen"/>
        <obtainedfrom rdf:resource="https://w3id.org/skgo/pham#50_patients_with_newly_diagnosed_AML"/>
        <rdfs:label xml:lang="en">Bone_marrow_aspirates</rdfs:label>
    </owl:NamedIndividual>
    


    <!-- https://w3id.org/skgo/pham#Bortezomib -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#Bortezomib">
        <rdf:type rdf:resource="https://w3id.org/skgo/pham#Drug"/>
        <rdfs:label xml:lang="en">Bortezomib</rdfs:label>
    </owl:NamedIndividual>
    


    <!-- https://w3id.org/skgo/pham#Branimir_I._Sikic -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#Branimir_I._Sikic">
        <rdf:type rdf:resource="http://xmlns.com/foaf/0.1/Person"/>
        <rdfs:label>Branimir I. Sikic</rdfs:label>
    </owl:NamedIndividual>
    


    <!-- https://w3id.org/skgo/pham#Breast_Cancer -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#Breast_Cancer">
        <rdf:type rdf:resource="https://w3id.org/skgo/pham#Disease"/>
        <rdfs:label xml:lang="en">Breast_Cancer</rdfs:label>
    </owl:NamedIndividual>
    


    <!-- https://w3id.org/skgo/pham#Breast_cancer_samples -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#Breast_cancer_samples">
        <rdf:type rdf:resource="https://w3id.org/skgo/pham#Specimen"/>
        <obtainedfromPatient rdf:resource="https://w3id.org/skgo/pham#Patient_with_adrenocortical_cancer_and_breast_cancer"/>
        <rdfs:label xml:lang="en">Breast_cancer_samples</rdfs:label>
    </owl:NamedIndividual>
    


    <!-- https://w3id.org/skgo/pham#CAVE -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#CAVE">
        <rdf:type rdf:resource="https://w3id.org/skgo/pham#Drug"/>
        <rdfs:label xml:lang="en">CAVE</rdfs:label>
    </owl:NamedIndividual>
    


    <!-- https://w3id.org/skgo/pham#CCL_127__PC12 -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#CCL_127__PC12">
        <rdf:type rdf:resource="https://w3id.org/skgo/pham#CellLine"/>
        <rdfs:label xml:lang="en">CCL_127__PC12</rdfs:label>
    </owl:NamedIndividual>
    


    <!-- https://w3id.org/skgo/pham#CI1033 -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#CI1033">
        <rdf:type rdf:resource="https://w3id.org/skgo/pham#Drug"/>
        <rdfs:label xml:lang="en">CI1033</rdfs:label>
    </owl:NamedIndividual>
    


    <!-- https://w3id.org/skgo/pham#CLONTECH -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#CLONTECH">
        <rdf:type rdf:resource="http://xmlns.com/foaf/0.1/Organization"/>
    </owl:NamedIndividual>
    


    <!-- https://w3id.org/skgo/pham#CML -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#CML">
        <rdf:type rdf:resource="https://w3id.org/skgo/pham#Disease"/>
        <rdfs:label xml:lang="en">CML</rdfs:label>
    </owl:NamedIndividual>
    


    <!-- https://w3id.org/skgo/pham#Caitriona_Holohan -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#Caitriona_Holohan">
        <rdf:type rdf:resource="http://xmlns.com/foaf/0.1/Person"/>
        <rdfs:label>Caitriona Holohan</rdfs:label>
    </owl:NamedIndividual>
    


    <!-- https://w3id.org/skgo/pham#Cancer_Cell_International -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#Cancer_Cell_International">
        <rdf:type rdf:resource="http://ns.nature.com/terms/Publisher"/>
    </owl:NamedIndividual>
    


    <!-- https://w3id.org/skgo/pham#Cancer_chemotherapy_doxorubicin_vinblastine -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#Cancer_chemotherapy_doxorubicin_vinblastine">
        <rdf:type rdf:resource="https://w3id.org/skgo/pham#Treatment"/>
        <useDrug rdf:resource="https://w3id.org/skgo/pham#Actinomycin_D"/>
        <useDrug rdf:resource="https://w3id.org/skgo/pham#Doxorubicin"/>
        <useDrug rdf:resource="https://w3id.org/skgo/pham#Mitomycin_C"/>
        <useDrug rdf:resource="https://w3id.org/skgo/pham#Vincristine"/>
        <useSpecimen rdf:resource="https://w3id.org/skgo/pham#Peripheral_blood_lymphocytes"/>
        <treatmentOutcome xml:lang="en">Vinca alkaloid, doxorubicin, or actinomycin D might not be effective in the therapy of pheochromocytoma.</treatmentOutcome>
        <rdfs:label xml:lang="en">Cancer_chemotherapy_doxorubicin_vinblastine</rdfs:label>
    </owl:NamedIndividual>
    


    <!-- https://w3id.org/skgo/pham#Cancer_drug_resistance_an_evolving_paradigm -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#Cancer_drug_resistance_an_evolving_paradigm">
        <rdf:type rdf:resource="http://ns.nature.com/terms/Publication"/>
        <rdf:type rdf:resource="http://purl.org/ontology/bibo/Article"/>
        <addressesStudy rdf:resource="https://w3id.org/skgo/pham#Mechanisms_that_enable_the_survival_of_cancer_cells_during_drug_treatment"/>
        <bibo:abstract xml:lang="en">Resistance to chemotherapy and molecularly targeted therapies is a major
problem facing current cancer research. The mechanisms of resistance to ‘classical’ cytotoxic chemotherapeutics and to therapies that are designed to be selective for specific molecular targets share many features, such as alterations in the drug target, activation of prosurvival pathways and ineffective induction of cell death. With the increasing arsenal of anticancer agents, improving preclinical models and the advent of powerful high-throughput screening techniques, there are now unprecedented opportunities to understand and overcome drug
resistance through the clinical assessment of rational therapeutic drug combinations and the use of predictive biomarkers to enable patient stratification.</bibo:abstract>
        <terms:creator rdf:resource="https://w3id.org/skgo/pham#Caitriona_Holohan"/>
        <terms:creator rdf:resource="https://w3id.org/skgo/pham#Daniel_B._Longley"/>
        <terms:creator rdf:resource="https://w3id.org/skgo/pham#Patrick_G._Johnston"/>
        <terms:creator rdf:resource="https://w3id.org/skgo/pham#Sandra_Van_Schaeybroeck"/>
        <terms:publisher rdf:resource="https://w3id.org/skgo/pham#Macmillan_Magazines_Ltd"/>
        <terms:title xml:lang="en">Cancer drug resistance: an evolving paradigm</terms:title>
    </owl:NamedIndividual>
    


    <!-- https://w3id.org/skgo/pham#Carboplatin -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#Carboplatin">
        <rdf:type rdf:resource="https://w3id.org/skgo/pham#Drug"/>
        <rdfs:label xml:lang="en">Carboplatin</rdfs:label>
    </owl:NamedIndividual>
    


    <!-- https://w3id.org/skgo/pham#Catherine_Booth-Genthe -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#Catherine_Booth-Genthe">
        <rdf:type rdf:resource="http://xmlns.com/foaf/0.1/Person"/>
        <rdfs:label>Catherine Booth Genthe</rdfs:label>
    </owl:NamedIndividual>
    


    <!-- https://w3id.org/skgo/pham#Cetuximab -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#Cetuximab">
        <rdf:type rdf:resource="https://w3id.org/skgo/pham#Drug"/>
        <rdfs:label xml:lang="en">Cetuximab</rdfs:label>
    </owl:NamedIndividual>
    


    <!-- https://w3id.org/skgo/pham#Chemotherapy -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#Chemotherapy">
        <rdf:type rdf:resource="https://w3id.org/skgo/pham#Treatment"/>
        <rdfs:label xml:lang="en">Chemotherapy</rdfs:label>
    </owl:NamedIndividual>
    


    <!-- https://w3id.org/skgo/pham#Chemotherapy_with_targeted_inhibitors_of_Pgp-mediated_drug_transport -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#Chemotherapy_with_targeted_inhibitors_of_Pgp-mediated_drug_transport">
        <rdf:type rdf:resource="https://w3id.org/skgo/pham#Treatment"/>
        <useSpecimen rdf:resource="https://w3id.org/skgo/pham#AML_sample"/>
        <useSpecimen rdf:resource="https://w3id.org/skgo/pham#Advanced_and_recurrent_breast_cancer_sample"/>
        <useSpecimen rdf:resource="https://w3id.org/skgo/pham#NSCLC_sample"/>
        <useSpecimen rdf:resource="https://w3id.org/skgo/pham#Poor-risk_acute_leukaemia_samples"/>
        <useSpecimen rdf:resource="https://w3id.org/skgo/pham#Refractory_AML_high-risk_MDS_sample"/>
        <useSpecimen rdf:resource="https://w3id.org/skgo/pham#Relapsed_and_refractory_AML_sample"/>
        <rdfs:label xml:lang="en">Chemotherapy_with_targeted_inhibitors_of_Pgp-mediated_drug_transport</rdfs:label>
    </owl:NamedIndividual>
    


    <!-- https://w3id.org/skgo/pham#Cheol-Hee_Choi -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#Cheol-Hee_Choi">
        <rdf:type rdf:resource="http://xmlns.com/foaf/0.1/Person"/>
        <rdfs:label>Cheol Hee Choi</rdfs:label>
    </owl:NamedIndividual>
    


    <!-- https://w3id.org/skgo/pham#ClinicalProblemSolution1 -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#ClinicalProblemSolution1"/>
    


    <!-- https://w3id.org/skgo/pham#ClinicalProblemSolution10 -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#ClinicalProblemSolution10"/>
    


    <!-- https://w3id.org/skgo/pham#ClinicalProblemSolution11 -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#ClinicalProblemSolution11"/>
    


    <!-- https://w3id.org/skgo/pham#ClinicalProblemSolution12 -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#ClinicalProblemSolution12"/>
    


    <!-- https://w3id.org/skgo/pham#ClinicalProblemSolution13 -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#ClinicalProblemSolution13"/>
    


    <!-- https://w3id.org/skgo/pham#ClinicalProblemSolution14 -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#ClinicalProblemSolution14"/>
    


    <!-- https://w3id.org/skgo/pham#ClinicalProblemSolution15 -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#ClinicalProblemSolution15"/>
    


    <!-- https://w3id.org/skgo/pham#ClinicalProblemSolution16 -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#ClinicalProblemSolution16"/>
    


    <!-- https://w3id.org/skgo/pham#ClinicalProblemSolution17 -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#ClinicalProblemSolution17"/>
    


    <!-- https://w3id.org/skgo/pham#ClinicalProblemSolution18 -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#ClinicalProblemSolution18"/>
    


    <!-- https://w3id.org/skgo/pham#ClinicalProblemSolution19 -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#ClinicalProblemSolution19"/>
    


    <!-- https://w3id.org/skgo/pham#ClinicalProblemSolution2 -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#ClinicalProblemSolution2"/>
    


    <!-- https://w3id.org/skgo/pham#ClinicalProblemSolution20 -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#ClinicalProblemSolution20"/>
    


    <!-- https://w3id.org/skgo/pham#ClinicalProblemSolution3 -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#ClinicalProblemSolution3"/>
    


    <!-- https://w3id.org/skgo/pham#ClinicalProblemSolution4 -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#ClinicalProblemSolution4"/>
    


    <!-- https://w3id.org/skgo/pham#ClinicalProblemSolution5 -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#ClinicalProblemSolution5"/>
    


    <!-- https://w3id.org/skgo/pham#ClinicalProblemSolution6 -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#ClinicalProblemSolution6"/>
    


    <!-- https://w3id.org/skgo/pham#ClinicalProblemSolution7 -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#ClinicalProblemSolution7"/>
    


    <!-- https://w3id.org/skgo/pham#ClinicalProblemSolution8 -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#ClinicalProblemSolution8"/>
    


    <!-- https://w3id.org/skgo/pham#ClinicalProblemSolution9 -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#ClinicalProblemSolution9"/>
    


    <!-- https://w3id.org/skgo/pham#Clonogenic_survival_assays -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#Clonogenic_survival_assays">
        <rdf:type rdf:resource="https://w3id.org/skgo/pham#Assay"/>
        <rdfs:label xml:lang="en">Clonogenic_survival_assays</rdfs:label>
    </owl:NamedIndividual>
    


    <!-- https://w3id.org/skgo/pham#Colchicine -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#Colchicine">
        <rdf:type rdf:resource="https://w3id.org/skgo/pham#Drug"/>
        <rdfs:label xml:lang="en">Colchicine</rdfs:label>
    </owl:NamedIndividual>
    


    <!-- https://w3id.org/skgo/pham#Colerectal_cancer -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#Colerectal_cancer">
        <rdf:type rdf:resource="https://w3id.org/skgo/pham#Disease"/>
        <rdfs:label xml:lang="en">Colerectal_cancer</rdfs:label>
    </owl:NamedIndividual>
    


    <!-- https://w3id.org/skgo/pham#Colon_Tumor -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#Colon_Tumor">
        <rdf:type rdf:resource="https://w3id.org/skgo/pham#Disease"/>
        <rdfs:label xml:lang="en">Colerectal_cancer</rdfs:label>
    </owl:NamedIndividual>
    


    <!-- https://w3id.org/skgo/pham#Colon_carcinoma -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#Colon_carcinoma">
        <rdf:type rdf:resource="https://w3id.org/skgo/pham#CellLine"/>
        <obtainedfrom rdf:resource="https://w3id.org/skgo/pham#National_Cancer_Institute"/>
        <rdfs:label xml:lang="en">Colon_carcinoma</rdfs:label>
    </owl:NamedIndividual>
    


    <!-- https://w3id.org/skgo/pham#Crizotinib -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#Crizotinib">
        <rdf:type rdf:resource="https://w3id.org/skgo/pham#Drug"/>
        <rdfs:label xml:lang="en">Crizotinib</rdfs:label>
    </owl:NamedIndividual>
    


    <!-- https://w3id.org/skgo/pham#Cyclosporine -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#Cyclosporine">
        <rdf:type rdf:resource="https://w3id.org/skgo/pham#Drug"/>
        <rdfs:label xml:lang="en">Cyclosporine</rdfs:label>
    </owl:NamedIndividual>
    


    <!-- https://w3id.org/skgo/pham#Cytarabine -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#Cytarabine">
        <rdf:type rdf:resource="https://w3id.org/skgo/pham#Drug"/>
        <rdfs:label xml:lang="en">Cytarabine</rdfs:label>
    </owl:NamedIndividual>
    


    <!-- https://w3id.org/skgo/pham#D._G._POPLACK -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#D._G._POPLACK">
        <rdf:type rdf:resource="http://xmlns.com/foaf/0.1/Person"/>
        <rdfs:label>D. G. Poplack</rdfs:label>
    </owl:NamedIndividual>
    


    <!-- https://w3id.org/skgo/pham#D._J._SLAMON -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#D._J._SLAMON">
        <rdf:type rdf:resource="http://xmlns.com/foaf/0.1/Person"/>
        <rdfs:label>D. J. Slamon</rdfs:label>
    </owl:NamedIndividual>
    


    <!-- https://w3id.org/skgo/pham#DOUGLAS_D._ROSS -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#DOUGLAS_D._ROSS">
        <rdf:type rdf:resource="http://xmlns.com/foaf/0.1/Person"/>
        <rdfs:label>Douglas D. Ross</rdfs:label>
    </owl:NamedIndividual>
    


    <!-- https://w3id.org/skgo/pham#Daniel_B._Longley -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#Daniel_B._Longley">
        <rdf:type rdf:resource="http://xmlns.com/foaf/0.1/Person"/>
        <rdfs:label>Daniel B. Longley</rdfs:label>
    </owl:NamedIndividual>
    


    <!-- https://w3id.org/skgo/pham#Dasatinib -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#Dasatinib">
        <rdf:type rdf:resource="https://w3id.org/skgo/pham#Drug"/>
        <rdfs:label xml:lang="en">Dasatinib</rdfs:label>
    </owl:NamedIndividual>
    


    <!-- https://w3id.org/skgo/pham#Daunomycin -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#Daunomycin">
        <rdf:type rdf:resource="https://w3id.org/skgo/pham#Drug"/>
        <owl:sameAs rdf:resource="https://w3id.org/skgo/pham#Daunorubicin"/>
        <rdfs:label xml:lang="en">Daunomycin</rdfs:label>
    </owl:NamedIndividual>
    


    <!-- https://w3id.org/skgo/pham#Daunorubicin -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#Daunorubicin">
        <rdf:type rdf:resource="https://w3id.org/skgo/pham#Drug"/>
        <rdfs:label xml:lang="en">Daunorubicin</rdfs:label>
    </owl:NamedIndividual>
    


    <!-- https://w3id.org/skgo/pham#Delta_RNA_Fingerprinting_kit -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#Delta_RNA_Fingerprinting_kit">
        <rdf:type rdf:resource="https://w3id.org/skgo/pham#ExperimentKit"/>
        <obtainedfrom rdf:resource="https://w3id.org/skgo/pham#CLONTECH"/>
        <rdfs:label xml:lang="en">Delta_RNA_Fingerprinting_kit</rdfs:label>
    </owl:NamedIndividual>
    


    <!-- https://w3id.org/skgo/pham#Describe_various_approaches_to_combating_multidrug-resistant_cancer -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#Describe_various_approaches_to_combating_multidrug-resistant_cancer">
        <rdf:type rdf:resource="https://w3id.org/skgo/pham#levels_of_mdr1_mRNA"/>
        <terms:description>The most common of these mechanisms, one that relies on drug efflux from cancer cells mediated by ATP-binding cassette (ABC) transporters.</terms:description>
        <rdfs:label xml:lang="en">Describe_various_approaches_to_combating_multidrug-resistant_cancer</rdfs:label>
    </owl:NamedIndividual>
    


    <!-- https://w3id.org/skgo/pham#DiOC2 -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#DiOC2">
        <rdf:type rdf:resource="https://w3id.org/skgo/pham#Reagent"/>
        <obtainedfrom rdf:resource="https://w3id.org/skgo/pham#Invitrogen"/>
        <rdfs:label xml:lang="en">DiOC2</rdfs:label>
    </owl:NamedIndividual>
    


    <!-- https://w3id.org/skgo/pham#Different_Efflux_Transporter_Aff_inity_and_Metabolism_of_99mTc-2-Methoxyisobutylisonitrile_and_99mTc-Tetrofosmin_for_Multidrug_Resistance_Monitoring_in_Cancer -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#Different_Efflux_Transporter_Aff_inity_and_Metabolism_of_99mTc-2-Methoxyisobutylisonitrile_and_99mTc-Tetrofosmin_for_Multidrug_Resistance_Monitoring_in_Cancer">
        <rdf:type rdf:resource="http://ns.nature.com/terms/Publication"/>
        <rdf:type rdf:resource="http://purl.org/ontology/bibo/Article"/>
        <addressesStudy rdf:resource="https://w3id.org/skgo/pham#Multidrug_Resistance_Monitoring_in_Cancer"/>
        <terms1:publicationYear xml:lang="en">2018</terms1:publicationYear>
        <bibo:abstract xml:lang="en">Background Little is known about the affinity and stability of
99mTc-labeled 2-methoxyisobutylisonitrile (99mTc-MIBI) and
tetrofosmin (99mTc-TF) for imaging of multiple drug resistance
transporters in cancer. We examined the affinity of 99mTc-labeled
compounds for these transporters and their stability.
Methods 99mTc-MIBI and 99mTc-TF were incubated in vesicles
expressing P-glycoprotein (MDR1), multidrug resistanceassociated
protein (MRP)1–4, or breast cancer resistance protein
with and without verapamil (MDR1 inhibitor) or MK-
571 (MRP inhibitor). Time activity curves of 99mTc-labeled
compounds were established using SK-N-SH neuroblastoma,
SK-MEL-28 melanoma, and PC-3 prostate adenocarcinoma
cell lines, and transporter expression of multiple drug resistance
was measured in these cells. The stability was evaluated.
Results In vesicles, 99mTc-labeled compounds had affinity for
MDR1 and MRP1. 99mTc-TF had additional affinity for
MRP2 and MRP3. In SK-N-SH cells expressing MDR1 and
MRP1, MK-571 produced the highest uptake of both 99mTclabeled
compounds. 99mTc-MIBI uptake with inhibitors was
higher than 99mTc-TF uptake with inhibitors. 99mTc-TF was
taken up more in SK-MEL-28 cells expressing MRP1 and
MRP2 than PC-3 cells expressing MRP1 and MRP3. 99mTc-
MIBI was metabolized, whereas 99mTc-TF had high stability.
Conclusion 99mTc-MIBI is exported via MDR1 and MRP1
(MRP1 &gt; MDR1) at greater levels and more quickly compared
to 99mTc-TF, which is exported via MDR1 and MRP1–3
(MRP1 &gt; MDR1; MRP1, 2 &gt;MRP3). Because 99mTc-MIBI
is metabolized, clinical imaging for monitoring MDR and
shorter examination times may be possible with an earlier scanning
time on late phase imaging. 99mTc-TF has high stability
and accurately reflects the function of MDR1 and MRP1–3.</bibo:abstract>
        <terms:creator rdf:resource="https://w3id.org/skgo/pham#Asuka_Mizutani"/>
        <terms:creator rdf:resource="https://w3id.org/skgo/pham#Ikumi_Tamai"/>
        <terms:creator rdf:resource="https://w3id.org/skgo/pham#Kazuki_Fukuchi"/>
        <terms:creator rdf:resource="https://w3id.org/skgo/pham#Keiichi_Kawai"/>
        <terms:creator rdf:resource="https://w3id.org/skgo/pham#Kodai_Nishi"/>
        <terms:creator rdf:resource="https://w3id.org/skgo/pham#Masato_Kobayashi"/>
        <terms:creator rdf:resource="https://w3id.org/skgo/pham#Ryuichi_Nishii"/>
        <terms:creator rdf:resource="https://w3id.org/skgo/pham#Takafumi_Tsujiuchi"/>
        <terms:creator rdf:resource="https://w3id.org/skgo/pham#Takeo_Nakanishi"/>
        <terms:creator rdf:resource="https://w3id.org/skgo/pham#Yuya_Okui"/>
        <terms:publisher rdf:resource="https://w3id.org/skgo/pham#Springer_Science+Business_Media_LLC"/>
        <terms:title xml:lang="en">Different Efflux Transporter Aff inity and Metabolism of 99mTc-2-Methoxyisobutylisonitrile and 99mTc-Tetrofosmin for Multidrug Resistance Monitoring in Cancer</terms:title>
    </owl:NamedIndividual>
    


    <!-- https://w3id.org/skgo/pham#Differential_inhibition_of_various_transporters_by_two_structurally_similar_MDR_modulators -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#Differential_inhibition_of_various_transporters_by_two_structurally_similar_MDR_modulators">
        <rdf:type rdf:resource="https://w3id.org/skgo/pham#Treatment"/>
        <useDrug rdf:resource="https://w3id.org/skgo/pham#Daunorubicin"/>
        <useDrug rdf:resource="https://w3id.org/skgo/pham#Leukotriene_C4"/>
        <useDrug rdf:resource="https://w3id.org/skgo/pham#Taurocholate"/>
        <treatmentOutcome xml:lang="en">There was increased intracellular
accumulation of doxorubicin as was evidenced using
confocal microscopy and reduced toxicity compared to the
free (unencapsulated) doxorubicin.</treatmentOutcome>
        <rdfs:label xml:lang="en">Differential_inhibition_of_various_transporters_by_two_structurally_similar_MDR_modulators</rdfs:label>
    </owl:NamedIndividual>
    


    <!-- https://w3id.org/skgo/pham#Doxorubicin -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#Doxorubicin">
        <rdf:type rdf:resource="https://w3id.org/skgo/pham#Drug"/>
        <rdfs:label xml:lang="en">Doxorubicin</rdfs:label>
    </owl:NamedIndividual>
    


    <!-- https://w3id.org/skgo/pham#Drosophila_white_gene -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#Drosophila_white_gene">
        <rdf:type rdf:resource="https://w3id.org/skgo/pham#Gene"/>
        <rdfs:label xml:lang="en">Drosophila_white_gene</rdfs:label>
    </owl:NamedIndividual>
    


    <!-- https://w3id.org/skgo/pham#Drug_Resistance -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#Drug_Resistance">
        <rdf:type rdf:resource="https://w3id.org/skgo/pham#ClinicalProblem"/>
        <hasMutationResult>Dubin-Johnson syndrome</hasMutationResult>
        <hasTissueLocalization>Liver, kidney, intestine, adrenal glands, pancreas, lung, ovary</hasTissueLocalization>
        <name>Drug Resistance</name>
        <rdfs:label xml:lang="en">Drug_Resistance</rdfs:label>
    </owl:NamedIndividual>
    


    <!-- https://w3id.org/skgo/pham#Drug_efflux_from_cancer_cells_mediated_by_ATP-binding_cassette_ABC_transporters -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#Drug_efflux_from_cancer_cells_mediated_by_ATP-binding_cassette_ABC_transporters">
        <rdf:type rdf:resource="https://w3id.org/skgo/pham#ClinicalStudy"/>
        <investigate rdf:resource="https://w3id.org/skgo/pham#AML"/>
        <investigate rdf:resource="https://w3id.org/skgo/pham#Breast_Cancer"/>
        <investigate rdf:resource="https://w3id.org/skgo/pham#Leukaemia"/>
        <investigate rdf:resource="https://w3id.org/skgo/pham#Lung_cancer"/>
        <investigate rdf:resource="https://w3id.org/skgo/pham#Myeloma"/>
        <performsExperiment rdf:resource="https://w3id.org/skgo/pham#ABC_transporters_and_in_vitro_MDR"/>
        <terms1:name>Targeting multidrug resistance in cancer</terms1:name>
        <rdfs:label xml:lang="en">Drug_efflux_from_cancer_cells_mediated_by_ATP-binding_cassette_ABC_transporters</rdfs:label>
    </owl:NamedIndividual>
    


    <!-- https://w3id.org/skgo/pham#Drug_resistance_and_its_role_in_clinical_oncology -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#Drug_resistance_and_its_role_in_clinical_oncology">
        <rdf:type rdf:resource="https://w3id.org/skgo/pham#levels_of_mdr1_mRNA"/>
        <terms:description>Cellular mechanisms of multidrug resistance and ATP-binding cassette (ABC) transporters</terms:description>
        <rdfs:label xml:lang="en">Drug_resistance_and_its_role_in_clinical_oncology</rdfs:label>
    </owl:NamedIndividual>
    


    <!-- https://w3id.org/skgo/pham#EasternBlotting -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#EasternBlotting">
        <foaf:name xml:lang="en">EasternBlotting</foaf:name>
    </owl:NamedIndividual>
    


    <!-- https://w3id.org/skgo/pham#Eastern_Blot_Analysis -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#Eastern_Blot_Analysis">
        <rdf:type rdf:resource="https://w3id.org/skgo/pham#EasternBlotting"/>
        <rdfs:label xml:lang="en">Eastern_Blot_Analysis</rdfs:label>
    </owl:NamedIndividual>
    


    <!-- https://w3id.org/skgo/pham#Efflux_Bioassay -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#Efflux_Bioassay">
        <rdf:type rdf:resource="https://w3id.org/skgo/pham#Assay"/>
        <rdfs:label xml:lang="en">Efflux_Bioassay</rdfs:label>
    </owl:NamedIndividual>
    


    <!-- https://w3id.org/skgo/pham#Elisabeth_Paietta -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#Elisabeth_Paietta">
        <rdf:type rdf:resource="http://xmlns.com/foaf/0.1/Person"/>
        <rdfs:label>Elisabeth Paietta</rdfs:label>
    </owl:NamedIndividual>
    


    <!-- https://w3id.org/skgo/pham#Endogenous_and_exogenous_substrates_for_ABC_transporters -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#Endogenous_and_exogenous_substrates_for_ABC_transporters">
        <rdf:type rdf:resource="https://w3id.org/skgo/pham#Multidrug_resistance_to_cancer_cells"/>
        <useDrug rdf:resource="https://w3id.org/skgo/pham#Actinomycin_D"/>
        <useDrug rdf:resource="https://w3id.org/skgo/pham#Anthracyclines-doxorubucin_daunorubicin_epirubicin"/>
        <useDrug rdf:resource="https://w3id.org/skgo/pham#Colchicine"/>
        <useDrug rdf:resource="https://w3id.org/skgo/pham#Methotrexate"/>
        <useDrug rdf:resource="https://w3id.org/skgo/pham#Podophyllotoxin-etoposide_teniposide"/>
        <useGene rdf:resource="https://w3id.org/skgo/pham#MRP1"/>
        <useGene rdf:resource="https://w3id.org/skgo/pham#MRP2"/>
        <useGene rdf:resource="https://w3id.org/skgo/pham#MRP3"/>
        <useGene rdf:resource="https://w3id.org/skgo/pham#MRP4"/>
        <useGene rdf:resource="https://w3id.org/skgo/pham#MRP5"/>
        <useGene rdf:resource="https://w3id.org/skgo/pham#MRP6"/>
        <useGene rdf:resource="https://w3id.org/skgo/pham#MRP7"/>
        <useGene rdf:resource="https://w3id.org/skgo/pham#MRP8"/>
        <useGene rdf:resource="https://w3id.org/skgo/pham#mdr1"/>
        <rdfs:label xml:lang="en">Endogenous_and_exogenous_substrates_for_ABC_transporters</rdfs:label>
    </owl:NamedIndividual>
    


    <!-- https://w3id.org/skgo/pham#Epirubicin -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#Epirubicin">
        <rdf:type rdf:resource="https://w3id.org/skgo/pham#Drug"/>
        <rdfs:label xml:lang="en">Epirubicin</rdfs:label>
    </owl:NamedIndividual>
    


    <!-- https://w3id.org/skgo/pham#Etoposide -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#Etoposide">
        <rdf:type rdf:resource="https://w3id.org/skgo/pham#Drug"/>
        <rdfs:label xml:lang="en">Etoposide</rdfs:label>
    </owl:NamedIndividual>
    


    <!-- https://w3id.org/skgo/pham#European_Journal_of_Pharmaceutical_Sciences -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#European_Journal_of_Pharmaceutical_Sciences">
        <rdf:type rdf:resource="http://ns.nature.com/terms/Publisher"/>
    </owl:NamedIndividual>
    


    <!-- https://w3id.org/skgo/pham#Evidence17 -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#Evidence17"/>
    


    <!-- https://w3id.org/skgo/pham#Evidence18 -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#Evidence18"/>
    


    <!-- https://w3id.org/skgo/pham#Evidence19 -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#Evidence19"/>
    


    <!-- https://w3id.org/skgo/pham#Evidence2 -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#Evidence2"/>
    


    <!-- https://w3id.org/skgo/pham#Evidence20 -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#Evidence20"/>
    


    <!-- https://w3id.org/skgo/pham#Evidence3 -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#Evidence3"/>
    


    <!-- https://w3id.org/skgo/pham#Evidence4 -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#Evidence4"/>
    


    <!-- https://w3id.org/skgo/pham#Evidence5 -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#Evidence5"/>
    


    <!-- https://w3id.org/skgo/pham#Evidence6 -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#Evidence6"/>
    


    <!-- https://w3id.org/skgo/pham#Evidence7 -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#Evidence7"/>
    


    <!-- https://w3id.org/skgo/pham#Evidence8 -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#Evidence8"/>
    


    <!-- https://w3id.org/skgo/pham#Evidence9 -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#Evidence9"/>
    


    <!-- https://w3id.org/skgo/pham#Evidence_of_a_Role_for_Functional_Heterogeneity_in_Multidrug_Resistance_Transporters_in_Clinical_Trials_of_P-Glycoprotein_Modulation_in_Acute_Myeloid_Leukemia -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#Evidence_of_a_Role_for_Functional_Heterogeneity_in_Multidrug_Resistance_Transporters_in_Clinical_Trials_of_P-Glycoprotein_Modulation_in_Acute_Myeloid_Leukemia">
        <rdf:type rdf:resource="http://ns.nature.com/terms/Publication"/>
        <rdf:type rdf:resource="http://purl.org/ontology/bibo/Article"/>
        <addressesStudy rdf:resource="https://w3id.org/skgo/pham#Analysis_of_leukemic_blast_MDR_function"/>
        <bibo:abstract xml:lang="en">Background: Multidrug resistance (MDR) transporter proteins such as P-glycoprotein (P-gp) efflux a variety
of chemotherapeutic drugs from acute myeloid leukemia (AML) blasts leading to clinical drug resistance.
Methods: This study examined heterogeneity of MDR functional efflux by AML blasts using two flow cytometry
bioassays. Bone marrow specimens (N = 50) from elderly patients with newly diagnosed AML were analyzed
for CD34+ blasts with MDR efflux function. Efflux was measured with a fluorescent dye (DiOC2) as a
surrogate for oncology drugs that are substrates for MDR efflux. P-gp-mediated efflux was differentiated from
non-P-gp MDR activities using zosuquidar, a highly selective P-gp modulator. The bioassays included a
zosuquidar-dependent DiOC2 accumulation bioassay that measured only P-gp. The second method, termed the
efflux bioassay, could detect P-gp and other non-P-gp efflux depending on bioassay culture conditions.
Results: Sixty-two percent of the specimens were considered positive for blasts with P-gp function, and
26% of such P-gp-positive specimens also exhibited zosuquidar-resistant (i.e., non-P-gp) MDR efflux activity;
37% of P-gp-negative AML blast specimens displayed zosuquidar-resistant MDR function in the efflux
bioassay.
Conclusions: These results confirm the heterogeneous nature of MDR efflux pumps in AML blasts, and provide
support for the hypothesis that non-P-gp MDR contributed to negative results with zosuquidar in AML trials
like ECOG-ACRIN E3999.</bibo:abstract>
        <dc:title xml:lang="en">Evidence of a Role for Functional Heterogeneity in
Multidrug Resistance Transporters in Clinical Trials of
P-Glycoprotein Modulation in Acute Myeloid Leukemia</dc:title>
        <terms:creator rdf:resource="https://w3id.org/skgo/pham#Branimir_I._Sikic"/>
        <terms:creator rdf:resource="https://w3id.org/skgo/pham#Elisabeth_Paietta"/>
        <terms:creator rdf:resource="https://w3id.org/skgo/pham#John_F._Marcelletti"/>
        <terms:creator rdf:resource="https://w3id.org/skgo/pham#Larry_D._Cripe"/>
        <terms:publisher rdf:resource="https://w3id.org/skgo/pham#International_Clinical_Cytometry_Society"/>
    </owl:NamedIndividual>
    


    <!-- https://w3id.org/skgo/pham#ExperimentalStudy -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#ExperimentalStudy">
        <foaf:name xml:lang="en">ExperimentalStudy</foaf:name>
    </owl:NamedIndividual>
    


    <!-- https://w3id.org/skgo/pham#Experimental_Study -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#Experimental_Study">
        <rdf:type rdf:resource="https://w3id.org/skgo/pham#ExperimentalStudy"/>
        <rdfs:label xml:lang="en">Experimental Study</rdfs:label>
    </owl:NamedIndividual>
    


    <!-- https://w3id.org/skgo/pham#Expression_of_a_multidrug-resistance_gene -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#Expression_of_a_multidrug-resistance_gene">
        <rdf:type rdf:resource="https://w3id.org/skgo/pham#ClinicalStudy"/>
        <investigate rdf:resource="https://w3id.org/skgo/pham#Adrenocortical_Cancer"/>
        <investigate rdf:resource="https://w3id.org/skgo/pham#Colon_Tumor"/>
        <investigate rdf:resource="https://w3id.org/skgo/pham#Neuroblastoma"/>
        <investigate rdf:resource="https://w3id.org/skgo/pham#Neuroepithelioma"/>
        <investigate rdf:resource="https://w3id.org/skgo/pham#Pheochromocytoma"/>
        <investigate rdf:resource="https://w3id.org/skgo/pham#Rhabdomyosarcoma"/>
        <investigatesProblem rdf:resource="https://w3id.org/skgo/pham#Multiple_chemotherapeutic_agents"/>
        <performsExperiment rdf:resource="https://w3id.org/skgo/pham#mdr1_gene_expression"/>
        <terms1:name>Expression of a multidrug-resistance gene in human tumors and tissues</terms1:name>
        <hasSuggestion>Some cases of colon cancer, increased expression of the mdr1 gene might be involved in the intrinsic resistance of these tumors to chemotherapeutic agents.</hasSuggestion>
        <rdfs:label xml:lang="en">Expression_of_a_multidrug-resistance_gene</rdfs:label>
    </owl:NamedIndividual>
    


    <!-- https://w3id.org/skgo/pham#Expression_of_a_multidrug-resistance_gene_in_human_tumors_and_tissues -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#Expression_of_a_multidrug-resistance_gene_in_human_tumors_and_tissues">
        <rdf:type rdf:resource="http://ns.nature.com/terms/Publication"/>
        <rdf:type rdf:resource="http://purl.org/ontology/bibo/Article"/>
        <addressesStudy rdf:resource="https://w3id.org/skgo/pham#Expression_of_a_multidrug-resistance_gene"/>
        <terms1:publicationYear rdf:datatype="http://www.w3.org/2001/XMLSchema#gYear">1987</terms1:publicationYear>
        <bibo:abstract>The identification and cloning of a segment of a human multidrug resistance gene (mdrl) was reported recently. To examine the molecular basis of one type of multidrug resistance, we have prepared RNA from human tumors and normal tissues and measured their content of mdrl RNA. We find that the mdrl gene is expressed at a very high level in the adrenal gland; at a high level in the kidney; at
intermediate levels in the lung, liver, lower jejunum, colon, and rectum; and at low levels in many other tissues. The mdrl gene is also expressed in several human tumors, including many but not all tumors derived from the adrenal gland and the colon. In addition, increased expression was detected in a few tumors at the time of relapse following initial chemotherapy. Although controlled clinical studies will be required, our results suggest that measurement of mdrl RNA may prove to be a valuable tool in the design of chemotherapy protocols.</bibo:abstract>
        <terms:creator rdf:resource="https://w3id.org/skgo/pham#D._G._POPLACK"/>
        <terms:creator rdf:resource="https://w3id.org/skgo/pham#D._J._SLAMON"/>
        <terms:creator rdf:resource="https://w3id.org/skgo/pham#I._PASTAN"/>
        <terms:creator rdf:resource="https://w3id.org/skgo/pham#K._UEDA"/>
        <terms:creator rdf:resource="https://w3id.org/skgo/pham#M._M._GOTTESMAN"/>
        <terms:publisher rdf:resource="https://w3id.org/skgo/pham#Proc._Nati._Acad._Sci._USA"/>
        <terms:title rdf:datatype="http://www.w3.org/2000/01/rdf-schema#Literal">Expression of a multidrug-resistance gene in human tumors and tissues</terms:title>
    </owl:NamedIndividual>
    


    <!-- https://w3id.org/skgo/pham#Finding1 -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#Finding1"/>
    


    <!-- https://w3id.org/skgo/pham#Finding10 -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#Finding10"/>
    


    <!-- https://w3id.org/skgo/pham#Finding11 -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#Finding11"/>
    


    <!-- https://w3id.org/skgo/pham#Finding12 -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#Finding12"/>
    


    <!-- https://w3id.org/skgo/pham#Finding13 -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#Finding13"/>
    


    <!-- https://w3id.org/skgo/pham#Finding14 -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#Finding14"/>
    


    <!-- https://w3id.org/skgo/pham#Finding15 -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#Finding15"/>
    


    <!-- https://w3id.org/skgo/pham#Finding16 -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#Finding16"/>
    


    <!-- https://w3id.org/skgo/pham#Finding17 -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#Finding17"/>
    


    <!-- https://w3id.org/skgo/pham#Finding18 -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#Finding18"/>
    


    <!-- https://w3id.org/skgo/pham#Finding19 -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#Finding19"/>
    


    <!-- https://w3id.org/skgo/pham#Finding2 -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#Finding2"/>
    


    <!-- https://w3id.org/skgo/pham#Finding20 -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#Finding20"/>
    


    <!-- https://w3id.org/skgo/pham#Finding3 -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#Finding3"/>
    


    <!-- https://w3id.org/skgo/pham#Finding4 -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#Finding4"/>
    


    <!-- https://w3id.org/skgo/pham#Finding5 -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#Finding5"/>
    


    <!-- https://w3id.org/skgo/pham#Finding6 -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#Finding6"/>
    


    <!-- https://w3id.org/skgo/pham#Finding7 -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#Finding7"/>
    


    <!-- https://w3id.org/skgo/pham#Finding8 -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#Finding8"/>
    


    <!-- https://w3id.org/skgo/pham#Finding9 -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#Finding9"/>
    


    <!-- https://w3id.org/skgo/pham#Flavopiridol -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#Flavopiridol">
        <rdf:type rdf:resource="https://w3id.org/skgo/pham#Drug"/>
        <rdfs:label xml:lang="en">Flavopiridol</rdfs:label>
    </owl:NamedIndividual>
    


    <!-- https://w3id.org/skgo/pham#Fluorochrome-labeled_anti-CD_antibodies -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#Fluorochrome-labeled_anti-CD_antibodies">
        <rdf:type rdf:resource="https://w3id.org/skgo/pham#Reagent"/>
        <obtainedfrom rdf:resource="https://w3id.org/skgo/pham#BD_Biosciences_La_Jolla_CA"/>
        <rdfs:label xml:lang="en">Fluorochrome-labeled_anti-CD_antibodies</rdfs:label>
    </owl:NamedIndividual>
    


    <!-- https://w3id.org/skgo/pham#Fluorouracil -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#Fluorouracil">
        <rdf:type rdf:resource="https://w3id.org/skgo/pham#Drug"/>
        <rdfs:label xml:lang="en">Fluorouracil</rdfs:label>
    </owl:NamedIndividual>
    


    <!-- https://w3id.org/skgo/pham#Functional_Assay -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#Functional_Assay">
        <rdf:type rdf:resource="https://w3id.org/skgo/pham#Assay"/>
        <rdfs:label xml:lang="en">Functional_Assay</rdfs:label>
    </owl:NamedIndividual>
    


    <!-- https://w3id.org/skgo/pham#Functional_Bioassay -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#Functional_Bioassay">
        <rdf:type rdf:resource="https://w3id.org/skgo/pham#Assay"/>
        <rdfs:label xml:lang="en">Functional_Bioassay</rdfs:label>
    </owl:NamedIndividual>
    


    <!-- https://w3id.org/skgo/pham#Functions_of_ABC_transporters_in_Chemotherapy -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#Functions_of_ABC_transporters_in_Chemotherapy">
        <rdf:type rdf:resource="https://w3id.org/skgo/pham#Treatment"/>
        <useSpecimen rdf:resource="https://w3id.org/skgo/pham#Breast_cancer_samples"/>
        <failureReason>PGP expression increased after therapy and was associated with a greater likelihood of treatment failure.</failureReason>
        <treatmentOutcome>Toxicity</treatmentOutcome>
        <rdfs:label xml:lang="en">Functions_of_ABC_transporters_in_Chemotherapy</rdfs:label>
    </owl:NamedIndividual>
    


    <!-- https://w3id.org/skgo/pham#Gastrointestinal_stromal_tumour_GIST_cell_lines -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#Gastrointestinal_stromal_tumour_GIST_cell_lines">
        <rdf:type rdf:resource="https://w3id.org/skgo/pham#CellLine"/>
        <rdfs:label xml:lang="en">Gastrointestinal_stromal_tumour_GIST_cell_lines</rdfs:label>
    </owl:NamedIndividual>
    


    <!-- https://w3id.org/skgo/pham#Gefitinib -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#Gefitinib">
        <rdf:type rdf:resource="https://w3id.org/skgo/pham#Drug"/>
        <rdfs:label xml:lang="en">Gefitinib</rdfs:label>
    </owl:NamedIndividual>
    


    <!-- https://w3id.org/skgo/pham#Gergely_Szakács -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#Gergely_Szakács">
        <rdf:type rdf:resource="http://xmlns.com/foaf/0.1/Person"/>
    </owl:NamedIndividual>
    


    <!-- https://w3id.org/skgo/pham#Growth_inhibition_assays -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#Growth_inhibition_assays">
        <rdf:type rdf:resource="https://w3id.org/skgo/pham#Assay"/>
        <rdfs:label xml:lang="en">Growth_inhibition_assays</rdfs:label>
    </owl:NamedIndividual>
    


    <!-- https://w3id.org/skgo/pham#HTB_10_HTB_11_HTB_38 -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#HTB_10_HTB_11_HTB_38">
        <rdf:type rdf:resource="https://w3id.org/skgo/pham#CellLine"/>
        <rdfs:label xml:lang="en">HTB_10_HTB_11_HTB_38</rdfs:label>
    </owl:NamedIndividual>
    


    <!-- https://w3id.org/skgo/pham#Head_and_neck_cancer -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#Head_and_neck_cancer">
        <rdf:type rdf:resource="https://w3id.org/skgo/pham#Disease"/>
        <rdfs:label xml:lang="en">Head_and_neck_cancer</rdfs:label>
    </owl:NamedIndividual>
    


    <!-- https://w3id.org/skgo/pham#High-risk_MDS_sample -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#High-risk_MDS_sample">
        <rdf:type rdf:resource="https://w3id.org/skgo/pham#Specimen"/>
        <rdfs:label xml:lang="en">High-risk_MDS_sample</rdfs:label>
    </owl:NamedIndividual>
    


    <!-- https://w3id.org/skgo/pham#I._PASTAN -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#I._PASTAN">
        <rdf:type rdf:resource="http://xmlns.com/foaf/0.1/Person"/>
    </owl:NamedIndividual>
    


    <!-- https://w3id.org/skgo/pham#IL-2 -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#IL-2">
        <rdf:type rdf:resource="https://w3id.org/skgo/pham#Drug"/>
        <rdfs:label xml:lang="en">IL-2</rdfs:label>
    </owl:NamedIndividual>
    


    <!-- https://w3id.org/skgo/pham#Iamivudine -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#Iamivudine">
        <rdf:type rdf:resource="https://w3id.org/skgo/pham#Drug"/>
        <rdfs:label xml:lang="en">Iamivudine</rdfs:label>
    </owl:NamedIndividual>
    


    <!-- https://w3id.org/skgo/pham#Idarubicine -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#Idarubicine">
        <rdf:type rdf:resource="https://w3id.org/skgo/pham#Drug"/>
        <rdfs:label xml:lang="en">Idarubicine</rdfs:label>
    </owl:NamedIndividual>
    


    <!-- https://w3id.org/skgo/pham#Idarubicinol -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#Idarubicinol">
        <rdf:type rdf:resource="https://w3id.org/skgo/pham#Drug"/>
        <rdfs:label xml:lang="en">Idarubicinol</rdfs:label>
    </owl:NamedIndividual>
    


    <!-- https://w3id.org/skgo/pham#Identification_of_the_BCRP_gene-Functional_configuration_of_BCRP -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#Identification_of_the_BCRP_gene-Functional_configuration_of_BCRP">
        <rdf:type rdf:resource="https://w3id.org/skgo/pham#ClinicalStudy"/>
        <hasStudyDesign rdf:resource="https://w3id.org/skgo/pham#Review_Study"/>
        <investigate rdf:resource="https://w3id.org/skgo/pham#AML"/>
        <performsExperiment rdf:resource="https://w3id.org/skgo/pham#BCRP_substrate/inhibitors"/>
        <rdfs:label xml:lang="en">Identification_of_the_BCRP_gene-Functional_configuration_of_BCRP</rdfs:label>
    </owl:NamedIndividual>
    


    <!-- https://w3id.org/skgo/pham#Ifosfamide -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#Ifosfamide">
        <rdf:type rdf:resource="https://w3id.org/skgo/pham#Drug"/>
        <rdfs:label xml:lang="en">Ifosfamide</rdfs:label>
    </owl:NamedIndividual>
    


    <!-- https://w3id.org/skgo/pham#Ikumi_Tamai -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#Ikumi_Tamai">
        <rdf:type rdf:resource="http://xmlns.com/foaf/0.1/Person"/>
    </owl:NamedIndividual>
    


    <!-- https://w3id.org/skgo/pham#Imatinib -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#Imatinib">
        <rdf:type rdf:resource="https://w3id.org/skgo/pham#Drug"/>
        <rdfs:label xml:lang="en">Imatinib</rdfs:label>
    </owl:NamedIndividual>
    


    <!-- https://w3id.org/skgo/pham#Immunosuppressant_cyclosporin_A -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#Immunosuppressant_cyclosporin_A">
        <rdf:type rdf:resource="https://w3id.org/skgo/pham#Drug"/>
        <rdfs:label xml:lang="en">Immunosuppressant_cyclosporin_A</rdfs:label>
    </owl:NamedIndividual>
    


    <!-- https://w3id.org/skgo/pham#Indolocarbazole -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#Indolocarbazole">
        <rdf:type rdf:resource="https://w3id.org/skgo/pham#Drug"/>
        <rdfs:label xml:lang="en">Indolocarbazole</rdfs:label>
    </owl:NamedIndividual>
    


    <!-- https://w3id.org/skgo/pham#International_Clinical_Cytometry_Society -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#International_Clinical_Cytometry_Society">
        <rdf:type rdf:resource="http://ns.nature.com/terms/Publisher"/>
    </owl:NamedIndividual>
    


    <!-- https://w3id.org/skgo/pham#Invitrogen -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#Invitrogen">
        <rdf:type rdf:resource="http://xmlns.com/foaf/0.1/Organization"/>
    </owl:NamedIndividual>
    


    <!-- https://w3id.org/skgo/pham#Jill_K._Paterson -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#Jill_K._Paterson">
        <rdf:type rdf:resource="http://xmlns.com/foaf/0.1/Person"/>
    </owl:NamedIndividual>
    


    <!-- https://w3id.org/skgo/pham#John_F._Marcelletti -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#John_F._Marcelletti">
        <rdf:type rdf:resource="http://xmlns.com/foaf/0.1/Person"/>
    </owl:NamedIndividual>
    


    <!-- https://w3id.org/skgo/pham#Joseph_A._Ludwig -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#Joseph_A._Ludwig">
        <rdf:type rdf:resource="http://xmlns.com/foaf/0.1/Person"/>
    </owl:NamedIndividual>
    


    <!-- https://w3id.org/skgo/pham#K._UEDA -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#K._UEDA">
        <rdf:type rdf:resource="http://xmlns.com/foaf/0.1/Person"/>
    </owl:NamedIndividual>
    


    <!-- https://w3id.org/skgo/pham#KB-3-1_KB-8-5_KB-V1 -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#KB-3-1_KB-8-5_KB-V1">
        <rdf:type rdf:resource="https://w3id.org/skgo/pham#CellLine"/>
        <rdfs:label xml:lang="en">KB-3-1_KB-8-5_KB-V1</rdfs:label>
    </owl:NamedIndividual>
    


    <!-- https://w3id.org/skgo/pham#Kazuki_Fukuchi -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#Kazuki_Fukuchi">
        <rdf:type rdf:resource="http://xmlns.com/foaf/0.1/Person"/>
    </owl:NamedIndividual>
    


    <!-- https://w3id.org/skgo/pham#Keiichi_Kawai -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#Keiichi_Kawai">
        <rdf:type rdf:resource="http://xmlns.com/foaf/0.1/Person"/>
    </owl:NamedIndividual>
    


    <!-- https://w3id.org/skgo/pham#Kodai_Nishi -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#Kodai_Nishi">
        <rdf:type rdf:resource="http://xmlns.com/foaf/0.1/Person"/>
    </owl:NamedIndividual>
    


    <!-- https://w3id.org/skgo/pham#L._AUSTIN_DOYLE -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#L._AUSTIN_DOYLE">
        <rdf:type rdf:resource="http://xmlns.com/foaf/0.1/Person"/>
    </owl:NamedIndividual>
    


    <!-- https://w3id.org/skgo/pham#LYNNE_V._ABRUZZO -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#LYNNE_V._ABRUZZO">
        <rdf:type rdf:resource="http://xmlns.com/foaf/0.1/Person"/>
    </owl:NamedIndividual>
    


    <!-- https://w3id.org/skgo/pham#Larry_D._Cripe -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#Larry_D._Cripe">
        <rdf:type rdf:resource="http://xmlns.com/foaf/0.1/Person"/>
    </owl:NamedIndividual>
    


    <!-- https://w3id.org/skgo/pham#Lawrence_D._Mayer -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#Lawrence_D._Mayer">
        <rdf:type rdf:resource="http://xmlns.com/foaf/0.1/Person"/>
    </owl:NamedIndividual>
    


    <!-- https://w3id.org/skgo/pham#Leukaemia -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#Leukaemia">
        <rdf:type rdf:resource="https://w3id.org/skgo/pham#Disease"/>
        <rdfs:label xml:lang="en">Leukaemia</rdfs:label>
    </owl:NamedIndividual>
    


    <!-- https://w3id.org/skgo/pham#Leukotriene_C4 -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#Leukotriene_C4">
        <rdf:type rdf:resource="https://w3id.org/skgo/pham#Drug"/>
        <rdfs:label xml:lang="en">Leukotriene_C4</rdfs:label>
    </owl:NamedIndividual>
    


    <!-- https://w3id.org/skgo/pham#Levels_of_mdrl_mRNA -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#Levels_of_mdrl_mRNA">
        <rdf:type rdf:resource="https://w3id.org/skgo/pham#levels_of_mdr1_mRNA"/>
        <terms:description>Since expression of the mdrl gene is responsible for multidrug resistance in tissue culture systems, we measured levels of mdrl mRNA in normal human tissues and in untreated and treated human cancers.</terms:description>
        <rdfs:label xml:lang="en">Levels_of_mdrl_mRNA</rdfs:label>
    </owl:NamedIndividual>
    


    <!-- https://w3id.org/skgo/pham#Lung_cancer -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#Lung_cancer">
        <rdf:type rdf:resource="https://w3id.org/skgo/pham#Disease"/>
        <rdfs:label xml:lang="en">Lung_cancer</rdfs:label>
    </owl:NamedIndividual>
    


    <!-- https://w3id.org/skgo/pham#Lymphoma -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#Lymphoma">
        <rdf:type rdf:resource="https://w3id.org/skgo/pham#Disease"/>
        <rdfs:label xml:lang="en">Lymphoma</rdfs:label>
    </owl:NamedIndividual>
    


    <!-- https://w3id.org/skgo/pham#M._M._GOTTESMAN -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#M._M._GOTTESMAN">
        <rdf:type rdf:resource="http://xmlns.com/foaf/0.1/Person"/>
    </owl:NamedIndividual>
    


    <!-- https://w3id.org/skgo/pham#MCF-7_human_breast_carcinoma_cells -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#MCF-7_human_breast_carcinoma_cells">
        <rdf:type rdf:resource="https://w3id.org/skgo/pham#CellLine"/>
        <obtainedfrom rdf:resource="https://w3id.org/skgo/pham#National_Cancer_Institute"/>
        <rdfs:label xml:lang="en">MCF-7_human_breast_carcinoma_cells</rdfs:label>
    </owl:NamedIndividual>
    


    <!-- https://w3id.org/skgo/pham#MDR2 -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#MDR2">
        <rdf:type rdf:resource="https://w3id.org/skgo/pham#Gene"/>
        <rdfs:label xml:lang="en">MDR2</rdfs:label>
    </owl:NamedIndividual>
    


    <!-- https://w3id.org/skgo/pham#MRP1 -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#MRP1">
        <rdf:type rdf:resource="https://w3id.org/skgo/pham#Gene"/>
        <rdfs:label xml:lang="en">MRP1</rdfs:label>
    </owl:NamedIndividual>
    


    <!-- https://w3id.org/skgo/pham#MRP2 -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#MRP2">
        <rdf:type rdf:resource="https://w3id.org/skgo/pham#Gene"/>
        <rdfs:label xml:lang="en">MRP2</rdfs:label>
    </owl:NamedIndividual>
    


    <!-- https://w3id.org/skgo/pham#MRP3 -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#MRP3">
        <rdf:type rdf:resource="https://w3id.org/skgo/pham#Gene"/>
        <rdfs:label xml:lang="en">MRP3</rdfs:label>
    </owl:NamedIndividual>
    


    <!-- https://w3id.org/skgo/pham#MRP4 -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#MRP4">
        <rdf:type rdf:resource="https://w3id.org/skgo/pham#Gene"/>
        <rdfs:label xml:lang="en">MRP4</rdfs:label>
    </owl:NamedIndividual>
    


    <!-- https://w3id.org/skgo/pham#MRP5 -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#MRP5">
        <rdf:type rdf:resource="https://w3id.org/skgo/pham#Gene"/>
        <rdfs:label xml:lang="en">MRP5</rdfs:label>
    </owl:NamedIndividual>
    


    <!-- https://w3id.org/skgo/pham#MRP6 -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#MRP6">
        <rdf:type rdf:resource="https://w3id.org/skgo/pham#Gene"/>
        <rdfs:label xml:lang="en">MRP6</rdfs:label>
    </owl:NamedIndividual>
    


    <!-- https://w3id.org/skgo/pham#MRP7 -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#MRP7">
        <rdf:type rdf:resource="https://w3id.org/skgo/pham#Gene"/>
        <rdfs:label xml:lang="en">MRP7</rdfs:label>
    </owl:NamedIndividual>
    


    <!-- https://w3id.org/skgo/pham#MRP8 -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#MRP8">
        <rdf:type rdf:resource="https://w3id.org/skgo/pham#Gene"/>
        <rdfs:label xml:lang="en">MRP8</rdfs:label>
    </owl:NamedIndividual>
    


    <!-- https://w3id.org/skgo/pham#Macmillan_Magazines_Ltd -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#Macmillan_Magazines_Ltd">
        <rdf:type rdf:resource="http://ns.nature.com/terms/Publisher"/>
        <rdf:type rdf:resource="http://xmlns.com/foaf/0.1/Agent"/>
        <terms1:name rdf:datatype="http://www.w3.org/2000/01/rdf-schema#Literal">Macmillan Magazines Ltd</terms1:name>
    </owl:NamedIndividual>
    


    <!-- https://w3id.org/skgo/pham#Masato_Kobayashi -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#Masato_Kobayashi">
        <rdf:type rdf:resource="http://xmlns.com/foaf/0.1/Person"/>
    </owl:NamedIndividual>
    


    <!-- https://w3id.org/skgo/pham#Mechanisms_that_enable_the_survival_of_cancer_cells_during_drug_treatment -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#Mechanisms_that_enable_the_survival_of_cancer_cells_during_drug_treatment">
        <rdf:type rdf:resource="https://w3id.org/skgo/pham#ClinicalStudy"/>
        <investigate rdf:resource="https://w3id.org/skgo/pham#ALL"/>
        <investigate rdf:resource="https://w3id.org/skgo/pham#Breast_Cancer"/>
        <investigate rdf:resource="https://w3id.org/skgo/pham#CML"/>
        <investigate rdf:resource="https://w3id.org/skgo/pham#Colerectal_cancer"/>
        <investigate rdf:resource="https://w3id.org/skgo/pham#Head_and_neck_cancer"/>
        <investigate rdf:resource="https://w3id.org/skgo/pham#Lymphoma"/>
        <investigate rdf:resource="https://w3id.org/skgo/pham#Melanoma"/>
        <investigate rdf:resource="https://w3id.org/skgo/pham#NSCLC"/>
        <investigate rdf:resource="https://w3id.org/skgo/pham#Ovarian_cancer"/>
        <investigate rdf:resource="https://w3id.org/skgo/pham#Pancreatic_cancer"/>
        <performsExperiment rdf:resource="https://w3id.org/skgo/pham#BH3_profiling"/>
        <rdfs:label xml:lang="en">Mechanisms_that_enable_the_survival_of_cancer_cells_during_drug_treatment</rdfs:label>
    </owl:NamedIndividual>
    


    <!-- https://w3id.org/skgo/pham#Melanoma -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#Melanoma">
        <rdf:type rdf:resource="https://w3id.org/skgo/pham#Disease"/>
        <rdfs:label xml:lang="en">Melanoma</rdfs:label>
    </owl:NamedIndividual>
    


    <!-- https://w3id.org/skgo/pham#Melanoma_cell_line -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#Melanoma_cell_line">
        <rdf:type rdf:resource="https://w3id.org/skgo/pham#CellLine"/>
        <rdfs:label xml:lang="en">Melanoma_cell_line</rdfs:label>
    </owl:NamedIndividual>
    


    <!-- https://w3id.org/skgo/pham#Methotrexate -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#Methotrexate">
        <rdf:type rdf:resource="https://w3id.org/skgo/pham#Drug"/>
        <rdfs:label xml:lang="en">Methotrexate</rdfs:label>
    </owl:NamedIndividual>
    


    <!-- https://w3id.org/skgo/pham#Michael_M._Gottesman -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#Michael_M._Gottesman">
        <rdf:type rdf:resource="http://xmlns.com/foaf/0.1/Person"/>
    </owl:NamedIndividual>
    


    <!-- https://w3id.org/skgo/pham#Mitomycin_C -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#Mitomycin_C">
        <rdf:type rdf:resource="https://w3id.org/skgo/pham#Drug"/>
        <rdfs:label xml:lang="en">Mitomycin_C</rdfs:label>
    </owl:NamedIndividual>
    


    <!-- https://w3id.org/skgo/pham#Mitoxantrone -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#Mitoxantrone">
        <rdf:type rdf:resource="https://w3id.org/skgo/pham#Drug"/>
        <rdfs:label xml:lang="en">Mitoxantrone</rdfs:label>
    </owl:NamedIndividual>
    


    <!-- https://w3id.org/skgo/pham#Multidrug_Resistance_Monitoring_in_Cancer -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#Multidrug_Resistance_Monitoring_in_Cancer">
        <rdf:type rdf:resource="https://w3id.org/skgo/pham#ClinicalStudy"/>
        <rdfs:label xml:lang="en">Multidrug_Resistance_Monitoring_in_Cancer</rdfs:label>
    </owl:NamedIndividual>
    


    <!-- https://w3id.org/skgo/pham#Multidrug_resistance-MDR_in_cancer_Mechanisms -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#Multidrug_resistance-MDR_in_cancer_Mechanisms">
        <rdf:type rdf:resource="https://w3id.org/skgo/pham#ClinicalStudy"/>
        <investigate rdf:resource="https://w3id.org/skgo/pham#Breast_Cancer"/>
        <investigate rdf:resource="https://w3id.org/skgo/pham#Colerectal_cancer"/>
        <investigate rdf:resource="https://w3id.org/skgo/pham#Lung_cancer"/>
        <investigate rdf:resource="https://w3id.org/skgo/pham#Myeloma"/>
        <investigate rdf:resource="https://w3id.org/skgo/pham#Ovarian_cancer"/>
        <investigate rdf:resource="https://w3id.org/skgo/pham#Renal_cell_cancer"/>
        <investigatesProblem rdf:resource="https://w3id.org/skgo/pham#Role_of_P-GP_in_MDR"/>
        <performsExperiment rdf:resource="https://w3id.org/skgo/pham#Vesicle_transport_experiments"/>
        <terms1:name>Multidrug resistance (MDR) in cancer Mechanisms, reversal using modulators of MDR and the role of MDR modulators in influencing the pharmacokinetics of anticancer drugs</terms1:name>
        <rdfs:label xml:lang="en">Multidrug_resistance-MDR_in_cancer_Mechanisms</rdfs:label>
    </owl:NamedIndividual>
    


    <!-- https://w3id.org/skgo/pham#Multidrug_resistance_MDR_efflux_pumps_capable_of_eliminating_chemotherapeutic_drugs_from_tumor_cells -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#Multidrug_resistance_MDR_efflux_pumps_capable_of_eliminating_chemotherapeutic_drugs_from_tumor_cells">
        <rdf:type rdf:resource="https://w3id.org/skgo/pham#ClinicalProblem"/>
        <rdfs:label xml:lang="en">Multidrug_resistance_MDR_efflux_pumps_capable_of_eliminating_chemotherapeutic_drugs_from_tumor_cells</rdfs:label>
        <skos:definition xml:lang="en">Multidrug resistance (MDR) efflux pumps capable of
eliminating chemotherapeutic drugs from tumor cells
contribute to clinical drug resistance in acute myeloid
leukemia (AML) and other cancers.</skos:definition>
    </owl:NamedIndividual>
    


    <!-- https://w3id.org/skgo/pham#Multidrug_resistance_MDR_in_cancer_Mechanisms_reversal_using_modulators_of_MDR_and_the_role_of_MDR_modulators_in_influencing_the_pharmacokinetics_of_anticancer_drugs -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#Multidrug_resistance_MDR_in_cancer_Mechanisms_reversal_using_modulators_of_MDR_and_the_role_of_MDR_modulators_in_influencing_the_pharmacokinetics_of_anticancer_drugs">
        <rdf:type rdf:resource="http://ns.nature.com/terms/Publication"/>
        <rdf:type rdf:resource="http://purl.org/ontology/bibo/Article"/>
        <addressesStudy rdf:resource="https://w3id.org/skgo/pham#Multidrug_resistance-MDR_in_cancer_Mechanisms"/>
        <terms1:publicationYear rdf:datatype="http://www.w3.org/2001/XMLSchema#gYear">2000</terms1:publicationYear>
        <bibo:abstract xml:lang="en">In recent years, there has been an increased understanding of P-glycoprotein (P-GP)-mediated pharmacokinetic interactions. In addition,
its role in modifying the bioavailability of orally administered drugs via induction or inhibition has been also been demonstrated in
various studies. This overview presents a background on some of the commonly documented mechanisms of multidrug resistance (MDR),
reversal using modulators of MDR, followed by a discussion on the functional aspects of P-GP in the context of the pharmacokinetic
interactions when multiple agents are coadministered. While adverse pharmacokinetic interactions have been documented with first and
second generation MDR modulators, certain newer agents of the third generation class of compounds have been less susceptible in
eliciting pharmacokinetic interactions. Although the review focuses on P-GP and the pharmacology of MDR reversal using MDR
modulators, relevance of these drug transport proteins in the context of pharmacokinetic implications (drug absorption, distribution,
clearance, and interactions) will also be discussed.</bibo:abstract>
        <terms:creator rdf:resource="https://w3id.org/skgo/pham#Lawrence_D._Mayer"/>
        <terms:creator rdf:resource="https://w3id.org/skgo/pham#Rajesh_Krishna"/>
        <terms:publisher rdf:resource="https://w3id.org/skgo/pham#European_Journal_of_Pharmaceutical_Sciences"/>
        <terms:title rdf:datatype="http://www.w3.org/2000/01/rdf-schema#Literal">Multidrug resistance (MDR) in cancer Mechanisms, reversal using modulators of MDR and the role of MDR modulators in influencing the pharmacokinetics of anticancer drugs</terms:title>
    </owl:NamedIndividual>
    


    <!-- https://w3id.org/skgo/pham#Multidrug_resistance_mediated_by_the_breast_cancer_resistance_protein_BCRP -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#Multidrug_resistance_mediated_by_the_breast_cancer_resistance_protein_BCRP">
        <rdf:type rdf:resource="http://ns.nature.com/terms/Publication"/>
        <rdf:type rdf:resource="http://purl.org/ontology/bibo/Article"/>
        <addressesStudy rdf:resource="https://w3id.org/skgo/pham#Identification_of_the_BCRP_gene-Functional_configuration_of_BCRP"/>
        <terms1:publicationYear rdf:datatype="http://www.w3.org/2001/XMLSchema#gYear">2003</terms1:publicationYear>
        <bibo:abstract xml:lang="en">Observations of functional adenosine triphosphate (ATP)-dependent drug efflux in certain multidrug-resistant cancer cell lines without overexpression of P-glycoprotein or multidrug resistance protein (MRP) family members
suggested the existence of another ATP-binding cassette (ABC) transporter capable of causing cancer drug resistance. In one such cell line (MCF-7/AdrVp), the overexpression of a novel member of the G subfamily of ABC transporters was found. The new transporter was termed the breast cancer resistance protein (BCRP), because of its identification in MCF-7 human breast carcinoma cells. BCRP is a 655 amino-acid polypeptide, formally designated as ABCG2. Like all members of the ABC G (white) subfamily, BCRP is a half transporter. Transfection and enforced overexpression of BCRP in drug-sensitive MCF-7 or MDA-MB-231 cells recapitulates the drug-resistance phenotype of MCF-7/AdrVp cells, consistent with current evidence suggesting that
functional BCRP is a homodimer. BCRP maps to chromosome 4q22, downstream from a TATA-less promoter. The spectrum of anticancer drugs effluxed by BCRP includes mitoxantrone, camptothecin-derived and
indolocarbazole topoisomerase I inhibitors, methotrexate, flavopiridol, and quinazoline ErbB1 inhibitors. Transport of anthracyclines is variable and appears to depend on the presence of a BCRP mutation at codon 482. Potent and
specific inhibitors of BCRP are now being developed, opening the door to clinical applications of BCRP inhibition. Owing to tissue localization in the placenta, bile canaliculi, colon, small bowel, and brain microvessel endothelium, BCRP may play a role in protecting the organism from potentially harmful xenobiotics. BCRP expression has also been demonstrated in pluripotential ‘side population’ stem cells, responsible for the characteristic ability of these cells to exclude Hoechst 33342 dye, and possibly for the maintenance of the stem cell
phenotype. Studies are emerging on the role of BCRP expression in drug resistance in clinical cancers. More prospective studies are needed, preferably combining BCRP protein or mRNA quantification with functional
assays, in order to determine the contribution of BCRP to drug resistance in human cancers.</bibo:abstract>
        <terms:creator rdf:resource="https://w3id.org/skgo/pham#DOUGLAS_D._ROSS"/>
        <terms:creator rdf:resource="https://w3id.org/skgo/pham#L._AUSTIN_DOYLE"/>
        <terms:publisher rdf:resource="https://w3id.org/skgo/pham#Nature_Publishing_Group"/>
        <terms:title rdf:datatype="http://www.w3.org/2000/01/rdf-schema#Literal">Multidrug resistance mediated by the breast cancer resistance protein BCRP (ABCG2)</terms:title>
    </owl:NamedIndividual>
    


    <!-- https://w3id.org/skgo/pham#Multiple_chemotherapeutic_agents -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#Multiple_chemotherapeutic_agents">
        <rdf:type rdf:resource="https://w3id.org/skgo/pham#ClinicalProblem"/>
        <rdfs:label xml:lang="en">Multiple_chemotherapeutic_agents</rdfs:label>
    </owl:NamedIndividual>
    


    <!-- https://w3id.org/skgo/pham#MutationResult1 -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#MutationResult1"/>
    


    <!-- https://w3id.org/skgo/pham#MutationResult10 -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#MutationResult10"/>
    


    <!-- https://w3id.org/skgo/pham#MutationResult11 -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#MutationResult11"/>
    


    <!-- https://w3id.org/skgo/pham#MutationResult12 -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#MutationResult12"/>
    


    <!-- https://w3id.org/skgo/pham#MutationResult13 -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#MutationResult13"/>
    


    <!-- https://w3id.org/skgo/pham#MutationResult14 -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#MutationResult14"/>
    


    <!-- https://w3id.org/skgo/pham#MutationResult15 -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#MutationResult15"/>
    


    <!-- https://w3id.org/skgo/pham#MutationResult16 -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#MutationResult16"/>
    


    <!-- https://w3id.org/skgo/pham#MutationResult17 -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#MutationResult17"/>
    


    <!-- https://w3id.org/skgo/pham#MutationResult18 -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#MutationResult18"/>
    


    <!-- https://w3id.org/skgo/pham#MutationResult19 -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#MutationResult19"/>
    


    <!-- https://w3id.org/skgo/pham#MutationResult2 -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#MutationResult2"/>
    


    <!-- https://w3id.org/skgo/pham#MutationResult20 -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#MutationResult20"/>
    


    <!-- https://w3id.org/skgo/pham#MutationResult3 -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#MutationResult3"/>
    


    <!-- https://w3id.org/skgo/pham#MutationResult4 -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#MutationResult4"/>
    


    <!-- https://w3id.org/skgo/pham#MutationResult5 -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#MutationResult5"/>
    


    <!-- https://w3id.org/skgo/pham#MutationResult6 -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#MutationResult6"/>
    


    <!-- https://w3id.org/skgo/pham#MutationResult7 -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#MutationResult7"/>
    


    <!-- https://w3id.org/skgo/pham#MutationResult8 -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#MutationResult8"/>
    


    <!-- https://w3id.org/skgo/pham#MutationResult9 -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#MutationResult9"/>
    


    <!-- https://w3id.org/skgo/pham#Myeloma -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#Myeloma">
        <rdf:type rdf:resource="https://w3id.org/skgo/pham#Disease"/>
        <rdfs:label xml:lang="en">Myeloma</rdfs:label>
    </owl:NamedIndividual>
    


    <!-- https://w3id.org/skgo/pham#NSCLC -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#NSCLC">
        <rdf:type rdf:resource="https://w3id.org/skgo/pham#Disease"/>
        <rdfs:label xml:lang="en">NSCLC</rdfs:label>
    </owl:NamedIndividual>
    


    <!-- https://w3id.org/skgo/pham#NSCLC_cell_lines -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#NSCLC_cell_lines">
        <rdf:type rdf:resource="https://w3id.org/skgo/pham#CellLine"/>
        <rdfs:label xml:lang="en">NSCLC_cell_lines</rdfs:label>
    </owl:NamedIndividual>
    


    <!-- https://w3id.org/skgo/pham#NSCLC_sample -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#NSCLC_sample">
        <rdf:type rdf:resource="https://w3id.org/skgo/pham#Specimen"/>
        <obtainedfromPatient rdf:resource="https://w3id.org/skgo/pham#Phase_III_clinical_trials_with_ABC_transporter_inhibitors"/>
        <rdfs:label xml:lang="en">NSCLC_sample</rdfs:label>
    </owl:NamedIndividual>
    


    <!-- https://w3id.org/skgo/pham#National_Cancer_Institute -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#National_Cancer_Institute">
        <rdf:type rdf:resource="http://xmlns.com/foaf/0.1/Organization"/>
    </owl:NamedIndividual>
    


    <!-- https://w3id.org/skgo/pham#Nature_Publishing_Group -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#Nature_Publishing_Group">
        <rdf:type rdf:resource="http://ns.nature.com/terms/Publisher"/>
        <rdf:type rdf:resource="http://xmlns.com/foaf/0.1/Agent"/>
        <terms1:name rdf:datatype="http://www.w3.org/2000/01/rdf-schema#Literal">Nature Publishing Group</terms1:name>
    </owl:NamedIndividual>
    


    <!-- https://w3id.org/skgo/pham#Neck_squamous_cell_carcinoma_cell_lines -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#Neck_squamous_cell_carcinoma_cell_lines">
        <rdf:type rdf:resource="https://w3id.org/skgo/pham#CellLine"/>
        <rdfs:label xml:lang="en">Neck_squamous_cell_carcinoma_cell_lines</rdfs:label>
    </owl:NamedIndividual>
    


    <!-- https://w3id.org/skgo/pham#Neuroblastoma -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#Neuroblastoma">
        <rdf:type rdf:resource="https://w3id.org/skgo/pham#Disease"/>
        <rdfs:label xml:lang="en">Neuroblastoma</rdfs:label>
    </owl:NamedIndividual>
    


    <!-- https://w3id.org/skgo/pham#Neuroblastoma_Cell -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#Neuroblastoma_Cell">
        <rdf:type rdf:resource="https://w3id.org/skgo/pham#CellLine"/>
        <obtainedfrom rdf:resource="https://w3id.org/skgo/pham#American_Type_Culture_Collection"/>
        <rdfs:label xml:lang="en">Neuroblastoma_Cell</rdfs:label>
    </owl:NamedIndividual>
    


    <!-- https://w3id.org/skgo/pham#Neuroepithelioma -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#Neuroepithelioma">
        <rdf:type rdf:resource="https://w3id.org/skgo/pham#Disease"/>
        <rdfs:label xml:lang="en">Neuroepithelioma</rdfs:label>
    </owl:NamedIndividual>
    


    <!-- https://w3id.org/skgo/pham#Nilotinib -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#Nilotinib">
        <rdf:type rdf:resource="https://w3id.org/skgo/pham#Drug"/>
        <rdfs:label xml:lang="en">Nilotinib</rdfs:label>
    </owl:NamedIndividual>
    


    <!-- https://w3id.org/skgo/pham#Non-P-gp_MDR_contributed_to_negative_results_with_zosuquidar -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#Non-P-gp_MDR_contributed_to_negative_results_with_zosuquidar">
        <rdf:type rdf:resource="https://w3id.org/skgo/pham#levels_of_mdr1_mRNA"/>
        <rdfs:label xml:lang="en">Non-P-gp_MDR_contributed_to_negative_results_with_zosuquidar</rdfs:label>
        <skos:definition xml:lang="en">Non-P-gp MDR contributed to negative results with zosuquidar in AML trials
like ECOG-ACRIN E3999</skos:definition>
    </owl:NamedIndividual>
    


    <!-- https://w3id.org/skgo/pham#Non_Smallcell_Lung_Cancer -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#Non_Smallcell_Lung_Cancer">
        <rdf:type rdf:resource="https://w3id.org/skgo/pham#Disease"/>
        <rdfs:label xml:lang="en">Non_Smallcell_Lung_Cancer</rdfs:label>
    </owl:NamedIndividual>
    


    <!-- https://w3id.org/skgo/pham#Northern_analysis_of_the_expression_of_BCRP_mRNA -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#Northern_analysis_of_the_expression_of_BCRP_mRNA">
        <rdf:type rdf:resource="https://w3id.org/skgo/pham#NorthernBlotting"/>
        <rdfs:label xml:lang="en">Northern_analysis_of_the_expression_of_BCRP_mRNA</rdfs:label>
    </owl:NamedIndividual>
    


    <!-- https://w3id.org/skgo/pham#ObservationalStudy -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#ObservationalStudy">
        <foaf:name xml:lang="en">ObservationalStudy</foaf:name>
    </owl:NamedIndividual>
    


    <!-- https://w3id.org/skgo/pham#Observational_Study -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#Observational_Study">
        <rdf:type rdf:resource="https://w3id.org/skgo/pham#ObservationalStudy"/>
        <rdfs:label xml:lang="en">Observational Study</rdfs:label>
    </owl:NamedIndividual>
    


    <!-- https://w3id.org/skgo/pham#Ovarian_cancer -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#Ovarian_cancer">
        <rdf:type rdf:resource="https://w3id.org/skgo/pham#Disease"/>
        <rdfs:label xml:lang="en">Ovarian_cancer</rdfs:label>
    </owl:NamedIndividual>
    


    <!-- https://w3id.org/skgo/pham#P-GP-mediated_MDR_a_General_overview_of_the_underlying_mechanisms_and_types_of_drug_resistance -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#P-GP-mediated_MDR_a_General_overview_of_the_underlying_mechanisms_and_types_of_drug_resistance">
        <rdf:type rdf:resource="https://w3id.org/skgo/pham#levels_of_mdr1_mRNA"/>
        <terms:description>The focus of this review is P-GP-mediated MDR, a general overview of the underlying mechanisms and types of drug resistance is presented in the context of the overall MDR phenomenon.</terms:description>
        <rdfs:label xml:lang="en">P-GP-mediated_MDR_a_General_overview_of_the_underlying_mechanisms_and_types_of_drug_resistance</rdfs:label>
    </owl:NamedIndividual>
    


    <!-- https://w3id.org/skgo/pham#Paclitaxel -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#Paclitaxel">
        <rdf:type rdf:resource="https://w3id.org/skgo/pham#Drug"/>
        <rdfs:label xml:lang="en">Paclitaxel</rdfs:label>
    </owl:NamedIndividual>
    


    <!-- https://w3id.org/skgo/pham#Pancreatic_cancer -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#Pancreatic_cancer">
        <rdf:type rdf:resource="https://w3id.org/skgo/pham#Disease"/>
        <rdfs:label xml:lang="en">Pancreatic_cancer</rdfs:label>
    </owl:NamedIndividual>
    


    <!-- https://w3id.org/skgo/pham#Pancreatic_cancer_cell_lines -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#Pancreatic_cancer_cell_lines">
        <rdf:type rdf:resource="https://w3id.org/skgo/pham#CellLine"/>
        <rdfs:label xml:lang="en">Pancreatic_cancer_cell_lines</rdfs:label>
    </owl:NamedIndividual>
    


    <!-- https://w3id.org/skgo/pham#Patient_with_adrenocortical_cancer_and_breast_cancer -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#Patient_with_adrenocortical_cancer_and_breast_cancer">
        <rdf:type rdf:resource="https://w3id.org/skgo/pham#Patient"/>
        <hasDisease rdf:resource="https://w3id.org/skgo/pham#Adrenocortical_Cancer"/>
        <hasDisease rdf:resource="https://w3id.org/skgo/pham#Breast_Cancer"/>
        <has_Treatment rdf:resource="https://w3id.org/skgo/pham#Functions_of_ABC_transporters_in_Chemotherapy"/>
        <rdfs:label xml:lang="en">Patient_with_adrenocortical_cancer_and_breast_cancer</rdfs:label>
    </owl:NamedIndividual>
    


    <!-- https://w3id.org/skgo/pham#Patrick_G._Johnston -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#Patrick_G._Johnston">
        <rdf:type rdf:resource="http://xmlns.com/foaf/0.1/Person"/>
    </owl:NamedIndividual>
    


    <!-- https://w3id.org/skgo/pham#Peripheral_blood_lymphocytes -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#Peripheral_blood_lymphocytes">
        <rdf:type rdf:resource="https://w3id.org/skgo/pham#Specimen"/>
        <obtainedfromPatient rdf:resource="https://w3id.org/skgo/pham#10_patients_with_acute_lymphocytic_leukemia"/>
        <rdfs:label xml:lang="en">Peripheral_blood_lymphocytes</rdfs:label>
    </owl:NamedIndividual>
    


    <!-- https://w3id.org/skgo/pham#Phase_III_clinical_trials_with_ABC_transporter_inhibitors -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#Phase_III_clinical_trials_with_ABC_transporter_inhibitors">
        <rdf:type rdf:resource="https://w3id.org/skgo/pham#Patient"/>
        <hasDisease rdf:resource="https://w3id.org/skgo/pham#AML"/>
        <hasDisease rdf:resource="https://w3id.org/skgo/pham#Breast_Cancer"/>
        <hasDisease rdf:resource="https://w3id.org/skgo/pham#Lung_cancer"/>
        <has_Treatment rdf:resource="https://w3id.org/skgo/pham#Chemotherapy_with_targeted_inhibitors_of_Pgp-mediated_drug_transport"/>
        <rdfs:label xml:lang="en">Phase_III_clinical_trials_with_ABC_transporter_inhibitors</rdfs:label>
    </owl:NamedIndividual>
    


    <!-- https://w3id.org/skgo/pham#Phase_II_clinical_trials_in_patients -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#Phase_II_clinical_trials_in_patients">
        <rdf:type rdf:resource="https://w3id.org/skgo/pham#Patient"/>
        <hasDisease rdf:resource="https://w3id.org/skgo/pham#Breast_Cancer"/>
        <hasDisease rdf:resource="https://w3id.org/skgo/pham#Colerectal_cancer"/>
        <hasDisease rdf:resource="https://w3id.org/skgo/pham#Lung_cancer"/>
        <hasDisease rdf:resource="https://w3id.org/skgo/pham#Myeloma"/>
        <hasDisease rdf:resource="https://w3id.org/skgo/pham#Ovarian_cancer"/>
        <hasDisease rdf:resource="https://w3id.org/skgo/pham#Renal_cell_cancer"/>
        <has_Treatment rdf:resource="https://w3id.org/skgo/pham#Differential_inhibition_of_various_transporters_by_two_structurally_similar_MDR_modulators"/>
        <rdfs:label xml:lang="en">Phase_II_clinical_trials_in_patients</rdfs:label>
    </owl:NamedIndividual>
    


    <!-- https://w3id.org/skgo/pham#Pheochromocytoma -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#Pheochromocytoma">
        <rdf:type rdf:resource="https://w3id.org/skgo/pham#Disease"/>
        <rdfs:label xml:lang="en">Pheochromocytoma</rdfs:label>
    </owl:NamedIndividual>
    


    <!-- https://w3id.org/skgo/pham#Podophyllotoxin -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#Podophyllotoxin">
        <rdf:type rdf:resource="https://w3id.org/skgo/pham#Drug"/>
        <rdfs:label xml:lang="en">Podophyllotoxin</rdfs:label>
    </owl:NamedIndividual>
    


    <!-- https://w3id.org/skgo/pham#Podophyllotoxin-etoposide_teniposide -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#Podophyllotoxin-etoposide_teniposide">
        <rdf:type rdf:resource="https://w3id.org/skgo/pham#Drug"/>
        <rdfs:label xml:lang="en">Podophyllotoxin-etoposide_teniposide</rdfs:label>
    </owl:NamedIndividual>
    


    <!-- https://w3id.org/skgo/pham#Poor-risk_acute_leukaemia_samples -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#Poor-risk_acute_leukaemia_samples">
        <rdf:type rdf:resource="https://w3id.org/skgo/pham#Specimen"/>
        <obtainedfromPatient rdf:resource="https://w3id.org/skgo/pham#Phase_III_clinical_trials_with_ABC_transporter_inhibitors"/>
        <rdfs:label xml:lang="en">Poor-risk_acute_leukaemia_samples</rdfs:label>
    </owl:NamedIndividual>
    


    <!-- https://w3id.org/skgo/pham#Prazocin -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#Prazocin">
        <rdf:type rdf:resource="https://w3id.org/skgo/pham#Drug"/>
        <rdfs:label xml:lang="en">Prazocin</rdfs:label>
    </owl:NamedIndividual>
    


    <!-- https://w3id.org/skgo/pham#Proc._Nati._Acad._Sci._USA -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#Proc._Nati._Acad._Sci._USA">
        <rdf:type rdf:resource="http://ns.nature.com/terms/Publisher"/>
        <rdf:type rdf:resource="http://xmlns.com/foaf/0.1/Agent"/>
        <terms1:name rdf:datatype="http://www.w3.org/2000/01/rdf-schema#Literal">Proc. Nati. Acad. Sci. USA</terms1:name>
    </owl:NamedIndividual>
    


    <!-- https://w3id.org/skgo/pham#Promega_Biotec -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#Promega_Biotec">
        <rdf:type rdf:resource="http://xmlns.com/foaf/0.1/Organization"/>
    </owl:NamedIndividual>
    


    <!-- https://w3id.org/skgo/pham#RNA_Fingerprinting -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#RNA_Fingerprinting">
        <rdf:type rdf:resource="https://w3id.org/skgo/pham#Antibody-mediated_cytolysis_experiment"/>
        <hasBlotAnalysis rdf:resource="https://w3id.org/skgo/pham#Northern_analysis_of_the_expression_of_BCRP_mRNA"/>
        <useAssay rdf:resource="https://w3id.org/skgo/pham#RT-PCR_assay"/>
        <useAssay rdf:resource="https://w3id.org/skgo/pham#Sulforhodamine-B_cytotoxicity_assay"/>
        <rdfs:label xml:lang="en">RNA_Fingerprinting</rdfs:label>
    </owl:NamedIndividual>
    


    <!-- https://w3id.org/skgo/pham#ROLE_OF_ATP-DEPENDENT_TRANSPORTERS_in_chemotherapy_and_A_surrogate_assay_for_PGP_inhibition -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#ROLE_OF_ATP-DEPENDENT_TRANSPORTERS_in_chemotherapy_and_A_surrogate_assay_for_PGP_inhibition">
        <rdf:type rdf:resource="https://w3id.org/skgo/pham#Antibody-mediated_cytolysis_experiment"/>
        <hasTreatment rdf:resource="https://w3id.org/skgo/pham#Functions_of_ABC_transporters_in_Chemotherapy"/>
        <useAssay rdf:resource="https://w3id.org/skgo/pham#Surrogate_Assay"/>
        <rdfs:label xml:lang="en">ROLE_OF_ATP-DEPENDENT_TRANSPORTERS_in_chemotherapy_and_A_surrogate_assay_for_PGP_inhibition</rdfs:label>
    </owl:NamedIndividual>
    


    <!-- https://w3id.org/skgo/pham#RT-PCR_assay -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#RT-PCR_assay">
        <rdf:type rdf:resource="https://w3id.org/skgo/pham#Assay"/>
        <useGene rdf:resource="https://w3id.org/skgo/pham#Drosophila_white_gene"/>
        <rdfs:label xml:lang="en">RT-PCR_assay</rdfs:label>
    </owl:NamedIndividual>
    


    <!-- https://w3id.org/skgo/pham#Rajesh_Krishna -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#Rajesh_Krishna">
        <rdf:type rdf:resource="http://xmlns.com/foaf/0.1/Person"/>
    </owl:NamedIndividual>
    


    <!-- https://w3id.org/skgo/pham#Refractory_AML_high-risk_MDS_sample -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#Refractory_AML_high-risk_MDS_sample">
        <rdf:type rdf:resource="https://w3id.org/skgo/pham#Specimen"/>
        <obtainedfromPatient rdf:resource="https://w3id.org/skgo/pham#Phase_III_clinical_trials_with_ABC_transporter_inhibitors"/>
        <rdfs:label xml:lang="en">Refractory_AML_high-risk_MDS_sample</rdfs:label>
    </owl:NamedIndividual>
    


    <!-- https://w3id.org/skgo/pham#Relapsed_and_refractory_AML_sample -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#Relapsed_and_refractory_AML_sample">
        <rdf:type rdf:resource="https://w3id.org/skgo/pham#Specimen"/>
        <obtainedfromPatient rdf:resource="https://w3id.org/skgo/pham#Phase_III_clinical_trials_with_ABC_transporter_inhibitors"/>
        <rdfs:label xml:lang="en">Relapsed_and_refractory_AML_sample</rdfs:label>
    </owl:NamedIndividual>
    


    <!-- https://w3id.org/skgo/pham#Renal_cell_cancer -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#Renal_cell_cancer">
        <rdf:type rdf:resource="https://w3id.org/skgo/pham#Disease"/>
        <rdfs:label xml:lang="en">Renal_cell_cancer</rdfs:label>
    </owl:NamedIndividual>
    


    <!-- https://w3id.org/skgo/pham#Review_Study -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#Review_Study">
        <rdf:type rdf:resource="https://w3id.org/skgo/pham#ReviewStudy"/>
        <rdfs:label xml:lang="en">Review Study</rdfs:label>
    </owl:NamedIndividual>
    


    <!-- https://w3id.org/skgo/pham#Rhabdomyosarcoma -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#Rhabdomyosarcoma">
        <rdf:type rdf:resource="https://w3id.org/skgo/pham#Disease"/>
        <rdfs:label xml:lang="en">Rhabdomyosarcoma</rdfs:label>
    </owl:NamedIndividual>
    


    <!-- https://w3id.org/skgo/pham#Role_of_P-GP_in_MDR -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#Role_of_P-GP_in_MDR">
        <rdf:type rdf:resource="https://w3id.org/skgo/pham#ClinicalProblem"/>
        <rdfs:label xml:lang="en">Role_of_P-GP_in_MDR</rdfs:label>
    </owl:NamedIndividual>
    


    <!-- https://w3id.org/skgo/pham#Ryuichi_Nishii -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#Ryuichi_Nishii">
        <rdf:type rdf:resource="http://xmlns.com/foaf/0.1/Person"/>
    </owl:NamedIndividual>
    


    <!-- https://w3id.org/skgo/pham#Sandra_Van_Schaeybroeck -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#Sandra_Van_Schaeybroeck">
        <rdf:type rdf:resource="http://xmlns.com/foaf/0.1/Person"/>
    </owl:NamedIndividual>
    


    <!-- https://w3id.org/skgo/pham#Sarcoma -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#Sarcoma">
        <rdf:type rdf:resource="https://w3id.org/skgo/pham#Disease"/>
        <rdfs:label xml:lang="en">Sarcoma</rdfs:label>
    </owl:NamedIndividual>
    


    <!-- https://w3id.org/skgo/pham#Slot_Blot_Analysis -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#Slot_Blot_Analysis">
        <rdf:type rdf:resource="https://w3id.org/skgo/pham#BlotAnalysis"/>
    </owl:NamedIndividual>
    


    <!-- https://w3id.org/skgo/pham#Small_Cell_Lung_Cancer -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#Small_Cell_Lung_Cancer">
        <rdf:type rdf:resource="https://w3id.org/skgo/pham#Disease"/>
        <rdfs:label xml:lang="en">Small_Cell_Lung_Cancer</rdfs:label>
    </owl:NamedIndividual>
    


    <!-- https://w3id.org/skgo/pham#Southern_Blot_Analysis -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#Southern_Blot_Analysis">
        <rdf:type rdf:resource="https://w3id.org/skgo/pham#SouthernBlotting"/>
        <rdfs:label xml:lang="en">Southern_Blot_Analysis</rdfs:label>
    </owl:NamedIndividual>
    


    <!-- https://w3id.org/skgo/pham#StatisticalAnalysis -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#StatisticalAnalysis">
        <foaf:name xml:lang="en">StatisticalAnalysis</foaf:name>
    </owl:NamedIndividual>
    


    <!-- https://w3id.org/skgo/pham#Study -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#Study">
        <foaf:name xml:lang="en">Study</foaf:name>
    </owl:NamedIndividual>
    


    <!-- https://w3id.org/skgo/pham#Sulforhodamine-B_cytotoxicity_assay -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#Sulforhodamine-B_cytotoxicity_assay">
        <rdf:type rdf:resource="https://w3id.org/skgo/pham#Assay"/>
        <rdfs:label xml:lang="en">Sulforhodamine-B_cytotoxicity_assay</rdfs:label>
    </owl:NamedIndividual>
    


    <!-- https://w3id.org/skgo/pham#Surrogate_Assay -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#Surrogate_Assay">
        <rdf:type rdf:resource="https://w3id.org/skgo/pham#Assay"/>
        <hasAssayMethod xml:lang="en">This assay uses flow cytometry to test the ability of human CD56+ cells —
which express high levels of the efflux pump P-glycoprotein (PGP) — to retain the PGP substrate rhodamine after exposure to the efflux pump inhibitor PSC-833.</hasAssayMethod>
        <rdfs:label xml:lang="en">Surrogate_Assay</rdfs:label>
    </owl:NamedIndividual>
    


    <!-- https://w3id.org/skgo/pham#Susan_E._Bates -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#Susan_E._Bates">
        <rdf:type rdf:resource="http://xmlns.com/foaf/0.1/Person"/>
    </owl:NamedIndividual>
    


    <!-- https://w3id.org/skgo/pham#TAMMY_KROGMANN -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#TAMMY_KROGMANN">
        <rdf:type rdf:resource="http://xmlns.com/foaf/0.1/Person"/>
    </owl:NamedIndividual>
    


    <!-- https://w3id.org/skgo/pham#Takafumi_Tsujiuchi -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#Takafumi_Tsujiuchi">
        <rdf:type rdf:resource="http://xmlns.com/foaf/0.1/Person"/>
    </owl:NamedIndividual>
    


    <!-- https://w3id.org/skgo/pham#Takeo_Nakanishi -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#Takeo_Nakanishi">
        <rdf:type rdf:resource="http://xmlns.com/foaf/0.1/Person"/>
    </owl:NamedIndividual>
    


    <!-- https://w3id.org/skgo/pham#TargetingMethod1 -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#TargetingMethod1"/>
    


    <!-- https://w3id.org/skgo/pham#TargetingMethod10 -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#TargetingMethod10"/>
    


    <!-- https://w3id.org/skgo/pham#TargetingMethod11 -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#TargetingMethod11"/>
    


    <!-- https://w3id.org/skgo/pham#TargetingMethod12 -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#TargetingMethod12"/>
    


    <!-- https://w3id.org/skgo/pham#TargetingMethod13 -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#TargetingMethod13"/>
    


    <!-- https://w3id.org/skgo/pham#TargetingMethod14 -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#TargetingMethod14"/>
    


    <!-- https://w3id.org/skgo/pham#TargetingMethod15 -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#TargetingMethod15"/>
    


    <!-- https://w3id.org/skgo/pham#TargetingMethod16 -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#TargetingMethod16"/>
    


    <!-- https://w3id.org/skgo/pham#TargetingMethod17 -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#TargetingMethod17"/>
    


    <!-- https://w3id.org/skgo/pham#TargetingMethod18 -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#TargetingMethod18"/>
    


    <!-- https://w3id.org/skgo/pham#TargetingMethod19 -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#TargetingMethod19"/>
    


    <!-- https://w3id.org/skgo/pham#TargetingMethod2 -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#TargetingMethod2"/>
    


    <!-- https://w3id.org/skgo/pham#TargetingMethod20 -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#TargetingMethod20"/>
    


    <!-- https://w3id.org/skgo/pham#TargetingMethod3 -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#TargetingMethod3"/>
    


    <!-- https://w3id.org/skgo/pham#TargetingMethod4 -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#TargetingMethod4"/>
    


    <!-- https://w3id.org/skgo/pham#TargetingMethod5 -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#TargetingMethod5"/>
    


    <!-- https://w3id.org/skgo/pham#TargetingMethod6 -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#TargetingMethod6"/>
    


    <!-- https://w3id.org/skgo/pham#TargetingMethod7 -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#TargetingMethod7"/>
    


    <!-- https://w3id.org/skgo/pham#TargetingMethod8 -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#TargetingMethod8"/>
    


    <!-- https://w3id.org/skgo/pham#TargetingMethod9 -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#TargetingMethod9"/>
    


    <!-- https://w3id.org/skgo/pham#Targeting_multidrug_resistance_in_cancer -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#Targeting_multidrug_resistance_in_cancer">
        <rdf:type rdf:resource="http://ns.nature.com/terms/Publication"/>
        <rdf:type rdf:resource="http://purl.org/ontology/bibo/Article"/>
        <addressesStudy rdf:resource="https://w3id.org/skgo/pham#Drug_efflux_from_cancer_cells_mediated_by_ATP-binding_cassette_ABC_transporters"/>
        <terms1:publicationYear rdf:datatype="http://www.w3.org/2001/XMLSchema#gYear">2006</terms1:publicationYear>
        <bibo:abstract xml:lang="en">Effective treatment of metastatic cancers usually requires the use of toxic
chemotherapy. In most cases, multiple drugs are used, as resistance to single agents occurs almost universally. For this reason, elucidation of mechanisms that confer simultaneous resistance to different drugs with different targets and chemical structures — multidrug resistance — has been a major goal of cancer biologists during the past 35 years. Here, we review the most common of these mechanisms, one that relies on drug efflux from cancer cells mediated by ATP-binding cassette (ABC) transporters. We describe various approaches
to combating multidrug-resistant cancer, including the development of drugs that engage, evade or exploit efflux by ABC transporters.</bibo:abstract>
        <terms:creator rdf:resource="https://w3id.org/skgo/pham#Catherine_Booth-Genthe"/>
        <terms:creator rdf:resource="https://w3id.org/skgo/pham#Gergely_Szakács"/>
        <terms:creator rdf:resource="https://w3id.org/skgo/pham#Jill_K._Paterson"/>
        <terms:creator rdf:resource="https://w3id.org/skgo/pham#Joseph_A._Ludwig"/>
        <terms:creator rdf:resource="https://w3id.org/skgo/pham#Michael_M._Gottesman"/>
        <terms:publisher rdf:resource="https://w3id.org/ScienceOnto/phm#Publisher3"/>
        <terms:publisher rdf:resource="https://w3id.org/skgo/pham#Nature_Publishing_Group"/>
        <terms:title rdf:datatype="http://www.w3.org/2000/01/rdf-schema#Literal">Targeting multidrug resistance in cancer</terms:title>
    </owl:NamedIndividual>
    


    <!-- https://w3id.org/skgo/pham#Taurocholate -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#Taurocholate">
        <rdf:type rdf:resource="https://w3id.org/skgo/pham#Drug"/>
        <rdfs:label xml:lang="en">Taurocholate</rdfs:label>
    </owl:NamedIndividual>
    


    <!-- https://w3id.org/skgo/pham#Taxenes-paclitaxel_docetaxel -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#Taxenes-paclitaxel_docetaxel">
        <rdf:type rdf:resource="https://w3id.org/skgo/pham#Drug"/>
        <rdfs:label xml:lang="en">Taxenes-paclitaxel_docetaxel</rdfs:label>
    </owl:NamedIndividual>
    


    <!-- https://w3id.org/skgo/pham#Teniopside -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#Teniopside">
        <rdf:type rdf:resource="https://w3id.org/skgo/pham#Drug"/>
        <rdfs:label xml:lang="en">Teniopside</rdfs:label>
    </owl:NamedIndividual>
    


    <!-- https://w3id.org/skgo/pham#Testicular_cancer -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#Testicular_cancer">
        <rdf:type rdf:resource="https://w3id.org/skgo/pham#Disease"/>
        <rdfs:label xml:lang="en">Testicular_cancer</rdfs:label>
    </owl:NamedIndividual>
    


    <!-- https://w3id.org/skgo/pham#The_new_transporter_was_termed_the_breast_cancer_resistance_protein_BCRP -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#The_new_transporter_was_termed_the_breast_cancer_resistance_protein_BCRP">
        <rdf:type rdf:resource="https://w3id.org/skgo/pham#levels_of_mdr1_mRNA"/>
        <rdfs:label xml:lang="en">The_new_transporter_was_termed_the_breast_cancer_resistance_protein_BCRP</rdfs:label>
        <skos:definition xml:lang="en">The new transporter was
termed the breast cancer resistance protein (BCRP),
because of its identification in MCF-7 human breast
carcinoma cells.</skos:definition>
    </owl:NamedIndividual>
    


    <!-- https://w3id.org/skgo/pham#The_physiological_functions_and_structures_of_ABC_transporters -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#The_physiological_functions_and_structures_of_ABC_transporters">
        <rdf:type rdf:resource="https://w3id.org/skgo/pham#ClinicalStudy"/>
        <hasStudyDesign rdf:resource="https://w3id.org/skgo/pham#Review_Study"/>
        <investigate rdf:resource="https://w3id.org/skgo/pham#Breast_Cancer"/>
        <performsExperiment rdf:resource="https://w3id.org/skgo/pham#Endogenous_and_exogenous_substrates_for_ABC_transporters"/>
        <rdfs:label xml:lang="en">The_physiological_functions_and_structures_of_ABC_transporters</rdfs:label>
    </owl:NamedIndividual>
    


    <!-- https://w3id.org/skgo/pham#The_physiological_functions_and_structures_of_ABC_transporters_and_development_of_chemosensitizers -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#The_physiological_functions_and_structures_of_ABC_transporters_and_development_of_chemosensitizers">
        <rdf:type rdf:resource="https://w3id.org/skgo/pham#levels_of_mdr1_mRNA"/>
        <rdfs:label xml:lang="en">The_physiological_functions_and_structures_of_ABC_transporters_and_development_of_chemosensitizers</rdfs:label>
        <skos:definition xml:lang="en">The physiological functions and structures of ABC transporters, and
development of chemosensitizers are described focusing
on well-known proteins including Pgp, MRP, and BCRP.</skos:definition>
    </owl:NamedIndividual>
    


    <!-- https://w3id.org/skgo/pham#TissueLocalization1 -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#TissueLocalization1"/>
    


    <!-- https://w3id.org/skgo/pham#TissueLocalization10 -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#TissueLocalization10"/>
    


    <!-- https://w3id.org/skgo/pham#TissueLocalization11 -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#TissueLocalization11"/>
    


    <!-- https://w3id.org/skgo/pham#TissueLocalization12 -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#TissueLocalization12"/>
    


    <!-- https://w3id.org/skgo/pham#TissueLocalization13 -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#TissueLocalization13"/>
    


    <!-- https://w3id.org/skgo/pham#TissueLocalization14 -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#TissueLocalization14"/>
    


    <!-- https://w3id.org/skgo/pham#TissueLocalization15 -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#TissueLocalization15"/>
    


    <!-- https://w3id.org/skgo/pham#TissueLocalization16 -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#TissueLocalization16"/>
    


    <!-- https://w3id.org/skgo/pham#TissueLocalization17 -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#TissueLocalization17"/>
    


    <!-- https://w3id.org/skgo/pham#TissueLocalization18 -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#TissueLocalization18"/>
    


    <!-- https://w3id.org/skgo/pham#TissueLocalization19 -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#TissueLocalization19"/>
    


    <!-- https://w3id.org/skgo/pham#TissueLocalization2 -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#TissueLocalization2"/>
    


    <!-- https://w3id.org/skgo/pham#TissueLocalization20 -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#TissueLocalization20"/>
    


    <!-- https://w3id.org/skgo/pham#TissueLocalization3 -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#TissueLocalization3"/>
    


    <!-- https://w3id.org/skgo/pham#TissueLocalization4 -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#TissueLocalization4"/>
    


    <!-- https://w3id.org/skgo/pham#TissueLocalization5 -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#TissueLocalization5"/>
    


    <!-- https://w3id.org/skgo/pham#TissueLocalization6 -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#TissueLocalization6"/>
    


    <!-- https://w3id.org/skgo/pham#TissueLocalization7 -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#TissueLocalization7"/>
    


    <!-- https://w3id.org/skgo/pham#TissueLocalization8 -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#TissueLocalization8"/>
    


    <!-- https://w3id.org/skgo/pham#TissueLocalization9 -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#TissueLocalization9"/>
    


    <!-- https://w3id.org/skgo/pham#Tito_Fojo -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#Tito_Fojo">
        <rdf:type rdf:resource="http://xmlns.com/foaf/0.1/Person"/>
    </owl:NamedIndividual>
    


    <!-- https://w3id.org/skgo/pham#Topotecan -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#Topotecan">
        <rdf:type rdf:resource="https://w3id.org/skgo/pham#Drug"/>
        <rdfs:label xml:lang="en">Topotecan</rdfs:label>
    </owl:NamedIndividual>
    


    <!-- https://w3id.org/skgo/pham#Trastuzumab -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#Trastuzumab">
        <rdf:type rdf:resource="https://w3id.org/skgo/pham#Drug"/>
        <rdfs:label xml:lang="en">Trastuzumab</rdfs:label>
    </owl:NamedIndividual>
    


    <!-- https://w3id.org/skgo/pham#TreatmentOutcome1 -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#TreatmentOutcome1"/>
    


    <!-- https://w3id.org/skgo/pham#TreatmentOutcome10 -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#TreatmentOutcome10"/>
    


    <!-- https://w3id.org/skgo/pham#TreatmentOutcome11 -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#TreatmentOutcome11"/>
    


    <!-- https://w3id.org/skgo/pham#TreatmentOutcome12 -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#TreatmentOutcome12"/>
    


    <!-- https://w3id.org/skgo/pham#TreatmentOutcome13 -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#TreatmentOutcome13"/>
    


    <!-- https://w3id.org/skgo/pham#TreatmentOutcome14 -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#TreatmentOutcome14"/>
    


    <!-- https://w3id.org/skgo/pham#TreatmentOutcome15 -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#TreatmentOutcome15"/>
    


    <!-- https://w3id.org/skgo/pham#TreatmentOutcome16 -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#TreatmentOutcome16"/>
    


    <!-- https://w3id.org/skgo/pham#TreatmentOutcome17 -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#TreatmentOutcome17"/>
    


    <!-- https://w3id.org/skgo/pham#TreatmentOutcome18 -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#TreatmentOutcome18"/>
    


    <!-- https://w3id.org/skgo/pham#TreatmentOutcome19 -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#TreatmentOutcome19"/>
    


    <!-- https://w3id.org/skgo/pham#TreatmentOutcome2 -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#TreatmentOutcome2"/>
    


    <!-- https://w3id.org/skgo/pham#TreatmentOutcome20 -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#TreatmentOutcome20"/>
    


    <!-- https://w3id.org/skgo/pham#TreatmentOutcome3 -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#TreatmentOutcome3"/>
    


    <!-- https://w3id.org/skgo/pham#TreatmentOutcome4 -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#TreatmentOutcome4"/>
    


    <!-- https://w3id.org/skgo/pham#TreatmentOutcome5 -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#TreatmentOutcome5"/>
    


    <!-- https://w3id.org/skgo/pham#TreatmentOutcome6 -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#TreatmentOutcome6"/>
    


    <!-- https://w3id.org/skgo/pham#TreatmentOutcome7 -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#TreatmentOutcome7"/>
    


    <!-- https://w3id.org/skgo/pham#TreatmentOutcome8 -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#TreatmentOutcome8"/>
    


    <!-- https://w3id.org/skgo/pham#TreatmentOutcome9 -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#TreatmentOutcome9"/>
    


    <!-- https://w3id.org/skgo/pham#VAD -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#VAD">
        <rdf:type rdf:resource="https://w3id.org/skgo/pham#Drug"/>
        <rdfs:label xml:lang="en">VAD</rdfs:label>
    </owl:NamedIndividual>
    


    <!-- https://w3id.org/skgo/pham#Vemurafenib -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#Vemurafenib">
        <rdf:type rdf:resource="https://w3id.org/skgo/pham#Drug"/>
        <rdfs:label xml:lang="en">Vemurafenib</rdfs:label>
    </owl:NamedIndividual>
    


    <!-- https://w3id.org/skgo/pham#Verapamil -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#Verapamil">
        <rdf:type rdf:resource="https://w3id.org/skgo/pham#Drug"/>
        <rdfs:label xml:lang="en">Verapamil</rdfs:label>
    </owl:NamedIndividual>
    


    <!-- https://w3id.org/skgo/pham#Vesicle_transport_experiments -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#Vesicle_transport_experiments">
        <rdf:type rdf:resource="https://w3id.org/skgo/pham#Multidrug_resistance_to_cancer_cells"/>
        <hasTreatment rdf:resource="https://w3id.org/skgo/pham#Differential_inhibition_of_various_transporters_by_two_structurally_similar_MDR_modulators"/>
        <useDrug rdf:resource="https://w3id.org/skgo/pham#Daunomycin"/>
        <useProbe rdf:resource="https://w3id.org/skgo/pham#cDNA"/>
        <rdfs:label xml:lang="en">Vesicle_transport_experiments</rdfs:label>
    </owl:NamedIndividual>
    


    <!-- https://w3id.org/skgo/pham#Vincristine -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#Vincristine">
        <rdf:type rdf:resource="https://w3id.org/skgo/pham#Drug"/>
        <rdfs:label xml:lang="en">Vincristine</rdfs:label>
    </owl:NamedIndividual>
    


    <!-- https://w3id.org/skgo/pham#Vindesine -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#Vindesine">
        <rdf:type rdf:resource="https://w3id.org/skgo/pham#Drug"/>
        <rdfs:label xml:lang="en">Vindesine</rdfs:label>
    </owl:NamedIndividual>
    


    <!-- https://w3id.org/skgo/pham#WEIDONG_YANG -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#WEIDONG_YANG">
        <rdf:type rdf:resource="http://xmlns.com/foaf/0.1/Person"/>
    </owl:NamedIndividual>
    


    <!-- https://w3id.org/skgo/pham#Western_Blot_Analysis -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#Western_Blot_Analysis">
        <rdf:type rdf:resource="https://w3id.org/skgo/pham#WesternBlotting"/>
        <rdfs:label xml:lang="en">Western_Blot_Analysis</rdfs:label>
    </owl:NamedIndividual>
    


    <!-- https://w3id.org/skgo/pham#YONGMING_GAO -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#YONGMING_GAO">
        <rdf:type rdf:resource="http://xmlns.com/foaf/0.1/Person"/>
    </owl:NamedIndividual>
    


    <!-- https://w3id.org/skgo/pham#Yuya_Okui -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#Yuya_Okui">
        <rdf:type rdf:resource="http://xmlns.com/foaf/0.1/Person"/>
    </owl:NamedIndividual>
    


    <!-- https://w3id.org/skgo/pham#Zidovudine -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#Zidovudine">
        <rdf:type rdf:resource="https://w3id.org/skgo/pham#Drug"/>
        <rdfs:label xml:lang="en">Zidovudine</rdfs:label>
    </owl:NamedIndividual>
    


    <!-- https://w3id.org/skgo/pham#Zosuquidar -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#Zosuquidar">
        <rdf:type rdf:resource="https://w3id.org/skgo/pham#Drug"/>
        <rdfs:label xml:lang="en">Zosuquidar</rdfs:label>
    </owl:NamedIndividual>
    


    <!-- https://w3id.org/skgo/pham#Zosuquidar_AML_experiments -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#Zosuquidar_AML_experiments">
        <rdf:type rdf:resource="https://w3id.org/skgo/pham#Multidrug_resistance_to_cancer_cells"/>
        <hasExperimentMethod rdf:resource="https://w3id.org/skgo/pham#Comparative_CD34+_blast_responses_were_examined"/>
        <useCellLine rdf:resource="https://w3id.org/skgo/pham#CD34+_Leukemic_Blasts"/>
        <useDrug rdf:resource="https://w3id.org/skgo/pham#Zosuquidar"/>
        <useReagent rdf:resource="https://w3id.org/skgo/pham#DiOC2"/>
        <useReagent rdf:resource="https://w3id.org/skgo/pham#Fluorochrome-labeled_anti-CD_antibodies"/>
        <useSpecimen rdf:resource="https://w3id.org/skgo/pham#Bone_marrow_aspirates"/>
        <hasExperimentalResult xml:lang="en">50 AML specimens for MDR function
using zosuquidar, a P-gp-selective modulator, and two
ex vivo leukemic blast bioassays confirms the heterogeneous
nature of MDR efflux pump function by AML
blasts. Moreover, it supports the supposition that function
of multiple transporters could have circumvented
or obscured efficacy of P-gp modulators in AML clinical
trials like E3999 with zosuquidar.</hasExperimentalResult>
        <rdfs:label xml:lang="en">Zosuquidar_AML_experiments</rdfs:label>
    </owl:NamedIndividual>
    


    <!-- https://w3id.org/skgo/pham#antibody-mediated_cytolysis_experiment -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#antibody-mediated_cytolysis_experiment">
        <rdf:type rdf:resource="https://w3id.org/skgo/pham#Antibody-mediated_cytolysis_experiment"/>
        <hasTreatment rdf:resource="https://w3id.org/skgo/pham#Chemotherapy_with_targeted_inhibitors_of_Pgp-mediated_drug_transport"/>
        <useAssay rdf:resource="https://w3id.org/skgo/pham#Functional_Assay"/>
        <rdfs:label xml:lang="en">antibody-mediated_cytolysis_experiment</rdfs:label>
    </owl:NamedIndividual>
    


    <!-- https://w3id.org/skgo/pham#cDNA -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#cDNA">
        <rdf:type rdf:resource="https://w3id.org/skgo/pham#Probe"/>
        <rdfs:label xml:lang="en">cDNA</rdfs:label>
    </owl:NamedIndividual>
    


    <!-- https://w3id.org/skgo/pham#ex_vivo -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#ex_vivo">
        <rdf:type rdf:resource="https://w3id.org/skgo/pham#ex_vivo"/>
    </owl:NamedIndividual>
    


    <!-- https://w3id.org/skgo/pham#hasAssayMethod -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#hasAssayMethod">
        <foaf:name xml:lang="en">hasAssayMethod</foaf:name>
    </owl:NamedIndividual>
    


    <!-- https://w3id.org/skgo/pham#hasDrugEffects -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#hasDrugEffects">
        <foaf:name xml:lang="en">hasDrugEffects</foaf:name>
    </owl:NamedIndividual>
    


    <!-- https://w3id.org/skgo/pham#hasEligibilityCriteria -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#hasEligibilityCriteria">
        <foaf:name xml:lang="en">hasEligibilityCriteria</foaf:name>
    </owl:NamedIndividual>
    


    <!-- https://w3id.org/skgo/pham#hasExperimentalResult -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#hasExperimentalResult">
        <foaf:name xml:lang="en">hasExperimentalResult</foaf:name>
    </owl:NamedIndividual>
    


    <!-- https://w3id.org/skgo/pham#hasFindings -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#hasFindings">
        <foaf:name xml:lang="en">hasFindings</foaf:name>
    </owl:NamedIndividual>
    


    <!-- https://w3id.org/skgo/pham#hasMutationResult -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#hasMutationResult">
        <foaf:name xml:lang="en">hasMutationResult</foaf:name>
    </owl:NamedIndividual>
    


    <!-- https://w3id.org/skgo/pham#hasSuggestion -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#hasSuggestion">
        <foaf:name xml:lang="en">hasSuggestion</foaf:name>
    </owl:NamedIndividual>
    


    <!-- https://w3id.org/skgo/pham#hasTissueLocalization -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#hasTissueLocalization">
        <foaf:name xml:lang="en">hasTissueLocalization</foaf:name>
    </owl:NamedIndividual>
    


    <!-- https://w3id.org/skgo/pham#identify_and_overcome_underlying_mechanisms_of_resistance -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#identify_and_overcome_underlying_mechanisms_of_resistance">
        <rdf:type rdf:resource="https://w3id.org/skgo/pham#levels_of_mdr1_mRNA"/>
        <rdfs:label xml:lang="en">identify_and_overcome_underlying_mechanisms_of_resistance</rdfs:label>
        <skos:definition xml:lang="en">this Review focuses on the mechanisms that enable the survival of cancer
cells during drug treatment and on current research
efforts to identify and overcome underlying mechanisms
of resistance to both standard chemotherapeutic agents
and molecularly targeted therapies.</skos:definition>
    </owl:NamedIndividual>
    


    <!-- https://w3id.org/skgo/pham#in_silico -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#in_silico">
        <rdf:type rdf:resource="https://w3id.org/skgo/pham#in_silico"/>
    </owl:NamedIndividual>
    


    <!-- https://w3id.org/skgo/pham#in_vitro -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#in_vitro">
        <rdf:type rdf:resource="https://w3id.org/skgo/pham#in_vitro"/>
    </owl:NamedIndividual>
    


    <!-- https://w3id.org/skgo/pham#in_vivo -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#in_vivo">
        <rdf:type rdf:resource="https://w3id.org/skgo/pham#in_vivo"/>
    </owl:NamedIndividual>
    


    <!-- https://w3id.org/skgo/pham#inhibitors_NB-506_J-107088 -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#inhibitors_NB-506_J-107088">
        <rdf:type rdf:resource="https://w3id.org/skgo/pham#Drug"/>
        <rdfs:label xml:lang="en">inhibitors_NB-506_J-107088</rdfs:label>
    </owl:NamedIndividual>
    


    <!-- https://w3id.org/skgo/pham#mdr1 -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#mdr1">
        <rdf:type rdf:resource="https://w3id.org/skgo/pham#Gene"/>
        <rdfs:label xml:lang="en">MDR1</rdfs:label>
    </owl:NamedIndividual>
    


    <!-- https://w3id.org/skgo/pham#mdr1_gene_expression -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#mdr1_gene_expression">
        <rdf:type rdf:resource="https://w3id.org/skgo/pham#Multidrug_resistance_to_cancer_cells"/>
        <hasBlotAnalysis rdf:resource="https://w3id.org/skgo/pham#Slot_Blot_Analysis"/>
        <hasTreatment rdf:resource="https://w3id.org/skgo/pham#Cancer_chemotherapy_doxorubicin_vinblastine"/>
        <useCellLine rdf:resource="https://w3id.org/skgo/pham#CCL_127__PC12"/>
        <useCellLine rdf:resource="https://w3id.org/skgo/pham#Colon_carcinoma"/>
        <useCellLine rdf:resource="https://w3id.org/skgo/pham#HTB_10_HTB_11_HTB_38"/>
        <useCellLine rdf:resource="https://w3id.org/skgo/pham#KB-3-1_KB-8-5_KB-V1"/>
        <useDrug rdf:resource="https://w3id.org/skgo/pham#Actinomycin_D"/>
        <useDrug rdf:resource="https://w3id.org/skgo/pham#Doxorubicin"/>
        <useDrug rdf:resource="https://w3id.org/skgo/pham#Mitomycin_C"/>
        <useDrug rdf:resource="https://w3id.org/skgo/pham#Vincristine"/>
        <useGene rdf:resource="https://w3id.org/skgo/pham#mdr1"/>
        <useProbe rdf:resource="https://w3id.org/skgo/pham#cDNA"/>
        <hasExperimentalResult xml:lang="en">Expression of mdr1 in Tumors from Untreated and Treated Patients</hasExperimentalResult>
        <name xml:lang="en">Mdr1 Hybridization Probes, RNA Extraction, Electrophoresis</name>
        <rdfs:label xml:lang="en">mdr1_gene_expression</rdfs:label>
    </owl:NamedIndividual>
    


    <!-- https://w3id.org/skgo/pham#multidrug_resistance_to_cancer_cells -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#multidrug_resistance_to_cancer_cells">
        <rdf:type rdf:resource="https://w3id.org/skgo/pham#Multidrug_resistance_to_cancer_cells"/>
        <hasExperimentMethod rdf:resource="https://w3id.org/skgo/pham#ROLE_OF_ATP-DEPENDENT_TRANSPORTERS_in_chemotherapy_and_A_surrogate_assay_for_PGP_inhibition"/>
        <useCellLine rdf:resource="https://w3id.org/skgo/pham#CD56+"/>
        <useDrug rdf:resource="https://w3id.org/skgo/pham#Anthranilic-acid-based_drug"/>
        <useDrug rdf:resource="https://w3id.org/skgo/pham#Immunosuppressant_cyclosporin_A"/>
        <useDrug rdf:resource="https://w3id.org/skgo/pham#Mitoxantrone"/>
        <useDrug rdf:resource="https://w3id.org/skgo/pham#Paclitaxel"/>
        <useDrug rdf:resource="https://w3id.org/skgo/pham#Verapamil"/>
        <useGene rdf:resource="https://w3id.org/skgo/pham#ABCA2"/>
        <useGene rdf:resource="https://w3id.org/skgo/pham#MDR2"/>
        <useGene rdf:resource="https://w3id.org/skgo/pham#MRP1"/>
        <useGene rdf:resource="https://w3id.org/skgo/pham#MRP2"/>
        <useGene rdf:resource="https://w3id.org/skgo/pham#MRP3"/>
        <useGene rdf:resource="https://w3id.org/skgo/pham#MRP4"/>
        <useGene rdf:resource="https://w3id.org/skgo/pham#MRP5"/>
        <useGene rdf:resource="https://w3id.org/skgo/pham#MRP6"/>
        <name>Transfection Experiments</name>
        <rdfs:label xml:lang="en">multidrug_resistance_to_cancer_cells</rdfs:label>
    </owl:NamedIndividual>
    


    <!-- https://w3id.org/skgo/pham#topoisomerase_I -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#topoisomerase_I">
        <rdf:type rdf:resource="https://w3id.org/skgo/pham#Drug"/>
        <rdfs:label xml:lang="en">topoisomerase_I</rdfs:label>
    </owl:NamedIndividual>
    


    <!-- https://w3id.org/skgo/pham#useCellLine -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#useCellLine">
        <foaf:name xml:lang="en">useCellLine</foaf:name>
    </owl:NamedIndividual>
    


    <!-- https://w3id.org/skgo/pham#useDrug -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#useDrug">
        <foaf:name xml:lang="en">useDrug</foaf:name>
    </owl:NamedIndividual>
    


    <!-- https://w3id.org/skgo/pham#useGene -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#useGene">
        <foaf:name xml:lang="en">useGene</foaf:name>
    </owl:NamedIndividual>
    


    <!-- https://w3id.org/skgo/pham#useProbe -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#useProbe">
        <foaf:name xml:lang="en">useProbe</foaf:name>
    </owl:NamedIndividual>
    


    <!-- https://w3id.org/skgo/pham#useReagent -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#useReagent">
        <foaf:name xml:lang="en">useReagent</foaf:name>
    </owl:NamedIndividual>
    


    <!-- https://w3id.org/skgo/pham#useSpecimen -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#useSpecimen">
        <foaf:name xml:lang="en">Specimen that are used as material in experimental study.</foaf:name>
        <foaf:name xml:lang="en">useSpecimen</foaf:name>
    </owl:NamedIndividual>
    


    <!-- https://w3id.org/skgo/pham#useStatisticalAnalysis -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#useStatisticalAnalysis">
        <foaf:name xml:lang="en">useStatisticalAnalysis</foaf:name>
    </owl:NamedIndividual>
    


    <!-- https://w3id.org/skgo/pham#10_patients_with_acute_lymphocytic_leukemia -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#10_patients_with_acute_lymphocytic_leukemia">
        <rdf:type rdf:resource="https://w3id.org/skgo/pham#Patient"/>
        <hasDisease rdf:resource="https://w3id.org/skgo/pham#Leukaemia"/>
        <has_Treatment rdf:resource="https://w3id.org/skgo/pham#Cancer_chemotherapy_doxorubicin_vinblastine"/>
        <rdfs:label xml:lang="en">10_patients_with_acute_lymphocytic_leukemia</rdfs:label>
    </owl:NamedIndividual>
    


    <!-- https://w3id.org/skgo/pham#50_patients_with_newly_diagnosed_AML -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#50_patients_with_newly_diagnosed_AML">
        <rdf:type rdf:resource="https://w3id.org/skgo/pham#Patient"/>
        <hasDisease rdf:resource="https://w3id.org/skgo/pham#AML"/>
        <rdfs:label xml:lang="en">50_patients_with_newly_diagnosed_AML</rdfs:label>
    </owl:NamedIndividual>
    


    <!-- https://w3id.org/skgo/pham#795-bp_cDNA -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#795-bp_cDNA">
        <rdf:type rdf:resource="https://w3id.org/skgo/pham#Probe"/>
        <rdfs:label xml:lang="en">795-bp_cDNA</rdfs:label>
    </owl:NamedIndividual>
    


    <!-- https://w3id.org/skgo/pham#99mTc-labeled_compounds_were_exported_via_MRP2–4_and_BCRP -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#99mTc-labeled_compounds_were_exported_via_MRP2–4_and_BCRP">
        <rdf:type rdf:resource="https://w3id.org/skgo/pham#levels_of_mdr1_mRNA"/>
        <rdfs:label xml:lang="en">99mTc-labeled_compounds_were_exported_via_MRP2–4_and_BCRP</rdfs:label>
        <skos:definition xml:lang="en">We examinedwhether 99mTc-labeled compounds were
exported via MRP2–4 and BCRP and whether these compounds
had affinity for these transporters including MDR1
and MRP1 in cancer cells.</skos:definition>
    </owl:NamedIndividual>
    


    <!-- https://w3id.org/skgo/pham#ATP_dependent_xenobiotic_transporter_may_contribute_significantly_to_the_MCF-7/AdrVp_cells -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#ATP_dependent_xenobiotic_transporter_may_contribute_significantly_to_the_MCF-7/AdrVp_cells">
        <rdf:type rdf:resource="https://w3id.org/skgo/pham#levels_of_mdr1_mRNA"/>
        <terms:description>The hypothesis that an ATPdependent xenobiotic transporter may contribute significantly to the multidrug-resistance phenotype of MCF-7yAdrVp cells.</terms:description>
        <rdfs:label xml:lang="en">ATP_dependent_xenobiotic_transporter_may_contribute_significantly_to_the_MCF-7/AdrVp_cells</rdfs:label>
    </owl:NamedIndividual>
    


    <!-- https://w3id.org/skgo/pham#BCRP_substrate/inhibitors -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#BCRP_substrate/inhibitors">
        <rdf:type rdf:resource="https://w3id.org/skgo/pham#Multidrug_resistance_to_cancer_cells"/>
        <useDrug rdf:resource="https://w3id.org/skgo/pham#BBR3390"/>
        <useDrug rdf:resource="https://w3id.org/skgo/pham#CI1033"/>
        <useDrug rdf:resource="https://w3id.org/skgo/pham#Daunorubicin"/>
        <useDrug rdf:resource="https://w3id.org/skgo/pham#Doxorubicin"/>
        <useDrug rdf:resource="https://w3id.org/skgo/pham#Epirubicin"/>
        <useDrug rdf:resource="https://w3id.org/skgo/pham#Flavopiridol"/>
        <useDrug rdf:resource="https://w3id.org/skgo/pham#Iamivudine"/>
        <useDrug rdf:resource="https://w3id.org/skgo/pham#Idarubicinol"/>
        <useDrug rdf:resource="https://w3id.org/skgo/pham#Indolocarbazole"/>
        <useDrug rdf:resource="https://w3id.org/skgo/pham#Methotrexate"/>
        <useDrug rdf:resource="https://w3id.org/skgo/pham#Mitoxantrone"/>
        <useDrug rdf:resource="https://w3id.org/skgo/pham#Prazocin"/>
        <useDrug rdf:resource="https://w3id.org/skgo/pham#Topotecan"/>
        <useDrug rdf:resource="https://w3id.org/skgo/pham#Zidovudine"/>
        <useDrug rdf:resource="https://w3id.org/skgo/pham#topoisomerase_I"/>
        <rdfs:label xml:lang="en">BCRP_substrate/inhibitors</rdfs:label>
    </owl:NamedIndividual>
    


    <!-- https://w3id.org/skgo/pham#CAV/EP -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#CAV/EP">
        <rdf:type rdf:resource="https://w3id.org/skgo/pham#Drug"/>
        <rdfs:label xml:lang="en">CAV/EP</rdfs:label>
    </owl:NamedIndividual>
    


    <!-- https://w3id.org/skgo/pham#CD34+_Leukemic_Blasts -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#CD34+_Leukemic_Blasts">
        <rdf:type rdf:resource="https://w3id.org/skgo/pham#CellLine"/>
        <rdfs:label xml:lang="en">CD34+_Leukemic_Blasts</rdfs:label>
    </owl:NamedIndividual>
    


    <!-- https://w3id.org/skgo/pham#CD56+ -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#CD56+">
        <rdf:type rdf:resource="https://w3id.org/skgo/pham#CellLine"/>
        <rdfs:label xml:lang="en">CD56+</rdfs:label>
    </owl:NamedIndividual>
    


    <!-- https://w3id.org/skgo/pham#Comparative_CD34+_blast_responses_were_examined -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#Comparative_CD34+_blast_responses_were_examined">
        <rdf:type rdf:resource="https://w3id.org/skgo/pham#Antibody-mediated_cytolysis_experiment"/>
        <useAssay rdf:resource="https://w3id.org/skgo/pham#Accumulation_Bioassay"/>
        <useAssay rdf:resource="https://w3id.org/skgo/pham#Efflux_Bioassay"/>
        <useAssay rdf:resource="https://w3id.org/skgo/pham#Functional_Bioassay"/>
        <useStatisticalAnalysis rdf:resource="https://w3id.org/skgo/pham#Blast_populations_in_the_two_bioassays"/>
        <rdfs:label xml:lang="en">Comparative_CD34+_blast_responses_were_examined</rdfs:label>
    </owl:NamedIndividual>
    


    <!-- https://w3id.org/skgo/pham#Differentially_overexpressed_in_MCF-7/AdrVp_cells_compared_with_MCF-7_cells -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#Differentially_overexpressed_in_MCF-7/AdrVp_cells_compared_with_MCF-7_cells">
        <rdf:type rdf:resource="https://w3id.org/skgo/pham#ClinicalStudy"/>
        <investigate rdf:resource="https://w3id.org/skgo/pham#Breast_Cancer"/>
        <performsExperiment rdf:resource="https://w3id.org/skgo/pham#MCF-7/AdrVp_comparison"/>
        <terms1:name>A multidrug resistance transporter from human MCF-7 breast cancer cells</terms1:name>
        <hasSuggestion xml:lang="en">The presence of the phosphopantetheine attachment site on BCRP suggests
that BCRP may be part of a multiprotein complex.</hasSuggestion>
        <rdfs:label xml:lang="en">Differentially_overexpressed_in_MCF-7/AdrVp_cells_compared_with_MCF-7_cells</rdfs:label>
        <skos:definition xml:lang="en">MCF-7/AdrVp is a multidrug-resistant human
breast cancer subline that displays an ATP-dependent
reduction in the intracellular accumulation of anthracycline
anticancer drugs in the absence of overexpression of known
multidrug resistance transporters such as P glycoprotein or
the multidrug resistance protein.</skos:definition>
    </owl:NamedIndividual>
    


    <!-- https://w3id.org/skgo/pham#ERBB2‑amplified_breast_cancer_cell_lines -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#ERBB2‑amplified_breast_cancer_cell_lines">
        <rdf:type rdf:resource="https://w3id.org/skgo/pham#CellLine"/>
        <rdfs:label xml:lang="en">ERBB2_amplified_breast_cancer_cell_lines</rdfs:label>
    </owl:NamedIndividual>
    


    <!-- https://w3id.org/skgo/pham#MCF-7/AdrVp_comparison -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#MCF-7/AdrVp_comparison">
        <rdf:type rdf:resource="https://w3id.org/skgo/pham#Multidrug_resistance_to_cancer_cells"/>
        <hasExperimentKit rdf:resource="https://w3id.org/skgo/pham#Delta_RNA_Fingerprinting_kit"/>
        <hasExperimentMethod rdf:resource="https://w3id.org/skgo/pham#RNA_Fingerprinting"/>
        <useCellLine rdf:resource="https://w3id.org/skgo/pham#MCF-7_human_breast_carcinoma_cells"/>
        <useDrug rdf:resource="https://w3id.org/skgo/pham#Daunorubicin"/>
        <useDrug rdf:resource="https://w3id.org/skgo/pham#Doxorubicin"/>
        <useDrug rdf:resource="https://w3id.org/skgo/pham#Mitoxantrone"/>
        <useDrug rdf:resource="https://w3id.org/skgo/pham#Paclitaxel"/>
        <useDrug rdf:resource="https://w3id.org/skgo/pham#Vincristine"/>
        <useProbe rdf:resource="https://w3id.org/skgo/pham#795-bp_cDNA"/>
        <hasExperimentalResult xml:lang="en">Sensitivity of selected MCF-7 sublines to antineoplastic agents determined by sulforhodamine-B cytotoxicity assay (21). Experiments such as those
displayed in Figure 4D were used to obtain the LC50. For each drug and cell type, the table displays the median LC50 and range of LC50 measurements
(nM), the number of experimental determinations of LC50 that were performed (N), and the resistance factor (RF). The RF was calculated by
dividing the median LC50 for a given drug against a transfected cell line by the median LC50 of that drug against nontransfected MCF-7yW cells.
For each drug tested, the LC50 for the BCRP-transfected cells was examined for statistically significant difference from the LC50 of MCF-7yW or
MCF-7ypcDNA3 by the Mann–Whitney test, using MINITAB statistical software MINITAB release 8 extended, Minitab, State College, PA) and a 95%
confidence interval. The values of P for the statistically significant differences are as follows Mitoxantrone: MCF-7yW vs. MCF-7yBCRPclone6,
P 5 0.0107, MCF-7yW vs. MCF-7yBCRPclone8, P 5 0.0058, MCF-7ypcDNA3 vs. MCF-71BCRPclone6, P 5 0.0142, MCF-7ypcDNA3 vs.
MCF-7yBCRPclone8, P 5 0.0081; daunorubicin: MCF-7yW vs. MCF-7yBCRPclone6, P 5 0.0107, MCF-7yW vs. MCF-7yBCRPclone8, P 5
0.0058, MCF-7ypcDNA3 vs. MCF-7yBCRPclone6, P 5 0.0195, MCF-7ypcDNA3 vs. MCF-7yBCRPclone8, P 5 0.0163; doxorubicin: MCF-7yW
vs. MCF-7yBCRPclone6, P 5 0.0373, MCF-7yW vs. MCF-7yBCRPclone8, P 5 0.02, MCF-7ypcDNA3 vs. MCF-7yBCRPclone8, P 5 0.0304;
cis-platin: MCF-7yW vs. MCF-7yBCRPclone19, P 5 0.0497.</hasExperimentalResult>
        <rdfs:label xml:lang="en">MCF-7/AdrVp_comparison</rdfs:label>
    </owl:NamedIndividual>
    


    <!-- https://w3id.org/skgo/pham#MULTIDRUG_RESISTANCE_IN_CANCER:_ROLE_OF_ATP-DEPENDENT_TRANSPORTERS -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#MULTIDRUG_RESISTANCE_IN_CANCER:_ROLE_OF_ATP-DEPENDENT_TRANSPORTERS">
        <rdf:type rdf:resource="http://ns.nature.com/terms/Publication"/>
        <rdf:type rdf:resource="http://purl.org/ontology/bibo/Article"/>
        <addressesStudy rdf:resource="https://w3id.org/skgo/pham#ABC_transporters_in_human_cancers"/>
        <terms1:publicationYear rdf:datatype="http://www.w3.org/2001/XMLSchema#gYear">2002</terms1:publicationYear>
        <bibo:abstract>Chemotherapeutics are the most effective treatment for metastatic tumours. However, the ability of cancer cells to become simultaneously resistant to different drugs — a trait known as multidrug resistance — remains a significant impediment to successful chemotherapy. Three decades of multidrug-resistance research have identified a myriad of ways in which cancer cells can elude chemotherapy, and it has become apparent that resistance exists against every effective drug, even our newest agents. Therefore, the ability to predict and circumvent drug resistance is likely to improve chemotherapy.</bibo:abstract>
        <hasTitle xml:lang="en">MULTIDRUG RESISTANCE IN CANCER: ROLE OF ATP-DEPENDENT TRANSPORTERS</hasTitle>
        <terms:creator rdf:resource="https://w3id.org/skgo/pham#Michael_M._Gottesman"/>
        <terms:creator rdf:resource="https://w3id.org/skgo/pham#Susan_E._Bates"/>
        <terms:creator rdf:resource="https://w3id.org/skgo/pham#Tito_Fojo"/>
        <terms:publisher rdf:resource="https://w3id.org/skgo/pham#Macmillan_Magazines_Ltd"/>
        <terms:title rdf:datatype="http://www.w3.org/2000/01/rdf-schema#Literal">MULTIDRUG RESISTANCE IN CANCER: ROLE OF ATP-DEPENDENT TRANSPORTERS</terms:title>
    </owl:NamedIndividual>
    


    <!-- https://w3id.org/skgo/pham#PGP/MDR1 -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#PGP/MDR1">
        <rdf:type rdf:resource="https://w3id.org/skgo/pham#Gene"/>
        <rdfs:label xml:lang="en">PGP/MDR1</rdfs:label>
    </owl:NamedIndividual>
    


    <!-- https://w3id.org/skgo/pham#Springer_Science+Business_Media_LLC -->

    <owl:NamedIndividual rdf:about="https://w3id.org/skgo/pham#Springer_Science+Business_Media_LLC">
        <rdf:type rdf:resource="http://ns.nature.com/terms/Publisher"/>
    </owl:NamedIndividual>
    


    <!-- 
    ///////////////////////////////////////////////////////////////////////////////////////
    //
    // Annotations
    //
    ///////////////////////////////////////////////////////////////////////////////////////
     -->

    <rdf:Description rdf:about="http://purl.org/dc/terms/AgentClass">
        <terms:issued rdf:datatype="http://www.w3.org/2001/XMLSchema#date">2008-01-14</terms:issued>
        <rdfs:isDefinedBy rdf:resource="http://purl.org/dc/terms/"/>
        <rdfs:label xml:lang="en">Agent Class</rdfs:label>
        <terms:modified rdf:datatype="http://www.w3.org/2001/XMLSchema#date">2012-06-14</terms:modified>
        <rdfs:comment xml:lang="en">A group of agents.</rdfs:comment>
        <terms:description xml:lang="en">Examples of Agent Class include groups seen as classes, such as students, women, charities, lecturers.</terms:description>
        <terms:hasVersion rdf:resource="http://dublincore.org/usage/terms/history/#AgentClass-003"/>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.org/dc/terms/BibliographicResource">
        <rdfs:isDefinedBy rdf:resource="http://purl.org/dc/terms/"/>
        <terms:hasVersion rdf:resource="http://dublincore.org/usage/terms/history/#BibliographicResource-001"/>
        <rdfs:comment xml:lang="en">A book, article, or other documentary resource.</rdfs:comment>
        <rdfs:label xml:lang="en">Bibliographic Resource</rdfs:label>
        <terms:issued rdf:datatype="http://www.w3.org/2001/XMLSchema#date">2008-01-14</terms:issued>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.org/dc/terms/Box">
        <terms:issued rdf:datatype="http://www.w3.org/2001/XMLSchema#date">2000-07-11</terms:issued>
        <rdfs:comment xml:lang="en">The set of regions in space defined by their geographic coordinates according to the DCMI Box Encoding Scheme.</rdfs:comment>
        <rdfs:isDefinedBy rdf:resource="http://purl.org/dc/terms/"/>
        <rdfs:label xml:lang="en">DCMI Box</rdfs:label>
        <terms:modified rdf:datatype="http://www.w3.org/2001/XMLSchema#date">2008-01-14</terms:modified>
        <rdfs:seeAlso rdf:resource="http://dublincore.org/documents/dcmi-box/"/>
        <terms:hasVersion rdf:resource="http://dublincore.org/usage/terms/history/#Box-003"/>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.org/dc/terms/Frequency">
        <rdfs:label xml:lang="en">Frequency</rdfs:label>
        <terms:hasVersion rdf:resource="http://dublincore.org/usage/terms/history/#Frequency-001"/>
        <rdfs:isDefinedBy rdf:resource="http://purl.org/dc/terms/"/>
        <rdfs:comment xml:lang="en">A rate at which something recurs.</rdfs:comment>
        <terms:issued rdf:datatype="http://www.w3.org/2001/XMLSchema#date">2008-01-14</terms:issued>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.org/dc/terms/ISO3166">
        <rdfs:comment xml:lang="en">The set of codes listed in ISO 3166-1 for the representation of names of countries.</rdfs:comment>
        <terms:issued rdf:datatype="http://www.w3.org/2001/XMLSchema#date">2000-07-11</terms:issued>
        <terms:hasVersion rdf:resource="http://dublincore.org/usage/terms/history/#ISO3166-004"/>
        <rdfs:isDefinedBy rdf:resource="http://purl.org/dc/terms/"/>
        <terms:modified rdf:datatype="http://www.w3.org/2001/XMLSchema#date">2008-01-14</terms:modified>
        <rdfs:label xml:lang="en">ISO 3166</rdfs:label>
        <rdfs:seeAlso rdf:resource="http://www.iso.org/iso/en/prods-services/iso3166ma/02iso-3166-code-lists/list-en1.html"/>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.org/dc/terms/ISO639-2">
        <rdfs:seeAlso rdf:resource="http://lcweb.loc.gov/standards/iso639-2/langhome.html"/>
        <terms:modified rdf:datatype="http://www.w3.org/2001/XMLSchema#date">2008-01-14</terms:modified>
        <rdfs:comment xml:lang="en">The three-letter alphabetic codes listed in ISO639-2 for the representation of names of languages.</rdfs:comment>
        <terms:issued rdf:datatype="http://www.w3.org/2001/XMLSchema#date">2000-07-11</terms:issued>
        <rdfs:isDefinedBy rdf:resource="http://purl.org/dc/terms/"/>
        <rdfs:label xml:lang="en">ISO 639-2</rdfs:label>
        <terms:hasVersion rdf:resource="http://dublincore.org/usage/terms/history/#ISO639-2-003"/>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.org/dc/terms/ISO639-3">
        <rdfs:comment xml:lang="en">The set of three-letter codes listed in ISO 639-3 for the representation of names of languages.</rdfs:comment>
        <rdfs:label xml:lang="en">ISO 639-3</rdfs:label>
        <rdfs:isDefinedBy rdf:resource="http://purl.org/dc/terms/"/>
        <terms:issued rdf:datatype="http://www.w3.org/2001/XMLSchema#date">2008-01-14</terms:issued>
        <terms:hasVersion rdf:resource="http://dublincore.org/usage/terms/history/#ISO639-3-001"/>
        <rdfs:seeAlso rdf:resource="http://www.sil.org/iso639-3/"/>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.org/dc/terms/LicenseDocument">
        <rdfs:isDefinedBy rdf:resource="http://purl.org/dc/terms/"/>
        <rdfs:label xml:lang="en">License Document</rdfs:label>
        <terms:issued rdf:datatype="http://www.w3.org/2001/XMLSchema#date">2008-01-14</terms:issued>
        <rdfs:comment xml:lang="en">A legal document giving official permission to do something with a Resource.</rdfs:comment>
        <terms:hasVersion rdf:resource="http://dublincore.org/usage/terms/history/#LicenseDocument-001"/>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.org/dc/terms/LinguisticSystem">
        <terms:issued rdf:datatype="http://www.w3.org/2001/XMLSchema#date">2008-01-14</terms:issued>
        <terms:hasVersion rdf:resource="http://dublincore.org/usage/terms/history/#LinguisticSystem-001"/>
        <terms:description xml:lang="en">Examples include written, spoken, sign, and computer languages.</terms:description>
        <rdfs:isDefinedBy rdf:resource="http://purl.org/dc/terms/"/>
        <rdfs:comment xml:lang="en">A system of signs, symbols, sounds, gestures, or rules used in communication.</rdfs:comment>
        <rdfs:label xml:lang="en">Linguistic System</rdfs:label>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.org/dc/terms/MethodOfAccrual">
        <rdfs:comment xml:lang="en">A method by which resources are added to a collection.</rdfs:comment>
        <rdfs:isDefinedBy rdf:resource="http://purl.org/dc/terms/"/>
        <terms:hasVersion rdf:resource="http://dublincore.org/usage/terms/history/#MethodOfAccrual-001"/>
        <rdfs:label xml:lang="en">Method of Accrual</rdfs:label>
        <terms:issued rdf:datatype="http://www.w3.org/2001/XMLSchema#date">2008-01-14</terms:issued>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.org/dc/terms/MethodOfInstruction">
        <rdfs:label xml:lang="en">Method of Instruction</rdfs:label>
        <rdfs:comment xml:lang="en">A process that is used to engender knowledge, attitudes, and skills.</rdfs:comment>
        <rdfs:isDefinedBy rdf:resource="http://purl.org/dc/terms/"/>
        <terms:hasVersion rdf:resource="http://dublincore.org/usage/terms/history/#MethodOfInstruction-001"/>
        <terms:issued rdf:datatype="http://www.w3.org/2001/XMLSchema#date">2008-01-14</terms:issued>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.org/dc/terms/Period">
        <rdfs:seeAlso rdf:resource="http://dublincore.org/documents/dcmi-period/"/>
        <rdfs:comment xml:lang="en">The set of time intervals defined by their limits according to the DCMI Period Encoding Scheme.</rdfs:comment>
        <terms:modified rdf:datatype="http://www.w3.org/2001/XMLSchema#date">2008-01-14</terms:modified>
        <terms:issued rdf:datatype="http://www.w3.org/2001/XMLSchema#date">2000-07-11</terms:issued>
        <rdfs:label xml:lang="en">DCMI Period</rdfs:label>
        <rdfs:isDefinedBy rdf:resource="http://purl.org/dc/terms/"/>
        <terms:hasVersion rdf:resource="http://dublincore.org/usage/terms/history/#Period-003"/>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.org/dc/terms/PhysicalResource">
        <terms:issued rdf:datatype="http://www.w3.org/2001/XMLSchema#date">2008-01-14</terms:issued>
        <rdfs:isDefinedBy rdf:resource="http://purl.org/dc/terms/"/>
        <rdfs:comment xml:lang="en">A material thing.</rdfs:comment>
        <terms:hasVersion rdf:resource="http://dublincore.org/usage/terms/history/#PhysicalResource-001"/>
        <rdfs:label xml:lang="en">Physical Resource</rdfs:label>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.org/dc/terms/Point">
        <rdfs:comment xml:lang="en">The set of points in space defined by their geographic coordinates according to the DCMI Point Encoding Scheme.</rdfs:comment>
        <rdfs:label xml:lang="en">DCMI Point</rdfs:label>
        <terms:modified rdf:datatype="http://www.w3.org/2001/XMLSchema#date">2008-01-14</terms:modified>
        <terms:issued rdf:datatype="http://www.w3.org/2001/XMLSchema#date">2000-07-11</terms:issued>
        <terms:hasVersion rdf:resource="http://dublincore.org/usage/terms/history/#Point-003"/>
        <rdfs:seeAlso rdf:resource="http://dublincore.org/documents/dcmi-point/"/>
        <rdfs:isDefinedBy rdf:resource="http://purl.org/dc/terms/"/>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.org/dc/terms/Policy">
        <rdfs:label xml:lang="en">Policy</rdfs:label>
        <rdfs:isDefinedBy rdf:resource="http://purl.org/dc/terms/"/>
        <rdfs:comment xml:lang="en">A plan or course of action by an authority, intended to influence and determine decisions, actions, and other matters.</rdfs:comment>
        <terms:hasVersion rdf:resource="http://dublincore.org/usage/terms/history/#Policy-001"/>
        <terms:issued rdf:datatype="http://www.w3.org/2001/XMLSchema#date">2008-01-14</terms:issued>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.org/dc/terms/ProvenanceStatement">
        <rdfs:label xml:lang="en">Provenance Statement</rdfs:label>
        <rdfs:isDefinedBy rdf:resource="http://purl.org/dc/terms/"/>
        <terms:issued rdf:datatype="http://www.w3.org/2001/XMLSchema#date">2008-01-14</terms:issued>
        <terms:hasVersion rdf:resource="http://dublincore.org/usage/terms/history/#ProvenanceStatement-001"/>
        <rdfs:comment xml:lang="en">A statement of any changes in ownership and custody of a resource since its creation that are significant for its authenticity, integrity, and interpretation.</rdfs:comment>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.org/dc/terms/RFC1766">
        <rdfs:isDefinedBy rdf:resource="http://purl.org/dc/terms/"/>
        <terms:issued rdf:datatype="http://www.w3.org/2001/XMLSchema#date">2000-07-11</terms:issued>
        <terms:modified rdf:datatype="http://www.w3.org/2001/XMLSchema#date">2008-01-14</terms:modified>
        <terms:hasVersion rdf:resource="http://dublincore.org/usage/terms/history/#RFC1766-003"/>
        <rdfs:seeAlso rdf:resource="http://www.ietf.org/rfc/rfc1766.txt"/>
        <rdfs:comment xml:lang="en">The set of tags, constructed according to RFC 1766, for the identification of languages.</rdfs:comment>
        <rdfs:label xml:lang="en">RFC 1766</rdfs:label>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.org/dc/terms/RFC3066">
        <terms:issued rdf:datatype="http://www.w3.org/2001/XMLSchema#date">2002-07-13</terms:issued>
        <rdfs:label xml:lang="en">RFC 3066</rdfs:label>
        <rdfs:isDefinedBy rdf:resource="http://purl.org/dc/terms/"/>
        <terms:description xml:lang="en">RFC 3066 has been obsoleted by RFC 4646.</terms:description>
        <rdfs:comment xml:lang="en">The set of tags constructed according to RFC 3066 for the identification of languages.</rdfs:comment>
        <terms:modified rdf:datatype="http://www.w3.org/2001/XMLSchema#date">2008-01-14</terms:modified>
        <rdfs:seeAlso rdf:resource="http://www.ietf.org/rfc/rfc3066.txt"/>
        <terms:hasVersion rdf:resource="http://dublincore.org/usage/terms/history/#RFC3066-002"/>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.org/dc/terms/RFC4646">
        <terms:description xml:lang="en">RFC 4646 obsoletes RFC 3066.</terms:description>
        <terms:issued rdf:datatype="http://www.w3.org/2001/XMLSchema#date">2008-01-14</terms:issued>
        <terms:hasVersion rdf:resource="http://dublincore.org/usage/terms/history/#RFC4646-001"/>
        <rdfs:seeAlso rdf:resource="http://www.ietf.org/rfc/rfc4646.txt"/>
        <rdfs:isDefinedBy rdf:resource="http://purl.org/dc/terms/"/>
        <rdfs:label xml:lang="en">RFC 4646</rdfs:label>
        <rdfs:comment xml:lang="en">The set of tags constructed according to RFC 4646 for the identification of languages.</rdfs:comment>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.org/dc/terms/RFC5646">
        <terms:issued rdf:datatype="http://www.w3.org/2001/XMLSchema#date">2010-10-11</terms:issued>
        <rdfs:seeAlso rdf:resource="http://www.ietf.org/rfc/rfc5646.txt"/>
        <terms:hasVersion rdf:resource="http://dublincore.org/usage/terms/history/#RFC5646-001"/>
        <rdfs:comment xml:lang="en">The set of tags constructed according to RFC 5646 for the identification of languages.</rdfs:comment>
        <rdfs:label xml:lang="en">RFC 5646</rdfs:label>
        <terms:description xml:lang="en">RFC 5646 obsoletes RFC 4646.</terms:description>
        <rdfs:isDefinedBy rdf:resource="http://purl.org/dc/terms/"/>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.org/dc/terms/RightsStatement">
        <rdfs:label xml:lang="en">Rights Statement</rdfs:label>
        <rdfs:isDefinedBy rdf:resource="http://purl.org/dc/terms/"/>
        <rdfs:comment xml:lang="en">A statement about the intellectual property rights (IPR) held in or over a Resource, a legal document giving official permission to do something with a resource, or a statement about access rights.</rdfs:comment>
        <terms:issued rdf:datatype="http://www.w3.org/2001/XMLSchema#date">2008-01-14</terms:issued>
        <terms:hasVersion rdf:resource="http://dublincore.org/usage/terms/history/#RightsStatement-001"/>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.org/dc/terms/Standard">
        <rdfs:comment xml:lang="en">A basis for comparison; a reference point against which other things can be evaluated.</rdfs:comment>
        <rdfs:label xml:lang="en">Standard</rdfs:label>
        <rdfs:isDefinedBy rdf:resource="http://purl.org/dc/terms/"/>
        <terms:issued rdf:datatype="http://www.w3.org/2001/XMLSchema#date">2008-01-14</terms:issued>
        <terms:hasVersion rdf:resource="http://dublincore.org/usage/terms/history/#Standard-001"/>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.org/dc/terms/URI">
        <rdfs:isDefinedBy rdf:resource="http://purl.org/dc/terms/"/>
        <rdfs:comment xml:lang="en">The set of identifiers constructed according to the generic syntax for Uniform Resource Identifiers as specified by the Internet Engineering Task Force.</rdfs:comment>
        <terms:issued rdf:datatype="http://www.w3.org/2001/XMLSchema#date">2000-07-11</terms:issued>
        <rdfs:seeAlso rdf:resource="http://www.ietf.org/rfc/rfc3986.txt"/>
        <terms:hasVersion rdf:resource="http://dublincore.org/usage/terms/history/#URI-003"/>
        <rdfs:label xml:lang="en">URI</rdfs:label>
        <terms:modified rdf:datatype="http://www.w3.org/2001/XMLSchema#date">2008-01-14</terms:modified>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.org/dc/terms/W3CDTF">
        <rdfs:label xml:lang="en">W3C-DTF</rdfs:label>
        <rdfs:comment xml:lang="en">The set of dates and times constructed according to the W3C Date and Time Formats Specification.</rdfs:comment>
        <terms:hasVersion rdf:resource="http://dublincore.org/usage/terms/history/#W3CDTF-003"/>
        <rdfs:isDefinedBy rdf:resource="http://purl.org/dc/terms/"/>
        <terms:issued rdf:datatype="http://www.w3.org/2001/XMLSchema#date">2000-07-11</terms:issued>
        <rdfs:seeAlso rdf:resource="http://www.w3.org/TR/NOTE-datetime"/>
        <terms:modified rdf:datatype="http://www.w3.org/2001/XMLSchema#date">2008-01-14</terms:modified>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.org/dc/terms/abstract">
        <rdfs:label xml:lang="en">Abstract</rdfs:label>
        <terms:modified rdf:datatype="http://www.w3.org/2001/XMLSchema#date">2008-01-14</terms:modified>
        <terms:hasVersion rdf:resource="http://dublincore.org/usage/terms/history/#abstract-003"/>
        <terms:issued rdf:datatype="http://www.w3.org/2001/XMLSchema#date">2000-07-11</terms:issued>
        <rdfs:comment xml:lang="en">A summary of the resource.</rdfs:comment>
        <rdfs:isDefinedBy rdf:resource="http://purl.org/dc/terms/"/>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.org/dc/terms/alternative">
        <rdfs:comment xml:lang="en">An alternative name for the resource.</rdfs:comment>
        <rdfs:isDefinedBy rdf:resource="http://purl.org/dc/terms/"/>
        <terms:hasVersion rdf:resource="http://dublincore.org/usage/terms/history/#alternative-003"/>
        <dc:description xml:lang="en">An alternative name for the resource.</dc:description>
        <terms:modified rdf:datatype="http://www.w3.org/2001/XMLSchema#date">2010-10-11</terms:modified>
        <terms:description xml:lang="en">The distinction between titles and alternative titles is application-specific.</terms:description>
        <terms:issued rdf:datatype="http://www.w3.org/2001/XMLSchema#date">2000-07-11</terms:issued>
        <rdfs:label xml:lang="en">Alternative Title</rdfs:label>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.org/dc/terms/bibliographicCitation">
        <terms:modified rdf:datatype="http://www.w3.org/2001/XMLSchema#date">2008-01-14</terms:modified>
        <terms:description xml:lang="en">Recommended practice is to include sufficient bibliographic detail to identify the resource as unambiguously as possible.</terms:description>
        <rdfs:label xml:lang="en">Bibliographic Citation</rdfs:label>
        <terms:hasVersion rdf:resource="http://dublincore.org/usage/terms/history/#bibliographicCitation-002"/>
        <rdfs:comment xml:lang="en">A bibliographic reference for the resource.</rdfs:comment>
        <rdfs:isDefinedBy rdf:resource="http://purl.org/dc/terms/"/>
        <terms:issued rdf:datatype="http://www.w3.org/2001/XMLSchema#date">2003-02-15</terms:issued>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.org/dc/terms/contributor">
        <rdfs:comment xml:lang="en">An entity responsible for making contributions to the resource.</rdfs:comment>
        <terms:modified rdf:datatype="http://www.w3.org/2001/XMLSchema#date">2010-10-11</terms:modified>
        <rdfs:isDefinedBy rdf:resource="http://purl.org/dc/terms/"/>
        <terms:description xml:lang="en">Examples of a Contributor include a person, an organization, or a service.</terms:description>
        <terms:issued rdf:datatype="http://www.w3.org/2001/XMLSchema#date">2008-01-14</terms:issued>
        <terms:hasVersion rdf:resource="http://dublincore.org/usage/terms/history/#contributorT-001"/>
        <rdfs:label xml:lang="en">Contributor</rdfs:label>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.org/dc/terms/coverage">
        <rdfs:isDefinedBy rdf:resource="http://purl.org/dc/terms/"/>
        <rdfs:label xml:lang="en">Coverage</rdfs:label>
        <terms:description xml:lang="en">Spatial topic and spatial applicability may be a named place or a location specified by its geographic coordinates. Temporal topic may be a named period, date, or date range. A jurisdiction may be a named administrative entity or a geographic place to which the resource applies. Recommended best practice is to use a controlled vocabulary such as the Thesaurus of Geographic Names [TGN]. Where appropriate, named places or time periods can be used in preference to numeric identifiers such as sets of coordinates or date ranges.</terms:description>
        <terms:hasVersion rdf:resource="http://dublincore.org/usage/terms/history/#coverageT-001"/>
        <terms:issued rdf:datatype="http://www.w3.org/2001/XMLSchema#date">2008-01-14</terms:issued>
        <rdfs:comment xml:lang="en">The spatial or temporal topic of the resource, the spatial applicability of the resource, or the jurisdiction under which the resource is relevant.</rdfs:comment>
        <terms:modified rdf:datatype="http://www.w3.org/2001/XMLSchema#date">2008-01-14</terms:modified>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.org/dc/terms/creator">
        <rdfs:comment xml:lang="en">An entity primarily responsible for making the resource.</rdfs:comment>
        <terms:hasVersion rdf:resource="http://dublincore.org/usage/terms/history/#creatorT-002"/>
        <rdfs:isDefinedBy rdf:resource="http://purl.org/dc/terms/"/>
        <terms:modified rdf:datatype="http://www.w3.org/2001/XMLSchema#date">2010-10-11</terms:modified>
        <terms:issued rdf:datatype="http://www.w3.org/2001/XMLSchema#date">2008-01-14</terms:issued>
        <rdfs:label xml:lang="en">Creator</rdfs:label>
        <terms:description xml:lang="en">Examples of a Creator include a person, an organization, or a service.</terms:description>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.org/dc/terms/description">
        <terms:modified rdf:datatype="http://www.w3.org/2001/XMLSchema#date">2008-01-14</terms:modified>
        <rdfs:label xml:lang="en">Description</rdfs:label>
        <rdfs:isDefinedBy rdf:resource="http://purl.org/dc/terms/"/>
        <rdfs:comment xml:lang="en">An account of the resource.</rdfs:comment>
        <terms:hasVersion rdf:resource="http://dublincore.org/usage/terms/history/#descriptionT-001"/>
        <terms:issued rdf:datatype="http://www.w3.org/2001/XMLSchema#date">2008-01-14</terms:issued>
        <terms:description xml:lang="en">Description may include but is not limited to: an abstract, a table of contents, a graphical representation, or a free-text account of the resource.</terms:description>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.org/dc/terms/hasPart">
        <rdfs:isDefinedBy rdf:resource="http://purl.org/dc/terms/"/>
        <skos:note xml:lang="en">This term is intended to be used with non-literal values as defined in the DCMI Abstract Model (http://dublincore.org/documents/abstract-model/).  As of December 2007, the DCMI Usage Board is seeking a way to express this intention with a formal range declaration.</skos:note>
        <terms:issued rdf:datatype="http://www.w3.org/2001/XMLSchema#date">2000-07-11</terms:issued>
        <rdfs:label xml:lang="en">Has Part</rdfs:label>
        <terms:modified rdf:datatype="http://www.w3.org/2001/XMLSchema#date">2008-01-14</terms:modified>
        <rdfs:comment xml:lang="en">A related resource that is included either physically or logically in the described resource.</rdfs:comment>
        <terms:hasVersion rdf:resource="http://dublincore.org/usage/terms/history/#hasPart-003"/>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.org/dc/terms/identifier">
        <terms:hasVersion rdf:resource="http://dublincore.org/usage/terms/history/#identifierT-001"/>
        <rdfs:isDefinedBy rdf:resource="http://purl.org/dc/terms/"/>
        <terms:description xml:lang="en">Recommended best practice is to identify the resource by means of a string conforming to a formal identification system.</terms:description>
        <terms:modified rdf:datatype="http://www.w3.org/2001/XMLSchema#date">2008-01-14</terms:modified>
        <rdfs:comment xml:lang="en">An unambiguous reference to the resource within a given context.</rdfs:comment>
        <rdfs:label xml:lang="en">Identifier</rdfs:label>
        <terms:issued rdf:datatype="http://www.w3.org/2001/XMLSchema#date">2008-01-14</terms:issued>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.org/dc/terms/isPartOf">
        <terms:modified rdf:datatype="http://www.w3.org/2001/XMLSchema#date">2008-01-14</terms:modified>
        <rdfs:label xml:lang="en">Is Part Of</rdfs:label>
        <terms:hasVersion rdf:resource="http://dublincore.org/usage/terms/history/#isPartOf-003"/>
        <skos:note xml:lang="en">This term is intended to be used with non-literal values as defined in the DCMI Abstract Model (http://dublincore.org/documents/abstract-model/).  As of December 2007, the DCMI Usage Board is seeking a way to express this intention with a formal range declaration.</skos:note>
        <terms:issued rdf:datatype="http://www.w3.org/2001/XMLSchema#date">2000-07-11</terms:issued>
        <rdfs:isDefinedBy rdf:resource="http://purl.org/dc/terms/"/>
        <rdfs:comment xml:lang="en">A related resource in which the described resource is physically or logically included.</rdfs:comment>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.org/dc/terms/isReferencedBy">
        <rdfs:label xml:lang="en">Is Referenced By</rdfs:label>
        <rdfs:comment xml:lang="en">A related resource that references, cites, or otherwise points to the described resource.</rdfs:comment>
        <terms:modified rdf:datatype="http://www.w3.org/2001/XMLSchema#date">2008-01-14</terms:modified>
        <rdfs:isDefinedBy rdf:resource="http://purl.org/dc/terms/"/>
        <skos:note xml:lang="en">This term is intended to be used with non-literal values as defined in the DCMI Abstract Model (http://dublincore.org/documents/abstract-model/).  As of December 2007, the DCMI Usage Board is seeking a way to express this intention with a formal range declaration.</skos:note>
        <terms:issued rdf:datatype="http://www.w3.org/2001/XMLSchema#date">2000-07-11</terms:issued>
        <terms:hasVersion rdf:resource="http://dublincore.org/usage/terms/history/#isReferencedBy-003"/>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.org/dc/terms/isVersionOf">
        <rdfs:label xml:lang="en">Is Version Of</rdfs:label>
        <rdfs:isDefinedBy rdf:resource="http://purl.org/dc/terms/"/>
        <rdfs:comment xml:lang="en">A related resource of which the described resource is a version, edition, or adaptation.</rdfs:comment>
        <terms:issued rdf:datatype="http://www.w3.org/2001/XMLSchema#date">2000-07-11</terms:issued>
        <skos:note xml:lang="en">This term is intended to be used with non-literal values as defined in the DCMI Abstract Model (http://dublincore.org/documents/abstract-model/).  As of December 2007, the DCMI Usage Board is seeking a way to express this intention with a formal range declaration.</skos:note>
        <terms:hasVersion rdf:resource="http://dublincore.org/usage/terms/history/#isVersionOf-003"/>
        <terms:modified rdf:datatype="http://www.w3.org/2001/XMLSchema#date">2008-01-14</terms:modified>
        <terms:description xml:lang="en">Changes in version imply substantive changes in content rather than differences in format.</terms:description>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.org/dc/terms/language">
        <rdfs:label xml:lang="en">Language</rdfs:label>
        <terms:hasVersion rdf:resource="http://dublincore.org/usage/terms/history/#languageT-001"/>
        <terms:issued rdf:datatype="http://www.w3.org/2001/XMLSchema#date">2008-01-14</terms:issued>
        <terms:modified rdf:datatype="http://www.w3.org/2001/XMLSchema#date">2008-01-14</terms:modified>
        <rdfs:isDefinedBy rdf:resource="http://purl.org/dc/terms/"/>
        <terms:description xml:lang="en">Recommended best practice is to use a controlled vocabulary such as RFC 4646 [RFC4646].</terms:description>
        <rdfs:comment xml:lang="en">A language of the resource.</rdfs:comment>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.org/dc/terms/publisher">
        <terms:modified rdf:datatype="http://www.w3.org/2001/XMLSchema#date">2010-10-11</terms:modified>
        <terms:issued rdf:datatype="http://www.w3.org/2001/XMLSchema#date">2008-01-14</terms:issued>
        <rdfs:label xml:lang="en">Publisher</rdfs:label>
        <terms:description xml:lang="en">Examples of a Publisher include a person, an organization, or a service.</terms:description>
        <terms:hasVersion rdf:resource="http://dublincore.org/usage/terms/history/#publisherT-001"/>
        <rdfs:isDefinedBy rdf:resource="http://purl.org/dc/terms/"/>
        <dc:description xml:lang="en">An entity responsible for making the resource available.</dc:description>
        <rdfs:comment xml:lang="en">An entity responsible for making the resource available.</rdfs:comment>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.org/dc/terms/references">
        <rdfs:label xml:lang="en">References</rdfs:label>
        <rdfs:comment xml:lang="en">A related resource that is referenced, cited, or otherwise pointed to by the described resource.</rdfs:comment>
        <terms:modified rdf:datatype="http://www.w3.org/2001/XMLSchema#date">2008-01-14</terms:modified>
        <terms:issued rdf:datatype="http://www.w3.org/2001/XMLSchema#date">2000-07-11</terms:issued>
        <terms:hasVersion rdf:resource="http://dublincore.org/usage/terms/history/#references-003"/>
        <rdfs:isDefinedBy rdf:resource="http://purl.org/dc/terms/"/>
        <skos:note xml:lang="en">This term is intended to be used with non-literal values as defined in the DCMI Abstract Model (http://dublincore.org/documents/abstract-model/).  As of December 2007, the DCMI Usage Board is seeking a way to express this intention with a formal range declaration.</skos:note>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.org/dc/terms/relation">
        <terms:issued rdf:datatype="http://www.w3.org/2001/XMLSchema#date">2008-01-14</terms:issued>
        <skos:note xml:lang="en">This term is intended to be used with non-literal values as defined in the DCMI Abstract Model (http://dublincore.org/documents/abstract-model/).  As of December 2007, the DCMI Usage Board is seeking a way to express this intention with a formal range declaration.</skos:note>
        <rdfs:isDefinedBy rdf:resource="http://purl.org/dc/terms/"/>
        <terms:hasVersion rdf:resource="http://dublincore.org/usage/terms/history/#relationT-001"/>
        <rdfs:label xml:lang="en">Relation</rdfs:label>
        <rdfs:comment xml:lang="en">A related resource.</rdfs:comment>
        <terms:modified rdf:datatype="http://www.w3.org/2001/XMLSchema#date">2008-01-14</terms:modified>
        <terms:description xml:lang="en">Recommended best practice is to identify the related resource by means of a string conforming to a formal identification system.</terms:description>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.org/dc/terms/subject">
        <terms:modified rdf:datatype="http://www.w3.org/2001/XMLSchema#date">2012-06-14</terms:modified>
        <terms:hasVersion rdf:resource="http://dublincore.org/usage/terms/history/#subjectT-002"/>
        <skos:note xml:lang="en">This term is intended to be used with non-literal values as defined in the DCMI Abstract Model (http://dublincore.org/documents/abstract-model/).  As of December 2007, the DCMI Usage Board is seeking a way to express this intention with a formal range declaration.</skos:note>
        <terms:issued rdf:datatype="http://www.w3.org/2001/XMLSchema#date">2008-01-14</terms:issued>
        <rdfs:label xml:lang="en">Subject</rdfs:label>
        <rdfs:comment xml:lang="en">The topic of the resource.</rdfs:comment>
        <terms:description xml:lang="en">Typically, the subject will be represented using keywords, key phrases, or classification codes. Recommended best practice is to use a controlled vocabulary.</terms:description>
        <rdfs:isDefinedBy rdf:resource="http://purl.org/dc/terms/"/>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.org/dc/terms/title">
        <rdfs:label xml:lang="en">Title</rdfs:label>
        <dc:description xml:lang="en">A name given to the resource.</dc:description>
        <rdfs:comment xml:lang="en">A name given to the resource.</rdfs:comment>
        <terms:issued rdf:datatype="http://www.w3.org/2001/XMLSchema#date">2008-01-14</terms:issued>
        <terms:hasVersion rdf:resource="http://dublincore.org/usage/terms/history/#titleT-002"/>
        <rdfs:isDefinedBy rdf:resource="http://purl.org/dc/terms/"/>
        <terms:modified rdf:datatype="http://www.w3.org/2001/XMLSchema#date">2010-10-11</terms:modified>
    </rdf:Description>
    <rdf:Description rdf:about="http://purl.org/dc/terms/type">
        <rdfs:isDefinedBy rdf:resource="http://purl.org/dc/terms/"/>
        <terms:description xml:lang="en">Recommended best practice is to use a controlled vocabulary such as the DCMI Type Vocabulary [DCMITYPE]. To describe the file format, physical medium, or dimensions of the resource, use the Format element.</terms:description>
        <rdfs:comment xml:lang="en">The nature or genre of the resource.</rdfs:comment>
        <terms:modified rdf:datatype="http://www.w3.org/2001/XMLSchema#date">2008-01-14</terms:modified>
        <rdfs:label xml:lang="en">Type</rdfs:label>
        <terms:hasVersion rdf:resource="http://dublincore.org/usage/terms/history/#typeT-001"/>
        <terms:issued rdf:datatype="http://www.w3.org/2001/XMLSchema#date">2008-01-14</terms:issued>
    </rdf:Description>
    <rdf:Description rdf:about="https://w3id.org/skgo/pham#AssayKit">
        <dc:description xml:lang="en">The title of the kit/biologicals used in the assay.</dc:description>
        <rdfs:label xml:lang="en">AssayKit</rdfs:label>
    </rdf:Description>
    <rdf:Description rdf:about="https://w3id.org/skgo/pham#AssayMethod">
        <dc:description xml:lang="en">The methods required to perform typical screening assay. Assay methods include laboratory methods.</dc:description>
        <rdfs:label xml:lang="en">AssayMethod</rdfs:label>
    </rdf:Description>
    <rdf:Description rdf:about="https://w3id.org/skgo/pham#EasternBlotting">
        <rdfs:label xml:lang="en">EasternBlotting</rdfs:label>
        <dc:description xml:lang="en">The eastern blot is a biochemical technique used to analyze protein post translational modifications (PTM) including the addition of lipids, phosphates, and glycoconjugates.</dc:description>
        <rdfs:comment xml:lang="en">The eastern blot is a biochemical technique used to analyze protein post translational modifications (PTM) including the addition of lipids, phosphates, and glycoconjugates.</rdfs:comment>
    </rdf:Description>
    <rdf:Description rdf:about="https://w3id.org/skgo/pham#ExperimentalStudy">
        <dc:description xml:lang="en">Any Study conducted with a scientific approach, where a set of variables are kept constant while the other set of variables are being measured as the subject of experiment</dc:description>
        <rdfs:label xml:lang="en">ExperimentalStudy</rdfs:label>
    </rdf:Description>
    <rdf:Description rdf:about="https://w3id.org/skgo/pham#ObservationalStudy">
        <dc:description xml:lang="en">Observational studies are ones where researchers observe the effect of a risk factor, diagnostic test, treatment or other intervention without trying to change who is or isn&apos;t exposed to it.</dc:description>
        <rdfs:label xml:lang="en">ObservationalStudy</rdfs:label>
    </rdf:Description>
    <rdf:Description rdf:about="https://w3id.org/skgo/pham#StatisticalAnalysis">
        <dc:description xml:lang="en">Statistical methods involved in carrying out a study include planning, designing, collecting data, analysing, drawing meaningful interpretation and reporting of the research findings.</dc:description>
        <rdfs:label xml:lang="en">StatisticalAnalysis</rdfs:label>
    </rdf:Description>
    <rdf:Description rdf:about="https://w3id.org/skgo/pham#Study">
        <rdfs:label xml:lang="en">Study</rdfs:label>
        <dc:description xml:lang="en">A detailed investigation and analysis of a subject or situation.</dc:description>
    </rdf:Description>
    <rdf:Description rdf:about="https://w3id.org/skgo/pham#ex_vivo">
        <rdfs:label xml:lang="en">ex_vivo</rdfs:label>
        <dc:description xml:lang="en">Outside the living body; denoting removal of an organ (e.g., the kidney) for reparative surgery, after which it is returned to the original site.</dc:description>
    </rdf:Description>
    <rdf:Description rdf:about="https://w3id.org/skgo/pham#hasAssayMethod">
        <rdfs:comment xml:lang="en">Methods used in Assay.</rdfs:comment>
        <dc:description xml:lang="en">Methods used in Assay.</dc:description>
        <rdfs:label xml:lang="en">hasAssayMethod</rdfs:label>
    </rdf:Description>
    <rdf:Description rdf:about="https://w3id.org/skgo/pham#hasDrugEffects">
        <rdfs:label xml:lang="en">hasDrugEffects</rdfs:label>
        <dc:description xml:lang="en">The ability of a drug or treatment to produce a specific result.</dc:description>
    </rdf:Description>
    <rdf:Description rdf:about="https://w3id.org/skgo/pham#hasEligibilityCriteria">
        <rdfs:label xml:lang="en">hasEligibilityCriteria</rdfs:label>
        <dc:description xml:lang="en">Eligibility criteria for treatment studies often require that patients have a particular type and stage of disease.</dc:description>
    </rdf:Description>
    <rdf:Description rdf:about="https://w3id.org/skgo/pham#hasExperimentalResult">
        <dc:description xml:lang="en">Identification of Experimental results that are the set of facts and conclusions.</dc:description>
        <rdfs:label xml:lang="en">hasExperimentalResult</rdfs:label>
    </rdf:Description>
    <rdf:Description rdf:about="https://w3id.org/skgo/pham#hasFindings">
        <dc:description xml:lang="en">A conclusion reached after examination or investigation.</dc:description>
        <rdfs:label xml:lang="en">hasFindings</rdfs:label>
    </rdf:Description>
    <rdf:Description rdf:about="https://w3id.org/skgo/pham#hasMutationResult">
        <dc:description xml:lang="en">The result of an alteration or change, as in nature, form, or quality.</dc:description>
        <rdfs:label xml:lang="en">hasMutationResult</rdfs:label>
    </rdf:Description>
    <rdf:Description rdf:about="https://w3id.org/skgo/pham#hasSuggestion">
        <dc:description xml:lang="en">An idea is induced in or adopted by another without argument, command, or coercion.</dc:description>
        <rdfs:label xml:lang="en">hasSuggestion</rdfs:label>
    </rdf:Description>
    <rdf:Description rdf:about="https://w3id.org/skgo/pham#hasTissueLocalization">
        <dc:description xml:lang="en">A determination of the tissue place of proteins, genes.</dc:description>
        <rdfs:label xml:lang="en">hasTissueLocalization</rdfs:label>
    </rdf:Description>
    <rdf:Description rdf:about="https://w3id.org/skgo/pham#in_silico">
        <dc:description xml:lang="en">The mimicking or modeling of biological processes within computer hardware and software.</dc:description>
        <rdfs:label xml:lang="en">in_silico</rdfs:label>
    </rdf:Description>
    <rdf:Description rdf:about="https://w3id.org/skgo/pham#in_vitro">
        <dc:description xml:lang="en">In an artificial environment, referring to a process or reaction occurring therein, as in a test tube or culture media.</dc:description>
        <rdfs:label xml:lang="en">in_vitro</rdfs:label>
    </rdf:Description>
    <rdf:Description rdf:about="https://w3id.org/skgo/pham#in_vivo">
        <dc:description xml:lang="en">Biological processes or experiments occurring in the living organism.</dc:description>
        <rdfs:label xml:lang="en">in_vivo</rdfs:label>
    </rdf:Description>
    <rdf:Description rdf:about="https://w3id.org/skgo/pham#useCellLine">
        <dc:description xml:lang="en">Cell Lines  that are used as material in experimental study.</dc:description>
        <rdfs:label xml:lang="en">useCellLine</rdfs:label>
    </rdf:Description>
    <rdf:Description rdf:about="https://w3id.org/skgo/pham#useDrug">
        <rdfs:label xml:lang="en">useDrug</rdfs:label>
        <dc:description xml:lang="en">Drugs that are used as material in experimental study.</dc:description>
    </rdf:Description>
    <rdf:Description rdf:about="https://w3id.org/skgo/pham#useGene">
        <rdfs:label xml:lang="en">useGene</rdfs:label>
        <dc:description xml:lang="en">Genes that are used as material in experimental study.</dc:description>
    </rdf:Description>
    <rdf:Description rdf:about="https://w3id.org/skgo/pham#useProbe">
        <rdfs:label xml:lang="en">useProbe</rdfs:label>
        <dc:description xml:lang="en">Probes that are used as material in experimental study.</dc:description>
    </rdf:Description>
    <rdf:Description rdf:about="https://w3id.org/skgo/pham#useReagent">
        <rdfs:label xml:lang="en">useReagent</rdfs:label>
        <dc:description xml:lang="en">Reagents that are used as material in experimental study.</dc:description>
    </rdf:Description>
    <rdf:Description rdf:about="https://w3id.org/skgo/pham#useSpecimen">
        <dc:description xml:lang="en">Specimen that are used as material in experimental study.</dc:description>
        <rdfs:label xml:lang="en">useSpecimen</rdfs:label>
    </rdf:Description>
    <rdf:Description rdf:about="https://w3id.org/skgo/pham#useStatisticalAnalysis">
        <rdfs:label xml:lang="en">useStatisticalAnalysis</rdfs:label>
        <dc:description xml:lang="en">Study uses statistical analysis involves collecting and scrutinizing every data sample in a set of items from which samples can be drawn.</dc:description>
    </rdf:Description>
    


    <!-- 
    ///////////////////////////////////////////////////////////////////////////////////////
    //
    // General axioms
    //
    ///////////////////////////////////////////////////////////////////////////////////////
     -->

    <rdf:Description>
        <rdf:type rdf:resource="http://www.w3.org/2002/07/owl#AllDisjointClasses"/>
        <owl:members rdf:parseType="Collection">
            <rdf:Description rdf:about="https://w3id.org/skgo/pham#AssayKit"/>
            <rdf:Description rdf:about="https://w3id.org/skgo/pham#AssayMethod"/>
            <rdf:Description rdf:about="https://w3id.org/skgo/pham#CellLine"/>
            <rdf:Description rdf:about="https://w3id.org/skgo/pham#Chemical"/>
            <rdf:Description rdf:about="https://w3id.org/skgo/pham#Drug"/>
            <rdf:Description rdf:about="https://w3id.org/skgo/pham#EasternBlotting"/>
            <rdf:Description rdf:about="https://w3id.org/skgo/pham#ExperimentalStudy"/>
            <rdf:Description rdf:about="https://w3id.org/skgo/pham#Gene"/>
            <rdf:Description rdf:about="https://w3id.org/skgo/pham#NorthernBlotting"/>
            <rdf:Description rdf:about="https://w3id.org/skgo/pham#ObservationalStudy"/>
            <rdf:Description rdf:about="https://w3id.org/skgo/pham#Probe"/>
            <rdf:Description rdf:about="https://w3id.org/skgo/pham#Reagent"/>
            <rdf:Description rdf:about="https://w3id.org/skgo/pham#ReviewStudy"/>
            <rdf:Description rdf:about="https://w3id.org/skgo/pham#SouthernBlotting"/>
            <rdf:Description rdf:about="https://w3id.org/skgo/pham#WesternBlotting"/>
            <rdf:Description rdf:about="https://w3id.org/skgo/pham#ex_vivo"/>
            <rdf:Description rdf:about="https://w3id.org/skgo/pham#in_silico"/>
            <rdf:Description rdf:about="https://w3id.org/skgo/pham#in_vitro"/>
            <rdf:Description rdf:about="https://w3id.org/skgo/pham#in_vivo"/>
        </owl:members>
    </rdf:Description>
</rdf:RDF>



<!-- Generated by the OWL API (version 4.5.6.2018-09-06T00:27:41Z) https://github.com/owlcs/owlapi -->

